<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:fnuc="http://frontiernuclear.com/20251231"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fnuc-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-07-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_CashAndCashEquivalentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_ShortTermLoanReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:ShortTermLoanReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_ShortTermInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:ShortTermInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_LongTermLoanReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:LongTermLoanReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_LongTermInvestmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:LongTermInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_DueToOrFromRelatedPartiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:DueToOrFromRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_AccountsPayableAndAccruedLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:AccountsPayableAndAccruedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_LeaseLiablitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:LeaseLiablitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_DeferredliabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:DeferredliabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_LoanPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:LoanPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_DerivativeLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">fnuc:DerivativeLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_OtherLiabilities">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:FinancialAssetsAndFinancialLiabilitiesAxis">ifrs-full:OtherLiabilities</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_TIMEOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:TIMEOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_TIMEOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:TIMEOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TIMEOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:TIMEOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_MinglementSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:MinglementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_MinglementSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:MinglementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MinglementSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:MinglementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_AKHoldingsGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:AKHoldingsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_AKHoldingsGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:AKHoldingsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_AKHoldingsGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:AKHoldingsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_CV3GroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:CV3GroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_CV3GroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:CV3GroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_CV3GroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:CV3GroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_StarlinkCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:StarlinkCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_StarlinkCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:StarlinkCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StarlinkCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:StarlinkCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_SummitStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:SummitStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_SummitStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:SummitStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SummitStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:SummitStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-16_custom_TIMEOrganizationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:TIMEOrganizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-16</instant>
        </period>
    </context>
    <context id="AsOf2025-07-14_custom_MinglementSolutionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:MinglementSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-14</instant>
        </period>
    </context>
    <context id="AsOf2025-12-03_custom_AKHoldingsGroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:AKHoldingsGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-03</instant>
        </period>
    </context>
    <context id="AsOf2025-12-18_custom_CV3GroupMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:CV3GroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-18</instant>
        </period>
    </context>
    <context id="AsOf2025-12-22_custom_StarlinkCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:StarlinkCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-22</instant>
        </period>
    </context>
    <context id="AsOf2025-10-03_custom_SummitStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:SummitStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-03</instant>
        </period>
    </context>
    <context id="AsOf2025-10-30_custom_SummitStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:SummitStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-30</instant>
        </period>
    </context>
    <context id="AsOf2025-11-03_custom_SummitStrategiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:SummitStrategiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-03</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:TopEndEnergyLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:TopEndEnergyLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:TopEndEnergyLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:MontRoyalResourcesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:MontRoyalResourcesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:MontRoyalResourcesLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:DesertMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:DesertMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:DesertMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:US1CriticalMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:US1CriticalMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:US1CriticalMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:PinnacleMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:PinnacleMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:PinnacleMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:ResolutionMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:ResolutionMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:ResolutionMineralsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:ResolutionMineralsLtdOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:ResolutionMineralsLtdOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:ResolutionMineralsLtdOptionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_ShorttermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:ShorttermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-05-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-05-02</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:GlobalUraniumAndEnrichmentLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:GlobalUraniumAndEnrichmentLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:GlobalUraniumAndEnrichmentLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:AmericanUraniumLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:AmericanUraniumLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:AmericanUraniumLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:NuranWirelessIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:NuranWirelessIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:NuranWirelessIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_LongtermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LongtermContractsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ContractDurationAxis">ifrs-full:LongtermContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-04-16_custom_GlobalUraniumAndEnrichmentLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:GlobalUraniumAndEnrichmentLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-16</instant>
        </period>
    </context>
    <context id="AsOf2025-08-08_custom_AmericanUraniumLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:AmericanUraniumLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-08</instant>
        </period>
    </context>
    <context id="AsOf2025-08-29_custom_AmericanUraniumLimitedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:AmericanUraniumLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-29</instant>
        </period>
    </context>
    <context id="AsOf2025-12-22_custom_NuranWirelessIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">fnuc:NuranWirelessIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-22</instant>
        </period>
    </context>
    <context id="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">fnuc:KadmosEnergyServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-17</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_SettlementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:DerivativeLiabilities1Axis">fnuc:SettlementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_SettlementWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:DerivativeLiabilities1Axis">fnuc:SettlementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_AgentsWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:DerivativeLiabilities1Axis">fnuc:AgentsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_AgentsWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:DerivativeLiabilities1Axis">fnuc:AgentsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_OctagonWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:DerivativeLiabilities1Axis">fnuc:OctagonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-30</instant>
        </period>
    </context>
    <context id="AsOf2023-08-09_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-09</instant>
        </period>
    </context>
    <context id="AsOf2023-09-26_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-26</instant>
        </period>
    </context>
    <context id="AsOf2025-01-10_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-10</instant>
        </period>
    </context>
    <context id="AsOf2025-07-21_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-07-21</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2023-09-21</instant>
        </period>
    </context>
    <context id="AsOf2025-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-05-01</instant>
        </period>
    </context>
    <context id="AsOf2025-04-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-04-17</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ATMSalesAgreementWithThinkEquityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:ATMSalesAgreementWithThinkEquityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_ATMSalesAgreementWithThinkEquityLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:ATMSalesAgreementWithThinkEquityLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2024-08-07</instant>
        </period>
    </context>
    <context id="From2024-08-222024-10-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2024-08-22</startDate>
            <endDate>2024-10-18</endDate>
        </period>
    </context>
    <context id="AsOf2024-12-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2024-12-20</instant>
        </period>
    </context>
    <context id="From2024-12-012024-12-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-20</endDate>
        </period>
    </context>
    <context id="From2024-12-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-01-27</instant>
        </period>
    </context>
    <context id="From2025-01-012025-01-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-27</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2024-11-18</instant>
        </period>
    </context>
    <context id="AsOf2025-01-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-01-10</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_DebtSettlementTo10183923ManitobaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DebtSettlementTo10183923ManitobaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-02-28_custom_DebtSettlementTo10152300ManitobaLTDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DebtSettlementTo10152300ManitobaLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-28</instant>
        </period>
    </context>
    <context id="AsOf2025-03-12_custom_DebtSettlementTo10223254ManitobaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DebtSettlementTo10223254ManitobaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-12</instant>
        </period>
    </context>
    <context id="AsOf2025-03-13_custom_DebtSettlementTo10223778ManitobaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DebtSettlementTo10223778ManitobaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-13</instant>
        </period>
    </context>
    <context id="AsOf2025-03-12_custom_DebtSettlementTo10223778ManitobaLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DebtSettlementTo10223778ManitobaLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-12</instant>
        </period>
    </context>
    <context id="AsOf2025-01-10_custom_DirectorsAndCommitteeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DirectorsAndCommitteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-10</instant>
        </period>
    </context>
    <context id="AsOf2025-01-10_custom_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-10</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StockOptionsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-07-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-07-21</instant>
        </period>
    </context>
    <context id="From2025-07-212025-07-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <startDate>2025-07-21</startDate>
            <endDate>2025-07-21</endDate>
        </period>
    </context>
    <context id="AsOf2025-01-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
        </entity>
        <period>
            <instant>2025-01-09</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StockOptionsMember_custom_July172026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:July172026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_StockOptionsMember_custom_July172026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:July172026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StockOptionsMember_custom_November182026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:November182026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_StockOptionsMember_custom_November182026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:November182026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StockOptionsMember_custom_January302028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:January302028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_StockOptionsMember_custom_January302028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:January302028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_StockOptionsMember_custom_May242029Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:May242029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_StockOptionsMember_custom_May242029Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:May242029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">fnuc:StockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2024-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012025-06-30_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_March312026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:March312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_March312026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:March312026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_April12026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:April12026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_April12026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:April12026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_November192026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:November192026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_November192026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:November192026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_September212028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:September212028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_September212028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:StatementScenariosAxis">fnuc:September212028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_DirectorsAndOfficersConsultingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DirectorsAndOfficersConsultingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_DirectorsAndOfficersConsultingFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:DirectorsAndOfficersConsultingFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_custom_ExplorationAndEvaluationExpendituresMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:ExplorationAndEvaluationExpendituresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-07-012024-12-31_custom_ExplorationAndEvaluationExpendituresMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">fnuc:ExplorationAndEvaluationExpendituresMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-07-012025-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2026-02-012026-02-13_custom_SubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-13</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-13_custom_SubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-13</instant>
        </period>
    </context>
    <context id="From2026-02-242026-02-25_custom_SubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-24</startDate>
            <endDate>2026-02-25</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-25_custom_SubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-25</instant>
        </period>
    </context>
    <context id="AsOf2026-02-24_custom_SubsequentEventsMember_custom_TrancheOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:ShareIssuanceTrancheAxis">fnuc:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-24</instant>
        </period>
    </context>
    <context id="AsOf2026-02-25_custom_SubsequentEventsMember_custom_TrancheTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="fnuc:ShareIssuanceTrancheAxis">fnuc:TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-25</instant>
        </period>
    </context>
    <context id="AsOf2026-01-01_custom_SubsequentEventsMember_ifrs-full_RestrictedShareUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfAntidilutiveInstrumentsAxis">ifrs-full:RestrictedShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-01</instant>
        </period>
    </context>
    <context id="AsOf2026-06-30_custom_SubsequentEventsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001769697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">fnuc:SubsequentEventsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="CADPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="CAD">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:DocumentType contextRef="From2025-07-01to2025-12-31" id="Fact000021">6-K</dei:DocumentType>
    <dei:EntityFileNumber contextRef="From2025-07-01to2025-12-31" id="Fact000022">001-41085</dei:EntityFileNumber>
    <dei:AmendmentFlag contextRef="From2025-07-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="From2025-07-01to2025-12-31" id="Fact000004">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-07-01to2025-12-31" id="Fact000005">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2025-07-01to2025-12-31" id="Fact000006">2025</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-07-01to2025-12-31" id="Fact000007">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityRegistrantName contextRef="From2025-07-01to2025-12-31" id="Fact000008">Frontier Nuclear and Minerals Inc.</dei:EntityRegistrantName>
    <dei:DocumentType contextRef="From2025-07-01to2025-12-31" id="Fact000009">6-K</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="From2025-07-01to2025-12-31" id="Fact000010">0001769697</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="From2025-07-01to2025-12-31" id="xdx2ixbrl0023">Frontier Nuclear and Minerals Inc.</dei:EntityRegistrantName>
    <ifrs-full:NoncurrentLoansAndReceivables
      contextRef="AsOf2025-12-31"
      id="xdx2ixbrl0055"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0062"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0083"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LoanPayableCurrentPortion
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0086"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:OtherLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0095"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0101"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentPayables
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0104"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RealizedLossOnSaleOfShorttermInvestments
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0179"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:UnrealizedGainOnChangeOfFairValueOfInvestments
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0182"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShareOfLossOnInvestmentInJointVenture
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0185"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShareOfLossFromAssociate
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0188"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LossOnSharesForDebtSettlement
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0190"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:PremiumOnFlowThroughShares
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0196"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ReversalOnFlowthroughPremiumLiability
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0199"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:InterestIncomeOnDeposits
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0203"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0234"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0235"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0241"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0242"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IssuanceOfSharesPerAgreements
      contextRef="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0246"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IssuanceOfSharesPerAgreements
      contextRef="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0247"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IssuanceOfSharesPerOptionAgreements
      contextRef="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0253"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IssuanceOfSharesPerOptionAgreements
      contextRef="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0254"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0259"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0261"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0264"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0265"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2025-07-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0284"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2025-07-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0285"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-07-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0290"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-07-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0291"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0294"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-07-012025-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0296"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0299"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0300"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IssuanceOfWarrantsForClaimsSettlement
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0332"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InterestIncome
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0338"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:UnrealizedGainOnChangeOfFairValueOfInvestments
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0344"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RealizedLossOnSaleOfShorttermInvestment
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0347"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RealizedLossAndOnSaleOfShorttermInvestment
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0350"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:PremiumOnFlowThroughShares
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0355"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LossOnDebtSettlement
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0361"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:TaxesAndPenalties
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0364"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0368"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:PaymentOnRedemptionOfRestrictedShareUnits
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0401"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InvestmentsInJointVenture
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0416"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InvestmentsInAssociate
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0419"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InvestmentInShorttermLoansReceivable
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0422"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RepaymentsFromShorttermLoansReceivable
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0425"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:PurchasesOfShorttermInvestments
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0428"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ProceedsFromSaleOfShorttermInvestment
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0431"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:PurchasesOfLongtermInvestments
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0434"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="xdx2ixbrl0458"
      unitRef="CAD">-14954249</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="xdx2ixbrl0459"
      unitRef="CAD">-2357257</ifrs-full:ProfitLoss>
    <fnuc:CashFlowsFromUsedFromOperatingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="xdx2ixbrl0460"
      unitRef="CAD">-4443988</fnuc:CashFlowsFromUsedFromOperatingActivities>
    <fnuc:CashFlowsFromUsedFromOperatingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="xdx2ixbrl0461"
      unitRef="CAD">-2554578</fnuc:CashFlowsFromUsedFromOperatingActivities>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="xdx2ixbrl0462"
      unitRef="CAD">-57488275</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="xdx2ixbrl0463"
      unitRef="CAD">-42534026</ifrs-full:RetainedEarnings>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-012025-12-31_custom_TIMEOrganizationMember"
      id="xdx2ixbrl0625"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-012025-12-31_custom_TIMEOrganizationMember"
      id="xdx2ixbrl0629"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30_custom_MinglementSolutionsMember"
      id="xdx2ixbrl0634"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-012025-12-31_custom_MinglementSolutionsMember"
      id="xdx2ixbrl0636"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-012025-12-31_custom_MinglementSolutionsMember"
      id="xdx2ixbrl0637"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30_custom_AKHoldingsGroupMember"
      id="xdx2ixbrl0640"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-012025-12-31_custom_AKHoldingsGroupMember"
      id="xdx2ixbrl0642"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30_custom_CV3GroupMember"
      id="xdx2ixbrl0646"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-012025-12-31_custom_CV3GroupMember"
      id="xdx2ixbrl0648"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30_custom_StarlinkCapitalMember"
      id="xdx2ixbrl0652"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-012025-12-31_custom_StarlinkCapitalMember"
      id="xdx2ixbrl0654"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30_custom_SummitStrategiesMember"
      id="xdx2ixbrl0658"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-012025-12-31_custom_SummitStrategiesMember"
      id="xdx2ixbrl0660"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0700"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0707"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0714"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0716"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0717"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0721"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0723"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0724"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0726"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0728"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0730"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0731"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0739"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0741"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0742"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0743"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0746"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0747"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      id="xdx2ixbrl0748"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:AdditionsPerPropertyAgreements
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0768"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl0770"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:AmortizationExpenses
      contextRef="From2024-07-012024-12-31"
      id="xdx2ixbrl0821"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:AdditionsOnLongTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember"
      id="xdx2ixbrl0860"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember"
      id="xdx2ixbrl0865"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember"
      id="xdx2ixbrl0870"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0909"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0910"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:CashAndCashEquivalentsPaidForAcquisitionOfAssociate
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0913"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:AcquisitionsInvestmentsAccountedForUsingEquityMethod
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0916"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0919"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InvestmentsAccountedForUsingEquityMethod
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0922"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0934"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2024-06-30"
      id="xdx2ixbrl0935"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ProceedsFromBorrowings
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0938"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:InterestOnLoanAndDebentures
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0941"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ExchangeDifferencesOnTranslation
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl0944"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0947"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0949"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0951"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl0991"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ImpactOfForeignExchange
      contextRef="From2024-07-012025-06-30"
      id="xdx2ixbrl1008"
      unitRef="CAD"
      xsi:nil="true"/>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-06-30"
      id="xdx2ixbrl1010"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:FairValueOfDerivativeLiabilityOnDateOfIssuance
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl1020"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:FairValueChangesOfDerivativeLiabilityIncentiveWarrants
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl1026"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:FairValueChangesOfDerivativeLiabilityPerformanceWarrants
      contextRef="From2025-07-01to2025-12-31"
      id="xdx2ixbrl1035"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LiabilitiesArisingFromShareBasedPaymentTransactions
      contextRef="AsOf2025-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1081"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:LiabilitiesArisingFromShareBasedPaymentTransactions
      contextRef="AsOf2025-06-30_ifrs-full_RestrictedShareUnitsMember"
      id="xdx2ixbrl1094"
      unitRef="CAD"
      xsi:nil="true"/>
    <fnuc:ShareIssueCostsShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl1118"
      unitRef="Shares"
      xsi:nil="true"/>
    <fnuc:ShareIssueCostsShares
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl1150"
      unitRef="Shares"
      xsi:nil="true"/>
    <fnuc:NumberOfOctagonWarrantsIssued
      contextRef="From2025-07-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1309"
      unitRef="Shares"
      xsi:nil="true"/>
    <fnuc:NumberOfOctagonWarrantsIssuedPerShare
      contextRef="From2025-07-012025-12-31_ifrs-full_WarrantsMember"
      id="xdx2ixbrl1311"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="xdx2ixbrl1391"
      unitRef="CAD">-14954249</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="xdx2ixbrl1392"
      unitRef="CAD">-2357257</ifrs-full:ProfitLoss>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="CAD">16141406</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000032"
      unitRef="CAD">17829149</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentReceivablesFromSaleOfProperties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000034"
      unitRef="CAD">38348</ifrs-full:CurrentReceivablesFromSaleOfProperties>
    <ifrs-full:CurrentReceivablesFromSaleOfProperties
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000035"
      unitRef="CAD">81395</ifrs-full:CurrentReceivablesFromSaleOfProperties>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000037"
      unitRef="CAD">648751</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000038"
      unitRef="CAD">689127</ifrs-full:CurrentPrepaidExpenses>
    <fnuc:ShorttermLoanReceivable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000040"
      unitRef="CAD">29395726</fnuc:ShorttermLoanReceivable>
    <fnuc:ShorttermLoanReceivable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000041"
      unitRef="CAD">2046450</fnuc:ShorttermLoanReceivable>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000043"
      unitRef="CAD">3402202</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000044"
      unitRef="CAD">1660738</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000046"
      unitRef="CAD">49626433</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000047"
      unitRef="CAD">22306859</ifrs-full:CurrentAssets>
    <fnuc:ExplorationAndEvaluationAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000049"
      unitRef="CAD">35144640</fnuc:ExplorationAndEvaluationAssets>
    <fnuc:ExplorationAndEvaluationAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000050"
      unitRef="CAD">32980487</fnuc:ExplorationAndEvaluationAssets>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000052"
      unitRef="CAD">17925956</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:InvestmentsInJointVentures
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000053"
      unitRef="CAD">16505997</ifrs-full:InvestmentsInJointVentures>
    <ifrs-full:NoncurrentLoansAndReceivables
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000056"
      unitRef="CAD">1128932</ifrs-full:NoncurrentLoansAndReceivables>
    <fnuc:LongtermsInvestments
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000058"
      unitRef="CAD">10775746</fnuc:LongtermsInvestments>
    <fnuc:LongtermsInvestments
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000059"
      unitRef="CAD">5203071</fnuc:LongtermsInvestments>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000061"
      unitRef="CAD">12502120</ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000064"
      unitRef="CAD">1175832</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000065"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <ifrs-full:Assets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="CAD">127150727</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000068"
      unitRef="CAD">78125346</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000076"
      unitRef="CAD">1070155</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000077"
      unitRef="CAD">1646662</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000079"
      unitRef="CAD">111230</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000080"
      unitRef="CAD">127925</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000082"
      unitRef="CAD">267102</ifrs-full:CurrentLeaseLiabilities>
    <fnuc:LoanPayableCurrentPortion
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000085"
      unitRef="CAD">4111800</fnuc:LoanPayableCurrentPortion>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000088"
      unitRef="CAD">24796</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <ifrs-full:CurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000089"
      unitRef="CAD">111913</ifrs-full:CurrentDerivativeFinancialLiabilities>
    <fnuc:DeferredLiabilitiesCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000091"
      unitRef="CAD">5116125</fnuc:DeferredLiabilitiesCurrent>
    <fnuc:DeferredLiabilitiesCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000092"
      unitRef="CAD">5116125</fnuc:DeferredLiabilitiesCurrent>
    <ifrs-full:OtherLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000094"
      unitRef="CAD">12271871</ifrs-full:OtherLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000097"
      unitRef="CAD">22973079</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000098"
      unitRef="CAD">7002625</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000100"
      unitRef="CAD">959780</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000103"
      unitRef="CAD">5610068</ifrs-full:NoncurrentPayables>
    <fnuc:DeferredLiabilitiesNonCurrent
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000106"
      unitRef="CAD">5116125</fnuc:DeferredLiabilitiesNonCurrent>
    <fnuc:DeferredLiabilitiesNonCurrent
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000107"
      unitRef="CAD">5116125</fnuc:DeferredLiabilitiesNonCurrent>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000109"
      unitRef="CAD">34659052</ifrs-full:Liabilities>
    <ifrs-full:Liabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000110"
      unitRef="CAD">12118750</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000115"
      unitRef="CAD">147952639</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000116"
      unitRef="CAD">106536406</ifrs-full:IssuedCapital>
    <ifrs-full:CapitalRedemptionReserve
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000118"
      unitRef="CAD">2027311</ifrs-full:CapitalRedemptionReserve>
    <ifrs-full:CapitalRedemptionReserve
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000119"
      unitRef="CAD">2004216</ifrs-full:CapitalRedemptionReserve>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000121"
      unitRef="CAD">-57488275</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000122"
      unitRef="CAD">-42534026</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000124"
      unitRef="CAD">92491675</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000125"
      unitRef="CAD">66006596</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000127"
      unitRef="CAD">127150727</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000128"
      unitRef="CAD">78125346</ifrs-full:EquityAndLiabilities>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000133"
      unitRef="CAD">544029</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000134"
      unitRef="CAD">742559</ifrs-full:ProfessionalFeesExpense>
    <fnuc:ConsultingFees
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000136"
      unitRef="CAD">1969358</fnuc:ConsultingFees>
    <fnuc:ConsultingFees
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000137"
      unitRef="CAD">1055643</fnuc:ConsultingFees>
    <fnuc:StockBasedCompensation
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000139"
      unitRef="CAD">12338372</fnuc:StockBasedCompensation>
    <fnuc:StockBasedCompensation
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000140"
      unitRef="CAD">169066</fnuc:StockBasedCompensation>
    <fnuc:DirectorsAndOfficersConsultingFees
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000142"
      unitRef="CAD">509395</fnuc:DirectorsAndOfficersConsultingFees>
    <fnuc:DirectorsAndOfficersConsultingFees
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000143"
      unitRef="CAD">476499</fnuc:DirectorsAndOfficersConsultingFees>
    <ifrs-full:InsuranceServiceExpensesFromInsuranceContractsIssued
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000145"
      unitRef="CAD">141634</ifrs-full:InsuranceServiceExpensesFromInsuranceContractsIssued>
    <ifrs-full:InsuranceServiceExpensesFromInsuranceContractsIssued
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000146"
      unitRef="CAD">270570</ifrs-full:InsuranceServiceExpensesFromInsuranceContractsIssued>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000148"
      unitRef="CAD">485370</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000149"
      unitRef="CAD">790908</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:TravelExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000151"
      unitRef="CAD">312981</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000152"
      unitRef="CAD">166414</ifrs-full:TravelExpense>
    <ifrs-full:BrokerageFeeExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000154"
      unitRef="CAD">308686</ifrs-full:BrokerageFeeExpense>
    <ifrs-full:BrokerageFeeExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000155"
      unitRef="CAD">142080</ifrs-full:BrokerageFeeExpense>
    <fnuc:DepreciationOnRightofuseAssets
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000157"
      unitRef="CAD">90449</fnuc:DepreciationOnRightofuseAssets>
    <fnuc:DepreciationOnRightofuseAssets
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000158"
      unitRef="CAD">15840</fnuc:DepreciationOnRightofuseAssets>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000160"
      unitRef="CAD">35064</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000161"
      unitRef="CAD">4730</ifrs-full:BankAndSimilarCharges>
    <fnuc:AccretionExpenses1
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000163"
      unitRef="CAD">87798</fnuc:AccretionExpenses1>
    <fnuc:AccretionExpenses1
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000164"
      unitRef="CAD">1418</fnuc:AccretionExpenses1>
    <fnuc:InterestExpenses
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000166"
      unitRef="CAD">223775</fnuc:InterestExpenses>
    <fnuc:InterestExpenses
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000167"
      unitRef="CAD">397</fnuc:InterestExpenses>
    <ifrs-full:InterestExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000169"
      unitRef="CAD">-17046911</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000170"
      unitRef="CAD">-3836124</ifrs-full:InterestExpense>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000175"
      unitRef="CAD">87117</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives>
    <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000176"
      unitRef="CAD">-47412</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives>
    <fnuc:RealizedLossOnSaleOfShorttermInvestments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000178"
      unitRef="CAD">861340</fnuc:RealizedLossOnSaleOfShorttermInvestments>
    <fnuc:UnrealizedGainOnChangeOfFairValueOfInvestments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000181"
      unitRef="CAD">-1032644</fnuc:UnrealizedGainOnChangeOfFairValueOfInvestments>
    <fnuc:ShareOfLossOnInvestmentInJointVenture
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000184"
      unitRef="CAD">-82860</fnuc:ShareOfLossOnInvestmentInJointVenture>
    <fnuc:ShareOfLossFromAssociate
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000187"
      unitRef="CAD">28248</fnuc:ShareOfLossFromAssociate>
    <fnuc:LossOnSharesForDebtSettlement
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000191"
      unitRef="CAD">-98416</fnuc:LossOnSharesForDebtSettlement>
    <ifrs-full:IncomeFromFinesAndPenalties
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000193"
      unitRef="CAD">-24166</ifrs-full:IncomeFromFinesAndPenalties>
    <ifrs-full:IncomeFromFinesAndPenalties
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000194"
      unitRef="CAD">-800000</ifrs-full:IncomeFromFinesAndPenalties>
    <fnuc:PremiumOnFlowThroughShares
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000197"
      unitRef="CAD">2016543</fnuc:PremiumOnFlowThroughShares>
    <fnuc:ReversalOnFlowthroughPremiumLiability
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000200"
      unitRef="CAD">460974</fnuc:ReversalOnFlowthroughPremiumLiability>
    <ifrs-full:InterestIncomeOnDeposits
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000202"
      unitRef="CAD">365492</ifrs-full:InterestIncomeOnDeposits>
    <ifrs-full:ForeignExchangeLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000205"
      unitRef="CAD">-118657</ifrs-full:ForeignExchangeLoss>
    <ifrs-full:ForeignExchangeLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000206"
      unitRef="CAD">-52822</ifrs-full:ForeignExchangeLoss>
    <ifrs-full:OtherIncome
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000208"
      unitRef="CAD">2092662</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000209"
      unitRef="CAD">1478867</ifrs-full:OtherIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000211"
      unitRef="CAD">-14954249</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000212"
      unitRef="CAD">-2357257</ifrs-full:ComprehensiveIncome>
    <ifrs-full:WeightedAverageShares
      contextRef="From2025-07-01to2025-12-31"
      decimals="INF"
      id="Fact000217"
      unitRef="Shares">12417745</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2024-07-012024-12-31"
      decimals="INF"
      id="Fact000218"
      unitRef="Shares">2354785</ifrs-full:WeightedAverageShares>
    <fnuc:BasicAndDiluted
      contextRef="From2025-07-01to2025-12-31"
      decimals="INF"
      id="Fact000223"
      unitRef="CADPShares">-1.20</fnuc:BasicAndDiluted>
    <fnuc:BasicAndDiluted
      contextRef="From2024-07-012024-12-31"
      decimals="INF"
      id="Fact000224"
      unitRef="CADPShares">-1.00</fnuc:BasicAndDiluted>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000231"
      unitRef="Shares">1982003</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000226"
      unitRef="CAD">50127974</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000227"
      unitRef="CAD">1917719</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000228"
      unitRef="CAD">-26548238</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000229"
      unitRef="CAD">25497455</ifrs-full:Equity>
    <fnuc:IssuanceOfSharesOnDebtSettlementShares
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000238"
      unitRef="Shares">3663766</fnuc:IssuanceOfSharesOnDebtSettlementShares>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000233"
      unitRef="CAD">34941250</ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000236"
      unitRef="CAD">34941250</ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000240"
      unitRef="CAD">-8931771</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000243"
      unitRef="CAD">-8931771</ifrs-full:ShareIssueRelatedCost>
    <fnuc:IssuanceOfSharesPerAgreementsShares
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000250"
      unitRef="Shares">76923</fnuc:IssuanceOfSharesPerAgreementsShares>
    <fnuc:IssuanceOfSharesPerAgreements
      contextRef="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000245"
      unitRef="CAD">308924</fnuc:IssuanceOfSharesPerAgreements>
    <fnuc:IssuanceOfSharesPerAgreements
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000248"
      unitRef="CAD">308924</fnuc:IssuanceOfSharesPerAgreements>
    <fnuc:IssuanceOfSharesPerOptionAgreementsShares
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000257"
      unitRef="Shares">155730</fnuc:IssuanceOfSharesPerOptionAgreementsShares>
    <fnuc:IssuanceOfSharesPerOptionAgreements
      contextRef="From2024-07-012024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000252"
      unitRef="CAD">1490860</fnuc:IssuanceOfSharesPerOptionAgreements>
    <fnuc:IssuanceOfSharesPerOptionAgreements
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000255"
      unitRef="CAD">1490860</fnuc:IssuanceOfSharesPerOptionAgreements>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-07-012024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000260"
      unitRef="CAD">79617</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000262"
      unitRef="CAD">79617</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000266"
      unitRef="CAD">-2357257</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000267"
      unitRef="CAD">-2357257</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000274"
      unitRef="Shares">5878422</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000269"
      unitRef="CAD">77937237</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000270"
      unitRef="CAD">1997336</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000271"
      unitRef="CAD">-28905495</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000272"
      unitRef="CAD">51029078</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000281"
      unitRef="Shares">8748167</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000276"
      unitRef="CAD">106536406</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000277"
      unitRef="CAD">2004216</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000278"
      unitRef="CAD">-42534026</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000279"
      unitRef="CAD">66006596</ifrs-full:Equity>
    <fnuc:IssuanceOfSharesOnDebtSettlementShares
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000287"
      unitRef="Shares">6755183</fnuc:IssuanceOfSharesOnDebtSettlementShares>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000283"
      unitRef="CAD">50685642</ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries>
    <ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000286"
      unitRef="CAD">50685642</ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000289"
      unitRef="CAD">-9269409</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000292"
      unitRef="CAD">-9269409</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-07-012025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000295"
      unitRef="CAD">23095</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000297"
      unitRef="CAD">23095</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-012025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000301"
      unitRef="CAD">-14954249</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000302"
      unitRef="CAD">-14954249</ifrs-full:ProfitLoss>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact000309"
      unitRef="Shares">15503350</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact000304"
      unitRef="CAD">147952639</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="0"
      id="Fact000305"
      unitRef="CAD">2027311</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_RetainedEarningsMember"
      decimals="0"
      id="Fact000306"
      unitRef="CAD">-57488275</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000307"
      unitRef="CAD">92491675</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">18026269</ifrs-full:NumberOfSharesIssued>
    <fnuc:NumberOfSharesHeldBySubsidiariesOrAssociates
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000313"
      unitRef="Shares">-2500000</fnuc:NumberOfSharesHeldBySubsidiariesOrAssociates>
    <fnuc:NumberOfTreasuryShares
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000315"
      unitRef="Shares">-22919</fnuc:NumberOfTreasuryShares>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact000316"
      unitRef="Shares">15503350</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:ProfitLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000322"
      unitRef="CAD">-14954249</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000323"
      unitRef="CAD">-2357257</ifrs-full:ProfitLoss>
    <fnuc:DepreciationOnRightofuseAssets
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000328"
      unitRef="CAD">90449</fnuc:DepreciationOnRightofuseAssets>
    <fnuc:DepreciationOnRightofuseAssets
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000329"
      unitRef="CAD">15840</fnuc:DepreciationOnRightofuseAssets>
    <fnuc:IssuanceOfWarrantsForClaimsSettlement
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000331"
      unitRef="CAD">223775</fnuc:IssuanceOfWarrantsForClaimsSettlement>
    <fnuc:AccretionExpenses
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000334"
      unitRef="CAD">87798</fnuc:AccretionExpenses>
    <fnuc:AccretionExpenses
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000335"
      unitRef="CAD">1418</fnuc:AccretionExpenses>
    <fnuc:InterestIncome
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000337"
      unitRef="CAD">-365492</fnuc:InterestIncome>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000340"
      unitRef="CAD">-87117</ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000341"
      unitRef="CAD">47412</ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss>
    <fnuc:UnrealizedGainOnChangeOfFairValueOfInvestments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000343"
      unitRef="CAD">-1032644</fnuc:UnrealizedGainOnChangeOfFairValueOfInvestments>
    <fnuc:RealizedLossOnSaleOfShorttermInvestment
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000346"
      unitRef="CAD">-861340</fnuc:RealizedLossOnSaleOfShorttermInvestment>
    <fnuc:RealizedLossAndOnSaleOfShorttermInvestment
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000349"
      unitRef="CAD">82860</fnuc:RealizedLossAndOnSaleOfShorttermInvestment>
    <fnuc:ShareOfLossFromAssociate
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000352"
      unitRef="CAD">28248</fnuc:ShareOfLossFromAssociate>
    <fnuc:PremiumOnFlowThroughShares
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000356"
      unitRef="CAD">2016543</fnuc:PremiumOnFlowThroughShares>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000358"
      unitRef="CAD">12338372</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000359"
      unitRef="CAD">169066</ifrs-full:AdjustmentsForSharebasedPayments>
    <fnuc:LossOnDebtSettlement
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000362"
      unitRef="CAD">98416</fnuc:LossOnDebtSettlement>
    <fnuc:TaxesAndPenalties
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000365"
      unitRef="CAD">339026</fnuc:TaxesAndPenalties>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000367"
      unitRef="CAD">-15134</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000370"
      unitRef="CAD">-4464474</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000371"
      unitRef="CAD">-3702622</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000376"
      unitRef="CAD">-43047</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000377"
      unitRef="CAD">154763</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000379"
      unitRef="CAD">40376</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000380"
      unitRef="CAD">-665353</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000382"
      unitRef="CAD">-46242</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000383"
      unitRef="CAD">1936615</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000385"
      unitRef="CAD">-16695</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000386"
      unitRef="CAD">31545</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <fnuc:CashFlowsFromUsedFromOperatingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000388"
      unitRef="CAD">-4443988</fnuc:CashFlowsFromUsedFromOperatingActivities>
    <fnuc:CashFlowsFromUsedFromOperatingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000389"
      unitRef="CAD">-2554578</fnuc:CashFlowsFromUsedFromOperatingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000394"
      unitRef="CAD">50685642</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000395"
      unitRef="CAD">34941250</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000397"
      unitRef="CAD">9917786</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000398"
      unitRef="CAD">2744501</ifrs-full:PaymentsForShareIssueCosts>
    <fnuc:PaymentOnRedemptionOfRestrictedShareUnits
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000400"
      unitRef="CAD">-54779</fnuc:PaymentOnRedemptionOfRestrictedShareUnits>
    <fnuc:LeasePayments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000403"
      unitRef="CAD">-133298</fnuc:LeasePayments>
    <fnuc:LeasePayments
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000404"
      unitRef="CAD">-17913</fnuc:LeasePayments>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000406"
      unitRef="CAD">40579779</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000407"
      unitRef="CAD">32178836</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000412"
      unitRef="CAD">2046041</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000413"
      unitRef="CAD">3755065</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <fnuc:InvestmentsInJointVenture
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000415"
      unitRef="CAD">-1502819</fnuc:InvestmentsInJointVenture>
    <fnuc:InvestmentsInAssociate
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000418"
      unitRef="CAD">-2810864</fnuc:InvestmentsInAssociate>
    <fnuc:InvestmentInShorttermLoansReceivable
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000421"
      unitRef="CAD">-28026040</fnuc:InvestmentInShorttermLoansReceivable>
    <fnuc:RepaymentsFromShorttermLoansReceivable
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000424"
      unitRef="CAD">577023</fnuc:RepaymentsFromShorttermLoansReceivable>
    <fnuc:PurchasesOfShorttermInvestments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000427"
      unitRef="CAD">-1976088</fnuc:PurchasesOfShorttermInvestments>
    <fnuc:ProceedsFromSaleOfShorttermInvestment
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000430"
      unitRef="CAD">2879361</fnuc:ProceedsFromSaleOfShorttermInvestment>
    <fnuc:PurchasesOfLongtermInvestments
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000433"
      unitRef="CAD">-4918066</fnuc:PurchasesOfLongtermInvestments>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000436"
      unitRef="CAD">-37823534</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000437"
      unitRef="CAD">-3755065</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000439"
      unitRef="CAD">-1687743</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000440"
      unitRef="CAD">25869193</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000442"
      unitRef="CAD">17829149</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000443"
      unitRef="CAD">2526957</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000445"
      unitRef="CAD">16141406</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact000446"
      unitRef="CAD">28396150</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000451"
      unitRef="CAD">278472</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000452"
      unitRef="CAD">463372</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherOperatingPayables>
    <fnuc:ShareIssuanceCostsInAccountsPayable
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000454"
      unitRef="CAD">13706</fnuc:ShareIssuanceCostsInAccountsPayable>
    <fnuc:ShareIssuanceCostsInAccountsPayable
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000455"
      unitRef="CAD">6187270</fnuc:ShareIssuanceCostsInAccountsPayable>
    <ifrs-full:DisclosureOfGoingConcernExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000457">&lt;p id="xdx_809_eifrs-full--DisclosureOfGoingConcernExplanatory_z4xrdzXvkf26" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;1.&lt;/td&gt;&lt;td&gt;&lt;span id="xdx_821_zWzmADf1HlK9"&gt;Nature of Operations and Going Concern&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Frontier Nuclear and Minerals Inc. (Formerly
Snow Lake Resources Ltd.) (&#x201c;Frontier&#x201d; or the &#x201c;Company&#x201d;) was incorporated&lt;span style="background-color: white"&gt;&#160;in
the Province of Manitoba, Canada under the Corporations Act (Manitoba)&lt;/span&gt; on May 25, 2018. The Company is a nuclear fuel cycle
company and is focused on advancing a strategy to build a focused U.S. nuclear fuel cycle platform with exposure to uranium resources
and select downstream technologies. The corporate and registered office of the Company is 360 Main St, 30&lt;sup&gt;th&lt;/sup&gt; Floor, Winnipeg,
Manitoba, R3C 4G1, Canada.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 22, 2021, the Company was listed
for trading under the NASDAQ Composite. Effective March 16, 2026, the Company changed its legal name from Snow Lake Resources Ltd.
to Frontier Nuclear and Minerals Inc. and its Nasdaq trading symbol from &#x2018;LITM&#x2019; to &#x2018;FNUC&#x2019;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;For the six months ended December 31, 2025,
the Company incurred a net loss of $&lt;span id="xdx_90F_eifrs-full--ProfitLoss_dxL_c20250701__20251231_z5cvLasW7lOb" title="::XDX::-14954249"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0458"&gt;14,954,249&lt;/span&gt;&lt;/span&gt; (2024 &#x2013; $&lt;span id="xdx_904_eifrs-full--ProfitLoss_dxL_c20240701__20241231_zupPiiwlRir2" title="::XDX::-2357257"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0459"&gt;2,357,257&lt;/span&gt;&lt;/span&gt;), had negative cash flow from operations of $&lt;span id="xdx_908_ecustom--CashFlowsFromUsedFromOperatingActivities_dxL_c20250701__20251231_z8dBZPokFqs9" title="::XDX::-4443988"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0460"&gt;4,443,988&lt;/span&gt;&lt;/span&gt;
(2024 &#x2013; $&lt;span id="xdx_900_ecustom--CashFlowsFromUsedFromOperatingActivities_dxL_c20240701__20241231_zwg6ozBIGLud" title="::XDX::-2554578"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0461"&gt;2,554,578&lt;/span&gt;&lt;/span&gt;), and as &lt;span style="color: windowtext"&gt;at December 31, 2025, the Company had an accumulated deficit
of $&lt;span id="xdx_903_eifrs-full--RetainedEarnings_iI_dxL_uCAD_c20251231_zSUGygMsXmv3" title="::XDX::-57488275"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0462"&gt;57,488,275&lt;/span&gt;&lt;/span&gt; (June 30, 2025 &#x2013; $&lt;span id="xdx_90F_eifrs-full--RetainedEarnings_iI_dxL_uCAD_c20250630_zRUASVSPrzMk" title="::XDX::-42534026"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0463"&gt;42,534,026&lt;/span&gt;&lt;/span&gt;). &lt;/span&gt;The Company has no source of operating cash flow. The Company&#x2019;s
ability to continue as a going concern is dependent upon the Company achieving profitable operations to generate sufficient cash
flows to fund continuing operations, or, in the absence of adequate cash flows from operations, obtaining additional financing
to support operations for the foreseeable future. It is not possible to predict whether financing efforts will be successful or
if the Company will attain profitable levels of operations. These conditions, and the unpredictability of the mining business,
represent material uncertainties which may cast significant doubt upon the Company&#x2019;s ability to continue as a going concern.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These unaudited condensed interim consolidated
financial statements have been prepared on the basis that the Company will continue as a going concern, and do not reflect the
adjustments to the carrying values of assets and liabilities and the reported revenues and expenses, and classifications of statements
of financial position that would be necessary if the Company were unable to realize its assets and settle its liabilities as a
going concern in the normal course of operations. Such adjustments could be material.&lt;/p&gt;

</ifrs-full:DisclosureOfGoingConcernExplanatory>
    <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000465">&lt;p id="xdx_80D_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_zg9hRCYiLJsl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82B_zRE9PCPrKlsk"&gt;Basis of Presentation&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Statement of Compliance&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These unaudited condensed interim consolidated
financial statements have been prepared in accordance with IFRS Accounting Standards as issued by the International Accounting
Standards Board (&#x201c;IFRS&#x201d;). These unaudited condensed interim consolidated financial statements have been prepared in
accordance with International Accounting Standards (&#x201c;IAS&#x201d;) 34 &#x2013; Interim Financial Reporting. Accordingly, they
do not include all of the information and disclosures required by IFRS for annual financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial
statements were reviewed, approved and authorized for issuance by the Board of Directors (the &#x201c;Board&#x201d;) of the
Company on August 21, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(b)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Basis of Measurement &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements
have been prepared on the historical cost basis except for certain financial instruments carried at fair value, as explained in
the accounting policies as set out in Note 3. In addition, these consolidated financial statements have been prepared using the
accrual basis of accounting, except for cash flow information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(c)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Basis of Consolidation&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements
include the accounts of the Company and its wholly owned subsidiaries, Snow Lake Exploration Ltd., Snow Lake (Crowduck) Ltd., Global
Uranium Acquisition Corp. PTY LTD., Snow Lake Exploration (US) Ltd., and Snow Lake Investments (US) Ltd.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsidiaries consist of entities over which
the Company is exposed to, or has rights to, variable returns as well as the ability to affect those returns through the power
to direct the relevant activities of the entity. Subsidiaries are fully consolidated from the date control is transferred to the
Company and are deconsolidated from the date control ceases. These consolidated financial statements include all the assets, liabilities,
revenues, expenses and cash flows of the Company and its subsidiaries after eliminating inter-entity balances and transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;





&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(d)&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;Functional Currency&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;These consolidated financial statements
are presented in Canadian dollars (&#x201c;$&#x201d; or &#x201c;CAD&#x201d;), which is the Company&#x2019;s functional currency. The
functional currency is the currency of the primary economic environment in which the Company operates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(e)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Significant Accounting Judgments and Estimates&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of these consolidated financial
statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application
of policies and reported amounts of assets, liabilities, revenue, and expenses. On an ongoing basis, management evaluates its judgments
and estimates in relation to assets, liabilities, revenue, and expenses. Management uses historical experience and various other
factors it believes to be reasonable under the given circumstances as the basis for its judgments and estimates. Actual outcomes
may differ from these estimates under different assumptions and conditions. These estimates are reviewed periodically, and adjustments
are made as appropriate in the period they become known.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Items for which actual results may differ
materially from these estimates are described as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Going concern&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At each reporting period, management exercises
judgment in assessing the Company&#x2019;s ability to continue as a going concern by reviewing the Company&#x2019;s performance,
resources, and future obligations. &lt;span style="color: windowtext"&gt;The conclusion that the Company will be able to continue as
a going concern is subject to critical judgments of management with respect to assumptions surrounding the short and long-term
operating budgets, expected profitability, investment and financing activities and management&#x2019;s strategic planning. The assumptions
used in management&#x2019;s going concern assessment are derived from actual operating results along with industry and market trends.
Management believes there is sufficient capital to meet the Company&#x2019;s business obligations for at least the next 12 months,
after taking into account expected cash flows, including financing activities, and the Company's cash position at year-end.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Fair value of financial assets and financial
liabilities&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Fair value of financial assets and financial
liabilities on the consolidated statements of financial position that cannot be derived from active markets, are determined using
a variety of techniques including the use of valuation models. The inputs to these models are derived from observable market data
where possible, but where observable market data are not available, judgment is required to establish fair values. Judgments include,
but are not limited to, consideration of model inputs such as volatility, estimated life and discount rates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Economic recoverability of future economic
benefits of exploration and evaluation assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management has determined that exploration
and evaluation (&#x201c;E&amp;amp;E&#x201d;) assets and related costs incurred, which have been recognized on the consolidated statements
of financial position, are economically recoverable. Management uses several criteria in its assessments of economic recoverability
and probability of future economic benefit including geological data, scoping studies, accessible facilities, and existing and
future permits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Technical feasibility and commercial
viability&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management exercises judgment, in accordance
with IFRS 6 &#x2013; Exploration for and Evaluation of Mineral Resources (&#x201c;IFRS 6&#x201d;), to determine an accounting policy
specifying which expenditures, if any, are capitalized as E&amp;amp;E assets, and to apply the policy consistently. E&amp;amp;E expenditures
not capitalized as E&amp;amp;E assets are expensed as incurred. Once the technical feasibility and commercial viability of extracting
a mineral resource are demonstrable, an entity stops recording E&amp;amp;E expenditures for that mineral project, tests capitalized
E&amp;amp;E assets (if any) for impairment and reclassifies those E&amp;amp;E assets to other applicable development-stage accounts. An
assessment of technical feasibility and commercial viability is conducted on a project-by-project basis with regard to all relevant
facts and circumstances. The nature and status of the mineral project is determined on the merits of the mineral project itself.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;










&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Provisions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Provisions recognized in the consolidated
financial statements involve judgments on the occurrence of future events, which could result in a material outlay for the Company.
In determining whether an outlay will be material, the Company considers the expected future cash flows based on facts, historical
experience and probabilities associated with such future events. Uncertainties exist with respect to estimates made by management
and as a result, the actual expenditure may differ from amounts currently reported.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Determination of joint control and classification&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The assessment of whether the Company has
control, joint control, or significant influence over another entity requires judgment. Key considerations include: (i) the activities
that most significantly affect returns and how decisions about those activities are made; (ii) whether decisions require unanimous
consent of the parties that collectively control the arrangement; (iii) whether rights held by other parties are substantive or
protective; and (iv) the legal form of any separate vehicle and the contractual terms. These judgments affect whether an investee
is consolidated as a subsidiary, accounted for as a joint operation or joint venture, or as an associate. Changes in facts and
circumstances may result in a re-assessment of the classification.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Income taxes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Income taxes and tax exposures recognized
in the consolidated financial statements reflect management&#x2019;s best estimate of the outcome based on facts known at the reporting
date. When the Company anticipates a future income tax payment based on its estimates, it recognizes a liability. The difference
between the expected amount and the final tax outcome has an impact on current and deferred taxes when the Company becomes aware
of this difference.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In addition, when the Company incurs losses
that cannot be associated with current or past profits, it assesses the probability of taxable profits being available in the future
based on its budgeted forecasts. These forecasts are adjusted to take account of certain non-taxable income and expenses and specific
rules on the use of unused credits and tax losses. When the forecasts indicate the sufficient future taxable income will be available
to deduct the temporary differences, a deferred tax asset is recognized for all deductible temporary differences.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Options, restricted share units and
warrants&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Options, restricted share units (&#x201c;RSUs&#x201d;)
and warrants, including finders&#x2019; warrants, are initially recognized at fair value using market-based valuation techniques.
The fair value of the market-based and performance-based share awards are determined at the date of grant using generally accepted
valuation techniques. Assumptions are made and judgments are used in applying the valuation techniques. These assumptions and judgments
include the expected volatility of the share price, expected forfeitures, expected dividend yield, expected term of the warrants
or options, and expected risk-free interest rate. Such assumptions and judgments are inherently uncertain. Changes in these assumptions
can affect the fair value estimates of stock-based compensation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Expected credit losses on financial
assets&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Determining an allowance for expected credit
losses (&#x201c;ECL&#x201d;) for amounts receivable and all debt financial assets not held at fair value through profit or loss (&#x201c;FVTPL&#x201d;)
requires management to make assumptions about the historical patterns for the probability of default, the timing of collection
and the amount of incurred credit losses, which are adjusted based on management&#x2019;s judgment about whether economic conditions
and credit terms are such that actual losses may be higher or lower than what the historical patterns suggest.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Functional currency&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The functional currency for the Company
and its subsidiaries is the currency of the primary economic environment in which they operate. Determination of functional currency
involves significant judgments and other entities may make different judgments based on similar facts. Periodically, the Company
reconsiders the functional currency of its business if there is a change in the underlying transactions, events or conditions which
determine its primary economic environment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Shares issued for non-cash consideration&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is required to recognize these
transactions at fair value which requires judgment in selecting valuation techniques and other factors.&lt;/p&gt;

</ifrs-full:DisclosureOfBasisOfConsolidationExplanatory>
    <fnuc:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000496">&lt;p id="xdx_808_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryTextBlock_z4VgAOodWmLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_821_z2oJMi3T6AVb"&gt;Summary of Material Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_zsxs9IPsqGR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zi0iWfiXvFda"&gt;Current and Non-Current Classification&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Assets and liabilities are presented in
the consolidated statements of financial position based on current and non-current classification.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;An asset is classified as current when
it is either expected to be realized or intended to be sold or consumed in the normal operating cycle; it is held primarily for
the purpose of trading; it is expected to be realized within 12 months after the reporting period; or the asset is cash or cash
equivalent unless restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period.
All other assets are classified as non-current.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A liability is classified as current when
it is either expected to be settled in the normal operating cycle; it is held primarily for the purpose of trading; it is due to
be settled within 12 months after the reporting period; or there is no unconditional right to defer the settlement of the liability
for at least 12 months after the reporting period. All other liabilities are classified as non-current.&lt;/p&gt;

&lt;p id="xdx_855_zBVYXvUheT9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForCashFlowsExplanatory_zmfXftrsYklk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(b)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zIN4CrsdnbCi"&gt;Cash&lt;/span&gt; &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cash in the consolidated statements of
financial position comprises cash at a chartered bank in Canada, funds held in trust with the Company&#x2019;s legal counsels, and
funds held with the Company&#x2019;s financing agent and investment broker, which are available on demand.&lt;/p&gt;

&lt;p id="xdx_856_zunO9dC26DD1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures_zDdTFXbWqDfh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(c)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zbPL1J0ztHY6"&gt;Exploration and Evaluation Assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Title to E&amp;amp;E assets including mineral
properties involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the
potential for problems arising from the frequently ambiguous conveyancing historical characteristic of many properties. The Company
has investigated title to all its mineral properties and, to the best of its knowledge, titles to all its mineral properties are
in good standing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for E&amp;amp;E assets
in accordance with IFRS 6. Once the legal right to explore a property has been acquired, costs directly related to exploration
and evaluation are recognized and capitalized, in addition to acquisition costs. These expenditures include but are not limited
to acquiring licenses, researching and analyzing existing exploration data, conducting geological studies, exploration drilling
and sampling and payments made to contractors and consultants in connection with the exploration and evaluation of the property.
Costs not directly attributable to E&amp;amp;E activities, including general administrative overhead costs, are expensed in the period
in which they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acquisition costs incurred in obtaining
legal right to explore a mineral property are deferred until the legal right is granted and thereon reclassified to mineral properties.
Transaction costs incurred in acquiring an asset are deferred until the transaction is completed and then included in the purchase
price of the asset acquired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When a project is deemed to no longer have
commercially viable prospects to the Company, E&amp;amp;E expenditures in respect of that project are deemed to be impaired. As a result,
those E&amp;amp;E expenditure costs, in excess of the estimated recoverable amount, are written off to the consolidated statements
of loss and comprehensive loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company assesses E&amp;amp;E assets for
impairment when facts and circumstances suggest that the carrying amount of the asset may exceed its recoverable amount. The recoverable
amount is the higher of the asset&#x2019;s fair value less costs to sell (&#x201c;FVLCS&#x201d;) and value-in-use (&#x201c;VIU&#x201d;).
Once the technical feasibility and commercial viability of extracting the mineral resource has been determined, the property is
considered a mine under development. E&amp;amp;E assets are also tested for impairment before the assets are transferred to development
properties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As the Company currently has no operational
income, any incidental revenues earned in connection with exploration activities are applied as a reduction to capitalized exploration
costs.&lt;/p&gt;

&lt;p id="xdx_85F_zMvwDqMQh76b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none; text-align: justify"&gt;&#160;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;








&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory_z6h7XdVmKi6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(d)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_z8CfjhFVO1u6"&gt;Joint arrangements&lt;/span&gt; &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company applies IFRS 11 Joint Arrangements
to all arrangements where two or more parties are bound by a contractual arrangement and share joint control. The Company determines
the type of joint arrangement by assessing its rights and obligations arising from the structure and terms of the arrangement,
considering the legal form of the vehicle, the terms agreed by the parties, and other facts and circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Joint operations&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Company has rights to the assets
and obligations for the liabilities of the arrangement, it recognizes its direct share of assets, liabilities, revenues and expenses
in accordance with the relevant IFRS standards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Joint ventures&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Company has rights to the net
assets of the arrangement, the interest is classified as a joint venture and accounted for using the equity method under IAS 28.
The investment is initially recognized at cost and subsequently adjusted for the Company&#x2019;s share of the joint venture&#x2019;s
profit or loss and other comprehensive income. Unrealized gains and losses on transactions with the joint venture are eliminated
to the extent of the Company&#x2019;s interest, unless the transaction provides evidence of impairment. If the Company&#x2019;s share
of losses exceeds the carrying amount of the investment, the carrying amount is reduced to nil and further losses are recognized
only to the extent that the Company has a legal or constructive obligation to make payments on behalf of the joint venture. The
Company assesses investments in joint ventures for impairment in accordance with IAS 36.&lt;/p&gt;

&lt;p id="xdx_855_zRgtdVmemeyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zhNHw2hpIy01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(e)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zxL3wpCLVGI5"&gt;Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company classifies and measures financial
instruments in accordance with IFRS 9 &#x2013; Financial Instruments (&#x201c;IFRS 9&#x201d;). &lt;span style="background-color: white"&gt;A&#160;financial
instrument&#160;is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument
of another entity.&lt;/span&gt; The Company recognizes financial assets and financial liabilities on the consolidated statements of financial
position when it becomes a party to the financial instrument or derivative contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;&lt;i&gt;Classification&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;The
Company classifies its financial assets in the following measurement categories: (a) those to be measured subsequently at FVTPL;
(b) those to be measured subsequently at fair value through other comprehensive income (loss) (&#x201c;FVTOCI&#x201d;); and (c) those
to be measured at amortized cost. The classification of financial assets depends on the business model for managing the financial
assets and the contractual terms of the cash flows. Financial liabilities are classified as those to be measured at amortized cost
unless they are designated as those to be measured subsequently at FVTPL (irrevocable election at the time of recognition). &lt;/span&gt;The
Company reclassifies financial assets when and only when its business model for managing those assets changes. Financial liabilities
are not reclassified.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="color: windowtext"&gt;The Company&#x2019;s
financial assets include cash, other receivables excluding any sales tax amounts, short-term and long-term loans receivable, and
short-term and long-term investments. The Company&#x2019;s financial liabilities include its accounts payable, due to related parties,
lease liabilities, derivative liabilities and other liabilities&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This category includes derivative instruments
as well as quoted equity instruments which the Company has not irrevocably elected, at initial recognition or transition, to classify
at FVTOCI. This category would also include debt instruments whose cash flow characteristics do not meet the solely payment of
principal and interest (&#x201c;SPPI&#x201d;) criterion or are not held within a business model whose objective is either to collect
contractual cash flows, or to both collect contractual cash flows and sell. Financial assets in this category are recorded at fair
value with changes recognized in &lt;span style="font-family: Times New Roman, Times, Serif"&gt;the consolidated statements of loss and
comprehensive loss&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Financial
assets at fair value through other comprehensive income&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
and equity instruments that are held for collection of contractual cash flows and for sale, and where the assets&#x2019; cash flows
represent solely payments of principal and interest, are classified as FVTOCI. Movements in fair values are recognized in other
comprehensive income (&#x201c;OCI&#x201d;) and accumulated in fair value reserve, except for the recognition of impairment gains
or losses, interest income and foreign exchange gains and losses, which are recognized in profit and loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the financial asset is derecognized, the cumulative gain or loss recognized in OCI is reclassified from equity to profit or loss
and presented in &#x201c;other gains and losses&#x201d;. Interest income from these financial assets is recognized using the effective
interest rate method and presented in &#x201c;interest income&#x201d;. As at December 31, 2025 and 2024, the Company did not have
any financial assets at FVTOCI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Amortized
cost &lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_zsY1EjmYbkz9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
and equity instruments that are held for collection of contractual cash flows where those cash flows represent SPPI are measured
at amortized cost. Interest income from these financial assets is included in interest income using the effective interest rate
method. &lt;span style="background-color: white"&gt;The Company&#x2019;s classification of financial assets and liabilities is summarized
below: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zCNOAwuaY1D" style="display: none; visibility: hidden"&gt;Schedule of Financial Assets and Financial Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--CashAndCashEquivalentMember_zWmlJht8gMH4" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--ShortTermLoanReceivableMember_zQKYDIIkRsX5" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    investments&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--ShortTermInvestmentMember_zrdayen9niDj" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LongTermLoanReceivableMember_zI2atP72ZIk" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    investment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LongTermInvestmentMember_zM9qgaUJ3xQ3" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due
    to/from related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DueToOrFromRelatedPartiesMember_zAmCJdY51sg7" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
    payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--AccountsPayableAndAccruedLiabilitiesMember_zNDrnUmC61l3" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LeaseLiablitiesMember_zy1SsV1ikgkc" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    liabilities &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DeferredliabilitiesMember_zXlqHlFeOa4j" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loan
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LoanPayableMember_zHdIGVXoQSM7" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zS5V8C2o5APf" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__ifrs-full--OtherLiabilities_z6o6hByCVs9h" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zUVxayY1IYR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Measurement
&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;All
financial instruments are required to be measured at fair value on initial recognition, plus, in the case of a financial asset
or financial liability not at FVTPL, transaction costs that are directly attributable to the acquisition or issuance of the financial
asset or financial liability. Transaction costs of financial assets and financial liabilities carried at FVTPL are expensed in
profit or loss. Financial assets and financial liabilities with embedded derivatives are considered in their entirety when determining
whether their cash flows are solely payment of principal and interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Financial
assets that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual
cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortized
cost at the end of the subsequent accounting periods. All other financial assets, including equity investments, are measured at
their fair values at the end of subsequent accounting periods, with any changes taken through profit and loss or OCI (irrevocable
election at the time of recognition). For financial liabilities measured subsequently at FVTPL, changes in fair value due to credit
risk are recorded in profit and loss. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Expected
credit loss impairment model&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Under
IFRS 9, the Company recognizes a provision for ECL on financial assets that are measured on amortized cost. The Company assumes
that the credit risk on a financial asset has increased significantly if it is more than 30 days past due. The Company considers
a financial asset to be in default when the borrower is unlikely to pay its credit obligations to the Company in full or when
the financial asset is more than 90 days past due. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect
of recovery. This is generally the case when the Company determines that the debtor does not have assets or sources of income
that could generate sufficient cash flows to repay the amounts.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derecognizes financial assets only when the contractual rights to cash flow from the financial assets expire, or when
it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derecognizes a financial liability when its contractual obligations are discharged, cancelled, or expire. The Company
also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of
the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized
at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gains
or losses on derecognition are generally recognized in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Determination
of fair value&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
determination of fair value requires judgment and is based on market information, where available and appropriate. The Company
classifies fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the
measurements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zYgXUNiE1TZ5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_zFsB3dFNCyy9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(f)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zHlpCL2bZvc3"&gt;Impairment
                                         of Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting date, the Company reviews the carrying amounts of its assets to determine whether there are any indicators of impairment.
If any such indicator exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment,
if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
the asset does not generate cash inflows that are independent from other assets, the Company estimates the recoverable amount
of the cash-generating unit (&#x201c;CGU&#x201d;) to which the asset belongs. Any intangible asset with an indefinite useful life
is tested for impairment annually and whenever there is an indication that the asset may be impaired. An asset&#x2019;s recoverable
amount is the higher of FVLCS and VIU. In assessing VIU, the estimated future cash flows are discounted to their present value,
using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset for which estimates of future cash flows have not been adjusted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount is reduced to
the recoverable amount and an impairment loss is recognized immediately in the consolidated statements of loss and comprehensive
loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount
but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously
been recognized. A reversal of impairment is recognized in the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zorzDmoc89K1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zYb7zy1ObHw3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(g)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zbwBX8lbzY5l"&gt;Impairment
                                         of Non-Financial Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
and other intangible assets that have an indefinite useful life are not subject to amortisation and are tested annually for impairment,
or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are
reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
An impairment loss is recognized for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverable
amount is the higher of an asset&#x2019;s FVLCS and VIU. The VIU is the present value of the estimated future cash flows relating
to the asset using a pre-tax discount rate specific to the asset or CGU to which the asset belongs. Assets that do not have independent
cash flows are grouped together to form a CGU.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zi7zyodCkpyb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;











&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zA5kSKKm2aq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(h)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zMUnSfvX5cPf"&gt;Leased
                                         Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is party to a lease for office space. The Company assesses service arrangements to determine if an asset is explicitly
or implicitly specified in the agreement and if it has the right to control the use of the identified asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys
the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company then recognizes a right-of-use (&#x201c;ROU&#x201d;) asset and a lease liability at the lease commencement date. The ROU
asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before
the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying
asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The assets are
depreciated to the earlier of the end of the useful life of the ROU asset or the lease term using the straight-line method. The
lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. The Company
elected to recognize expenses for leases with a term of 12 months or less on a straight-line basis over the lease term and lease
of assets of low value, and not to recognize these short-term leases on the consolidated statements of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted
using the Company&#x2019;s incremental borrowing rate, which was determined to be about 15%. The lease liability is measured at
amortized cost using the effective interest method. It is remeasured when there is a change in the Company&#x2019;s estimate of
the amount expected to be payable under a residual value guarantee, if there is a change in future lease payments arising from
a change in an index or rate, or if the Company changes its assessment whether it will exercise a purchase, extension or termination
option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the lease liability is remeasured, the amount of the remeasurement is recognized as a corresponding adjustment to the carrying
amount of the ROU asset or is recorded in profit or loss if the carrying amount of the ROU asset has been reduced to zero.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_z9O4iJmxVLMl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zigcvjyPbHE5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(i)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zBGovjSR5aSf"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
provision is recognized when the Company has a present legal or constructive obligation as a result of a past event, it is probable
that an outflow of economic benefits will be required to settle the obligation, and the amount of the obligation can be reliably
estimated. If the effect is material, provisions are determined by discounting the expected future cash flows at a pre-tax rate
that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
provision for onerous contracts is recognized when the expected benefits to be derived by the Company from a contract are lower
than the unavoidable cost of meeting its obligations under the contract.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zztnlm718fp7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zCTJP1LziJX8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(j)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zoLZQ5IdlYdd"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
tax expense consists of current and deferred tax expense. Current and deferred tax are recognized in profit or loss except to
the extent that it relates to items recognized directly in equity or OCI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
income tax is recognized and measured at the amount expected to be recovered from, or payable to, the taxation authorities based
on the income tax rates enacted or substantively enacted at the end of the reporting period and includes any adjustment to taxes
payable in respect of previous years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;Deferred
tax is recorded for temporary differences &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
the date of the consolidated statements of financial position between the tax bases of assets and liabilities and their carrying
amounts for financial reporting purposes. The carrying amount of a deferred tax asset is reviewed at the end of the reporting
period and is reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all
or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at the end of the reporting
period and are recognized to the extent that it has become probable that future &lt;span style="color: windowtext; background-color: white"&gt;taxable
&lt;/span&gt;profit will allow the deferred tax asset to be recovered&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or
the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the end of the
reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and deferred tax liabilities are offset if, and only if, they relate to income taxes levied by the same taxation authority
and the Company has the legal rights and intent to offset&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provisions
for taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant
factors. The Company reviews the adequacy of these provisions at the end of the reporting period. However, it is possible that
at some future date an additional liability could result from audits by taxing authorities. Where the final outcome of these tax-related
matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period
in which such determination is made.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zvyb9SYc14gd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--DescriptionOfAccountingPolicyForShareCapitalExplanatoryTextBlock_zX3wbUJYmPpe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(k)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_861_z41H9e5xwgVb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
                                         Capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;Common
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares are classified as share capital. Costs
directly attributable to the issue of common shares are recognized as a deduction from share capital, net of any tax effects&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_853_zcqqV6MNHeMc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zC8TmTrGRXyh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(l)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_z6sfDH1bx7Ma"&gt;Share-Based
                                         Payments Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;The
Company operates a stock option plan (the &#x201c;Option Plan&#x201d;). Share-based payments to employees are measured at the fair
value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at
the fair value of goods or services received, or at the fair value of the equity instruments issued, if it is determined the fair
value of the goods or services cannot be reliably measured and are recorded at the date the goods or services are received. The
fair value of options is determined &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;based on
the application of the Black-Scholes valuation model (&#x201c;Black-Scholes&#x201d;). &lt;span style="color: windowtext"&gt;The fair value
of equity-settled stock-based compensation transactions is recognized as an expense with a corresponding increase in the share-based
payments reserve.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
share-settled awards are modified, as a minimum an expense is recognized as if the modification has not been made. An additional
expense is recognized, over the remaining vesting period, for any modification that increases the total fair value of the share-based
compensation benefit as at the date of modification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
recorded for cancelled or expired unexercised options are transferred to accumulated deficit in the period of which the cancellation
or expiry occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also operates a RSUs Plan, where RSUs are granted to directors, employees and consultants from time to time. RSUs are
measured at the fair value of the date of grant, based on the closing price of the Company&#x2019;s common shares on the date of
grant. The fair value of stock-based compensation on RSUs is recognized as an expense with a corresponding increase in the reserve
for RSUs over the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may also grant RSUs with a put right option, which provides the grantee with the right (the &#x201c;Put
Right Option&#x201d;), but not the obligation to cause the Company to purchase all or a portion of the vested RSUs at a put purchase
price (the &#x201c;Put Purchase Price&#x201d;). As the grantee has the choice of settlement through cash or in shares, these RSUs
with the Put Right Option are considered to be a compound financial instrument that includes both a liability component and an
equity component. At the measurement date, the Company accounts for the two components separately i.e. applying the requirements
for cash-settled share-based payments to the liability component and applying the requirements for equity-settled share-based
payments to the equity component, if that component has a recognized value. Applying the requirements for equity-settled share-based
payments, the value of the equity component is not remeasured subsequently. Applying the requirements for cash-settled share-based
payments, the liability is remeasured at each reporting date and on settlement date to its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the grantee chooses cash settlement, then the cash payment settles the liability. Any equity component previously recognized in
equity remains in equity. If the grantee employee chooses settlement in equity instruments, then the liability is transferred
to equity as consideration for issuing the equity instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zK4gmEOq50Jg" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;











&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForWarrantsExplanatory_zcF45O3ZZ4z3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(m)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zxZ69fjHV80a"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
purchase warrants (each a &#x201c;Warrant&#x201d;) are classified as a component of equity. Warrants issued along with shares in
an equity unit financing are measured using the residual approach, whereby the fair value of the Warrant is determined after deducting
the fair value of the shares from the unit price less applicable financing costs. Warrants issued for broker/financing compensation,
are recognized at the fair value using Black-Scholes at the date of issuance. Warrants are initially recorded as a part of the
reserves in warrant in equity at the recognized fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
exercise of the Warrants, the previously recognized fair value of the Warrants exercised is reallocated to share capital from
warrants reserve. Proceeds generated from the payment of the exercise price are also allocated to share capital. Amounts recorded
for expired unexercised warrants are transferred to accumulated deficit in the period of which the expiry occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85E_zSP5NKdWFjP2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zLXy5Mqzec53" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(n)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zc2DJmV6Nnxl"&gt;Flow-Through
                                         Shares&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Proceeds
received from the issuance of flow-through shares are restricted to be used only for Canadian resource property exploration expenditures
within a two-year period. The portion of the proceeds received but not yet expended at the end of the year is disclosed separately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issuance of flow-through common shares results in the tax deductibility of the qualifying resource expenditures funded from the
proceeds of the sales of such common shares being transferred to the purchasers of the shares. On the issuance of such shares,
the Company bifurcates the flow-through shares into a flow-through share premium, equal to the estimated fair value of the premium
that investors pay for the flow-through tax feature, which is recognized as a liability, and equity values of share capital and/or
warrants. As related exploration expenditures are incurred, the Company derecognizes the premium liability and recognizes the
related recovery.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_856_zs29x3Nn63cf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zkPhaVFK4W13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(o)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_z0x5cNaFTZw5"&gt;Loss
                                         Per Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share is computed by dividing the net loss available to common shareholders by the weighted average number of common
shares outstanding during the period. Diluted loss per share is calculated by the treasury stock method. Under the treasury stock
method, the weighted average number of common shares outstanding for the calculation of diluted (loss) earnings per share assumes
that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at
the average market price during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zrnW6HNC3VHj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_znAW8XJ8Batd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(p)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zybFeq70ZJf7"&gt;Foreign
                                         Currency Translation&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements of the Company are prepared in its functional currency, determined on the basis of the primary
economic environment in which the entity operates. The presentation and functional currency of the Company is the Canadian dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Monetary
assets and liabilities denominated in currencies other than CAD are translated into CAD at the rate of exchange prevailing at
the reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
in currencies other than the functional currency are recorded at the rates of exchange prevailing at the transaction dates. At
each reporting date, monetary items denominated in foreign currencies are translated into the entity&#x2019;s functional currency
at the then prevailing rates and non-monetary items measured at historical cost are translated into the entity&#x2019;s functional
currency at rates in effect at the date the transaction took place.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which
they were translated on initial recognition during the period or in previous financial statements are included in the consolidated
statements of loss and comprehensive loss for the period in which they arise.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_znAWWpzV1Iti" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory_zH5tBOm7TrEe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(q)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zXILZVfySxBa"&gt;Related
                                         Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parties
are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operating decisions. Parties are also considered to be related if they
are subject to common control or common significant influence. Related parties may be individuals or corporate entities. A transaction
is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85F_zFGZDOmBlYZ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</fnuc:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000498">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory_zsxs9IPsqGR9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_869_zi0iWfiXvFda"&gt;Current and Non-Current Classification&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Assets and liabilities are presented in
the consolidated statements of financial position based on current and non-current classification.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;An asset is classified as current when
it is either expected to be realized or intended to be sold or consumed in the normal operating cycle; it is held primarily for
the purpose of trading; it is expected to be realized within 12 months after the reporting period; or the asset is cash or cash
equivalent unless restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period.
All other assets are classified as non-current.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;A liability is classified as current when
it is either expected to be settled in the normal operating cycle; it is held primarily for the purpose of trading; it is due to
be settled within 12 months after the reporting period; or there is no unconditional right to defer the settlement of the liability
for at least 12 months after the reporting period. All other liabilities are classified as non-current.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000500">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForCashFlowsExplanatory_zmfXftrsYklk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(b)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_868_zIN4CrsdnbCi"&gt;Cash&lt;/span&gt; &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Cash in the consolidated statements of
financial position comprises cash at a chartered bank in Canada, funds held in trust with the Company&#x2019;s legal counsels, and
funds held with the Company&#x2019;s financing agent and investment broker, which are available on demand.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForCashFlowsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures contextRef="From2025-07-01to2025-12-31" id="Fact000502">&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures_zDdTFXbWqDfh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(c)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86E_zbPL1J0ztHY6"&gt;Exploration and Evaluation Assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Title to E&amp;amp;E assets including mineral
properties involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the
potential for problems arising from the frequently ambiguous conveyancing historical characteristic of many properties. The Company
has investigated title to all its mineral properties and, to the best of its knowledge, titles to all its mineral properties are
in good standing.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for E&amp;amp;E assets
in accordance with IFRS 6. Once the legal right to explore a property has been acquired, costs directly related to exploration
and evaluation are recognized and capitalized, in addition to acquisition costs. These expenditures include but are not limited
to acquiring licenses, researching and analyzing existing exploration data, conducting geological studies, exploration drilling
and sampling and payments made to contractors and consultants in connection with the exploration and evaluation of the property.
Costs not directly attributable to E&amp;amp;E activities, including general administrative overhead costs, are expensed in the period
in which they occur.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Acquisition costs incurred in obtaining
legal right to explore a mineral property are deferred until the legal right is granted and thereon reclassified to mineral properties.
Transaction costs incurred in acquiring an asset are deferred until the transaction is completed and then included in the purchase
price of the asset acquired.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When a project is deemed to no longer have
commercially viable prospects to the Company, E&amp;amp;E expenditures in respect of that project are deemed to be impaired. As a result,
those E&amp;amp;E expenditure costs, in excess of the estimated recoverable amount, are written off to the consolidated statements
of loss and comprehensive loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company assesses E&amp;amp;E assets for
impairment when facts and circumstances suggest that the carrying amount of the asset may exceed its recoverable amount. The recoverable
amount is the higher of the asset&#x2019;s fair value less costs to sell (&#x201c;FVLCS&#x201d;) and value-in-use (&#x201c;VIU&#x201d;).
Once the technical feasibility and commercial viability of extracting the mineral resource has been determined, the property is
considered a mine under development. E&amp;amp;E assets are also tested for impairment before the assets are transferred to development
properties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As the Company currently has no operational
income, any incidental revenues earned in connection with exploration activities are applied as a reduction to capitalized exploration
costs.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures>
    <ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000511">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory_z6h7XdVmKi6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(d)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_86B_z8CfjhFVO1u6"&gt;Joint arrangements&lt;/span&gt; &lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company applies IFRS 11 Joint Arrangements
to all arrangements where two or more parties are bound by a contractual arrangement and share joint control. The Company determines
the type of joint arrangement by assessing its rights and obligations arising from the structure and terms of the arrangement,
considering the legal form of the vehicle, the terms agreed by the parties, and other facts and circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Joint operations&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Company has rights to the assets
and obligations for the liabilities of the arrangement, it recognizes its direct share of assets, liabilities, revenues and expenses
in accordance with the relevant IFRS standards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Joint ventures&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;When the Company has rights to the net
assets of the arrangement, the interest is classified as a joint venture and accounted for using the equity method under IAS 28.
The investment is initially recognized at cost and subsequently adjusted for the Company&#x2019;s share of the joint venture&#x2019;s
profit or loss and other comprehensive income. Unrealized gains and losses on transactions with the joint venture are eliminated
to the extent of the Company&#x2019;s interest, unless the transaction provides evidence of impairment. If the Company&#x2019;s share
of losses exceeds the carrying amount of the investment, the carrying amount is reduced to nil and further losses are recognized
only to the extent that the Company has a legal or constructive obligation to make payments on behalf of the joint venture. The
Company assesses investments in joint ventures for impairment in accordance with IAS 36.&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForInvestmentInAssociatesAndJointVenturesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000513">&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zhNHw2hpIy01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;b&gt;(e)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_867_zxL3wpCLVGI5"&gt;Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company classifies and measures financial
instruments in accordance with IFRS 9 &#x2013; Financial Instruments (&#x201c;IFRS 9&#x201d;). &lt;span style="background-color: white"&gt;A&#160;financial
instrument&#160;is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument
of another entity.&lt;/span&gt; The Company recognizes financial assets and financial liabilities on the consolidated statements of financial
position when it becomes a party to the financial instrument or derivative contract.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;&lt;i&gt;Classification&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="background-color: white"&gt;The
Company classifies its financial assets in the following measurement categories: (a) those to be measured subsequently at FVTPL;
(b) those to be measured subsequently at fair value through other comprehensive income (loss) (&#x201c;FVTOCI&#x201d;); and (c) those
to be measured at amortized cost. The classification of financial assets depends on the business model for managing the financial
assets and the contractual terms of the cash flows. Financial liabilities are classified as those to be measured at amortized cost
unless they are designated as those to be measured subsequently at FVTPL (irrevocable election at the time of recognition). &lt;/span&gt;The
Company reclassifies financial assets when and only when its business model for managing those assets changes. Financial liabilities
are not reclassified.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="color: windowtext"&gt;The Company&#x2019;s
financial assets include cash, other receivables excluding any sales tax amounts, short-term and long-term loans receivable, and
short-term and long-term investments. The Company&#x2019;s financial liabilities include its accounts payable, due to related parties,
lease liabilities, derivative liabilities and other liabilities&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Fair value through profit or loss&lt;/span&gt;&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;This category includes derivative instruments
as well as quoted equity instruments which the Company has not irrevocably elected, at initial recognition or transition, to classify
at FVTOCI. This category would also include debt instruments whose cash flow characteristics do not meet the solely payment of
principal and interest (&#x201c;SPPI&#x201d;) criterion or are not held within a business model whose objective is either to collect
contractual cash flows, or to both collect contractual cash flows and sell. Financial assets in this category are recorded at fair
value with changes recognized in &lt;span style="font-family: Times New Roman, Times, Serif"&gt;the consolidated statements of loss and
comprehensive loss&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;








&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;









&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Financial
assets at fair value through other comprehensive income&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
and equity instruments that are held for collection of contractual cash flows and for sale, and where the assets&#x2019; cash flows
represent solely payments of principal and interest, are classified as FVTOCI. Movements in fair values are recognized in other
comprehensive income (&#x201c;OCI&#x201d;) and accumulated in fair value reserve, except for the recognition of impairment gains
or losses, interest income and foreign exchange gains and losses, which are recognized in profit and loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the financial asset is derecognized, the cumulative gain or loss recognized in OCI is reclassified from equity to profit or loss
and presented in &#x201c;other gains and losses&#x201d;. Interest income from these financial assets is recognized using the effective
interest rate method and presented in &#x201c;interest income&#x201d;. As at December 31, 2025 and 2024, the Company did not have
any financial assets at FVTOCI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Amortized
cost &lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_zsY1EjmYbkz9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
and equity instruments that are held for collection of contractual cash flows where those cash flows represent SPPI are measured
at amortized cost. Interest income from these financial assets is included in interest income using the effective interest rate
method. &lt;span style="background-color: white"&gt;The Company&#x2019;s classification of financial assets and liabilities is summarized
below: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zCNOAwuaY1D" style="display: none; visibility: hidden"&gt;Schedule of Financial Assets and Financial Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--CashAndCashEquivalentMember_zWmlJht8gMH4" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--ShortTermLoanReceivableMember_zQKYDIIkRsX5" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    investments&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--ShortTermInvestmentMember_zrdayen9niDj" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LongTermLoanReceivableMember_zI2atP72ZIk" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    investment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LongTermInvestmentMember_zM9qgaUJ3xQ3" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due
    to/from related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DueToOrFromRelatedPartiesMember_zAmCJdY51sg7" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
    payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--AccountsPayableAndAccruedLiabilitiesMember_zNDrnUmC61l3" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LeaseLiablitiesMember_zy1SsV1ikgkc" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    liabilities &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DeferredliabilitiesMember_zXlqHlFeOa4j" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loan
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LoanPayableMember_zHdIGVXoQSM7" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zS5V8C2o5APf" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__ifrs-full--OtherLiabilities_z6o6hByCVs9h" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zUVxayY1IYR2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Measurement
&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;All
financial instruments are required to be measured at fair value on initial recognition, plus, in the case of a financial asset
or financial liability not at FVTPL, transaction costs that are directly attributable to the acquisition or issuance of the financial
asset or financial liability. Transaction costs of financial assets and financial liabilities carried at FVTPL are expensed in
profit or loss. Financial assets and financial liabilities with embedded derivatives are considered in their entirety when determining
whether their cash flows are solely payment of principal and interest.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Financial
assets that are held within a business model whose objective is to collect the contractual cash flows, and that have contractual
cash flows that are solely payments of principal and interest on the principal outstanding are generally measured at amortized
cost at the end of the subsequent accounting periods. All other financial assets, including equity investments, are measured at
their fair values at the end of subsequent accounting periods, with any changes taken through profit and loss or OCI (irrevocable
election at the time of recognition). For financial liabilities measured subsequently at FVTPL, changes in fair value due to credit
risk are recorded in profit and loss. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;&lt;i&gt;Expected
credit loss impairment model&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;Under
IFRS 9, the Company recognizes a provision for ECL on financial assets that are measured on amortized cost. The Company assumes
that the credit risk on a financial asset has increased significantly if it is more than 30 days past due. The Company considers
a financial asset to be in default when the borrower is unlikely to pay its credit obligations to the Company in full or when
the financial asset is more than 90 days past due. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;The
carrying amount of a financial asset is written off (either partially or in full) to the extent that there is no realistic prospect
of recovery. This is generally the case when the Company determines that the debtor does not have assets or sources of income
that could generate sufficient cash flows to repay the amounts.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derecognizes financial assets only when the contractual rights to cash flow from the financial assets expire, or when
it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company derecognizes a financial liability when its contractual obligations are discharged, cancelled, or expire. The Company
also derecognizes a financial liability when the terms of the liability are modified such that the terms and/or cash flows of
the modified instrument are substantially different, in which case a new financial liability based on the modified terms is recognized
at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Gains
or losses on derecognition are generally recognized in profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Determination
of fair value&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
determination of fair value requires judgment and is based on market information, where available and appropriate. The Company
classifies fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making the
measurements.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <fnuc:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000525">&lt;p id="xdx_89D_ecustom--ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock_zsY1EjmYbkz9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
and equity instruments that are held for collection of contractual cash flows where those cash flows represent SPPI are measured
at amortized cost. Interest income from these financial assets is included in interest income using the effective interest rate
method. &lt;span style="background-color: white"&gt;The Company&#x2019;s classification of financial assets and liabilities is summarized
below: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_zCNOAwuaY1D" style="display: none; visibility: hidden"&gt;Schedule of Financial Assets and Financial Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 60%; border-collapse: collapse; margin-right: auto"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--CashAndCashEquivalentMember_zWmlJht8gMH4" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--ShortTermLoanReceivableMember_zQKYDIIkRsX5" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Short-term
    investments&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--ShortTermInvestmentMember_zrdayen9niDj" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    loan receivable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LongTermLoanReceivableMember_zI2atP72ZIk" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Long-term
    investment&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LongTermInvestmentMember_zM9qgaUJ3xQ3" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Due
    to/from related parties&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DueToOrFromRelatedPartiesMember_zAmCJdY51sg7" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
    payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--AccountsPayableAndAccruedLiabilitiesMember_zNDrnUmC61l3" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LeaseLiablitiesMember_zy1SsV1ikgkc" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    liabilities &lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DeferredliabilitiesMember_zXlqHlFeOa4j" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loan
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--LoanPayableMember_zHdIGVXoQSM7" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Derivative
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__custom--DerivativeLiabilitiesMember_zS5V8C2o5APf" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialAssetsAndFinancialLiabilities_c20250701__20251231__custom--FinancialAssetsAndFinancialLiabilitiesAxis__ifrs-full--OtherLiabilities_z6o6hByCVs9h" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfFinancialAssetsAndFinancialLiabilitiesTableTextBlock>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_CashAndCashEquivalentMember"
      id="Fact000526">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_ShortTermLoanReceivableMember"
      id="Fact000527">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_ShortTermInvestmentMember"
      id="Fact000528">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_LongTermLoanReceivableMember"
      id="Fact000529">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_LongTermInvestmentMember"
      id="Fact000530">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_DueToOrFromRelatedPartiesMember"
      id="Fact000531">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_AccountsPayableAndAccruedLiabilitiesMember"
      id="Fact000532">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_LeaseLiablitiesMember"
      id="Fact000533">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_DeferredliabilitiesMember"
      id="Fact000534">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost &lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_LoanPayableMember"
      id="Fact000535">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortized
    cost&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_custom_DerivativeLiabilitiesMember"
      id="Fact000536">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <fnuc:FinancialAssetsAndFinancialLiabilities
      contextRef="From2025-07-012025-12-31_ifrs-full_OtherLiabilities"
      id="Fact000537">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FVTPL&lt;/span&gt;</fnuc:FinancialAssetsAndFinancialLiabilities>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000549">&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_zFsB3dFNCyy9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(f)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zHlpCL2bZvc3"&gt;Impairment
                                         of Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
each reporting date, the Company reviews the carrying amounts of its assets to determine whether there are any indicators of impairment.
If any such indicator exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment,
if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Where
the asset does not generate cash inflows that are independent from other assets, the Company estimates the recoverable amount
of the cash-generating unit (&#x201c;CGU&#x201d;) to which the asset belongs. Any intangible asset with an indefinite useful life
is tested for impairment annually and whenever there is an indication that the asset may be impaired. An asset&#x2019;s recoverable
amount is the higher of FVLCS and VIU. In assessing VIU, the estimated future cash flows are discounted to their present value,
using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the
asset for which estimates of future cash flows have not been adjusted.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount is reduced to
the recoverable amount and an impairment loss is recognized immediately in the consolidated statements of loss and comprehensive
loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount
but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously
been recognized. A reversal of impairment is recognized in the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000551">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zYb7zy1ObHw3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(g)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zbwBX8lbzY5l"&gt;Impairment
                                         of Non-Financial Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Goodwill
and other intangible assets that have an indefinite useful life are not subject to amortisation and are tested annually for impairment,
or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are
reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
An impairment loss is recognized for the amount by which the asset&#x2019;s carrying amount exceeds its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverable
amount is the higher of an asset&#x2019;s FVLCS and VIU. The VIU is the present value of the estimated future cash flows relating
to the asset using a pre-tax discount rate specific to the asset or CGU to which the asset belongs. Assets that do not have independent
cash flows are grouped together to form a CGU.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000560">&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zA5kSKKm2aq6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(h)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86F_zMUnSfvX5cPf"&gt;Leased
                                         Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is party to a lease for office space. The Company assesses service arrangements to determine if an asset is explicitly
or implicitly specified in the agreement and if it has the right to control the use of the identified asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
inception of a contract, the Company assesses whether a contract is, or contains, a lease based on whether the contract conveys
the right to control the use of an identified asset for a period of time in exchange for consideration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company then recognizes a right-of-use (&#x201c;ROU&#x201d;) asset and a lease liability at the lease commencement date. The ROU
asset is initially measured based on the initial amount of the lease liability adjusted for any lease payments made at or before
the commencement date, plus any initial direct costs incurred and an estimate of costs to dismantle and remove the underlying
asset or to restore the underlying asset or the site on which it is located, less any lease incentives received. The assets are
depreciated to the earlier of the end of the useful life of the ROU asset or the lease term using the straight-line method. The
lease term includes periods covered by an option to extend if the Company is reasonably certain to exercise that option. The Company
elected to recognize expenses for leases with a term of 12 months or less on a straight-line basis over the lease term and lease
of assets of low value, and not to recognize these short-term leases on the consolidated statements of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted
using the Company&#x2019;s incremental borrowing rate, which was determined to be about 15%. The lease liability is measured at
amortized cost using the effective interest method. It is remeasured when there is a change in the Company&#x2019;s estimate of
the amount expected to be payable under a residual value guarantee, if there is a change in future lease payments arising from
a change in an index or rate, or if the Company changes its assessment whether it will exercise a purchase, extension or termination
option.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the lease liability is remeasured, the amount of the remeasurement is recognized as a corresponding adjustment to the carrying
amount of the ROU asset or is recorded in profit or loss if the carrying amount of the ROU asset has been reduced to zero.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000562">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zigcvjyPbHE5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(i)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zBGovjSR5aSf"&gt;Provisions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
provision is recognized when the Company has a present legal or constructive obligation as a result of a past event, it is probable
that an outflow of economic benefits will be required to settle the obligation, and the amount of the obligation can be reliably
estimated. If the effect is material, provisions are determined by discounting the expected future cash flows at a pre-tax rate
that reflects current market assessments of the time value of money and, where appropriate, the risks specific to the liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
provision for onerous contracts is recognized when the expected benefits to be derived by the Company from a contract are lower
than the unavoidable cost of meeting its obligations under the contract.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000564">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zCTJP1LziJX8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(j)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zoLZQ5IdlYdd"&gt;Income
                                         Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
tax expense consists of current and deferred tax expense. Current and deferred tax are recognized in profit or loss except to
the extent that it relates to items recognized directly in equity or OCI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
income tax is recognized and measured at the amount expected to be recovered from, or payable to, the taxation authorities based
on the income tax rates enacted or substantively enacted at the end of the reporting period and includes any adjustment to taxes
payable in respect of previous years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;Deferred
tax is recorded for temporary differences &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at
the date of the consolidated statements of financial position between the tax bases of assets and liabilities and their carrying
amounts for financial reporting purposes. The carrying amount of a deferred tax asset is reviewed at the end of the reporting
period and is reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all
or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at the end of the reporting
period and are recognized to the extent that it has become probable that future &lt;span style="color: windowtext; background-color: white"&gt;taxable
&lt;/span&gt;profit will allow the deferred tax asset to be recovered&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realized or
the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the end of the
reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets and deferred tax liabilities are offset if, and only if, they relate to income taxes levied by the same taxation authority
and the Company has the legal rights and intent to offset&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provisions
for taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant
factors. The Company reviews the adequacy of these provisions at the end of the reporting period. However, it is possible that
at some future date an additional liability could result from audits by taxing authorities. Where the final outcome of these tax-related
matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period
in which such determination is made.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <fnuc:DescriptionOfAccountingPolicyForShareCapitalExplanatoryTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000576">&lt;p id="xdx_84B_ecustom--DescriptionOfAccountingPolicyForShareCapitalExplanatoryTextBlock_zX3wbUJYmPpe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(k)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_861_z41H9e5xwgVb" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Share
                                         Capital&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;Common
&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares are classified as share capital. Costs
directly attributable to the issue of common shares are recognized as a deduction from share capital, net of any tax effects&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

</fnuc:DescriptionOfAccountingPolicyForShareCapitalExplanatoryTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000578">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zC8TmTrGRXyh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(l)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_z6sfDH1bx7Ma"&gt;Share-Based
                                         Payments Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;The
Company operates a stock option plan (the &#x201c;Option Plan&#x201d;). Share-based payments to employees are measured at the fair
value of the instruments issued and amortized over the vesting periods. Share-based payments to non-employees are measured at
the fair value of goods or services received, or at the fair value of the equity instruments issued, if it is determined the fair
value of the goods or services cannot be reliably measured and are recorded at the date the goods or services are received. The
fair value of options is determined &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;based on
the application of the Black-Scholes valuation model (&#x201c;Black-Scholes&#x201d;). &lt;span style="color: windowtext"&gt;The fair value
of equity-settled stock-based compensation transactions is recognized as an expense with a corresponding increase in the share-based
payments reserve.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
share-settled awards are modified, as a minimum an expense is recognized as if the modification has not been made. An additional
expense is recognized, over the remaining vesting period, for any modification that increases the total fair value of the share-based
compensation benefit as at the date of modification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
recorded for cancelled or expired unexercised options are transferred to accumulated deficit in the period of which the cancellation
or expiry occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also operates a RSUs Plan, where RSUs are granted to directors, employees and consultants from time to time. RSUs are
measured at the fair value of the date of grant, based on the closing price of the Company&#x2019;s common shares on the date of
grant. The fair value of stock-based compensation on RSUs is recognized as an expense with a corresponding increase in the reserve
for RSUs over the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;From
time to time, the Company may also grant RSUs with a put right option, which provides the grantee with the right (the &#x201c;Put
Right Option&#x201d;), but not the obligation to cause the Company to purchase all or a portion of the vested RSUs at a put purchase
price (the &#x201c;Put Purchase Price&#x201d;). As the grantee has the choice of settlement through cash or in shares, these RSUs
with the Put Right Option are considered to be a compound financial instrument that includes both a liability component and an
equity component. At the measurement date, the Company accounts for the two components separately i.e. applying the requirements
for cash-settled share-based payments to the liability component and applying the requirements for equity-settled share-based
payments to the equity component, if that component has a recognized value. Applying the requirements for equity-settled share-based
payments, the value of the equity component is not remeasured subsequently. Applying the requirements for cash-settled share-based
payments, the liability is remeasured at each reporting date and on settlement date to its fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the grantee chooses cash settlement, then the cash payment settles the liability. Any equity component previously recognized in
equity remains in equity. If the grantee employee chooses settlement in equity instruments, then the liability is transferred
to equity as consideration for issuing the equity instruments.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000588">&lt;p id="xdx_846_eifrs-full--DescriptionOfAccountingPolicyForWarrantsExplanatory_zcF45O3ZZ4z3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(m)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_869_zxZ69fjHV80a"&gt;Warrants&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
purchase warrants (each a &#x201c;Warrant&#x201d;) are classified as a component of equity. Warrants issued along with shares in
an equity unit financing are measured using the residual approach, whereby the fair value of the Warrant is determined after deducting
the fair value of the shares from the unit price less applicable financing costs. Warrants issued for broker/financing compensation,
are recognized at the fair value using Black-Scholes at the date of issuance. Warrants are initially recorded as a part of the
reserves in warrant in equity at the recognized fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
exercise of the Warrants, the previously recognized fair value of the Warrants exercised is reallocated to share capital from
warrants reserve. Proceeds generated from the payment of the exercise price are also allocated to share capital. Amounts recorded
for expired unexercised warrants are transferred to accumulated deficit in the period of which the expiry occurs.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForWarrantsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000590">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForTreasurySharesExplanatory_zLXy5Mqzec53" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(n)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_zc2DJmV6Nnxl"&gt;Flow-Through
                                         Shares&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Proceeds
received from the issuance of flow-through shares are restricted to be used only for Canadian resource property exploration expenditures
within a two-year period. The portion of the proceeds received but not yet expended at the end of the year is disclosed separately.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issuance of flow-through common shares results in the tax deductibility of the qualifying resource expenditures funded from the
proceeds of the sales of such common shares being transferred to the purchasers of the shares. On the issuance of such shares,
the Company bifurcates the flow-through shares into a flow-through share premium, equal to the estimated fair value of the premium
that investors pay for the flow-through tax feature, which is recognized as a liability, and equity values of share capital and/or
warrants. As related exploration expenditures are incurred, the Company derecognizes the premium liability and recognizes the
related recovery.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000592">&lt;p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zkPhaVFK4W13" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(o)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_860_z0x5cNaFTZw5"&gt;Loss
                                         Per Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Basic
loss per share is computed by dividing the net loss available to common shareholders by the weighted average number of common
shares outstanding during the period. Diluted loss per share is calculated by the treasury stock method. Under the treasury stock
method, the weighted average number of common shares outstanding for the calculation of diluted (loss) earnings per share assumes
that the proceeds to be received on the exercise of dilutive share options and warrants are used to repurchase common shares at
the average market price during the period.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000594">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_znAW8XJ8Batd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(p)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zybFeq70ZJf7"&gt;Foreign
                                         Currency Translation&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements of the Company are prepared in its functional currency, determined on the basis of the primary
economic environment in which the entity operates. The presentation and functional currency of the Company is the Canadian dollar.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Monetary
assets and liabilities denominated in currencies other than CAD are translated into CAD at the rate of exchange prevailing at
the reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transactions
in currencies other than the functional currency are recorded at the rates of exchange prevailing at the transaction dates. At
each reporting date, monetary items denominated in foreign currencies are translated into the entity&#x2019;s functional currency
at the then prevailing rates and non-monetary items measured at historical cost are translated into the entity&#x2019;s functional
currency at rates in effect at the date the transaction took place.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exchange
differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which
they were translated on initial recognition during the period or in previous financial statements are included in the consolidated
statements of loss and comprehensive loss for the period in which they arise.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000596">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory_zH5tBOm7TrEe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(q)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_863_zXILZVfySxBa"&gt;Related
                                         Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Parties
are considered to be related if one party has the ability, directly or indirectly, to control the other party or exercise significant
influence over the other party in making financial and operating decisions. Parties are also considered to be related if they
are subject to common control or common significant influence. Related parties may be individuals or corporate entities. A transaction
is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForTransactionsWithRelatedPartiesExplanatory>
    <ifrs-full:DisclosureOfAcquiredReceivablesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000598">&lt;p id="xdx_800_eifrs-full--DisclosureOfAcquiredReceivablesExplanatory_ztYrTMx9dkX2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_822_zndA6CF3Vqd5"&gt;Sales
                                         Tax Receivable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s sales tax receivable balance represents amounts due from government taxation authorities in respect of the Good
and Services Tax/Harmonized Sales Tax. The Company anticipates full recovery of these amounts and therefore no ECL has been recorded
against these receivables, which are due in less than one year.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfAcquiredReceivablesExplanatory>
    <ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000600">&lt;p id="xdx_809_eifrs-full--DisclosureOfPrepaymentsAndOtherAssetsExplanatory_zV2OWooaF3H4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_828_z1ImfiYXtwXi"&gt;Prepaids
                                         and Deposits&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_892_eifrs-full--DisclosureOfExpensesExplanatory_zytEmhziE1ya" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zZhmrePEqh58" style="display: none; visibility: hidden"&gt;Schedule of prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250701__20251231_zU1sLb7Sk8ec" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240701__20250630_zlLmwlHRl9I4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--PrepaidInsurances_uCAD_zZYDB13dmovg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
    insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;349,509&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94,960&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--PrepaidProfessionalFees_uCAD_zRPj830oC9Bf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
    professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;157,269&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;434,419&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--PrepaidRents_uCAD_zeMyCyguTDj7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
    rent&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;133,868&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;133,868&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--AdvancesMadeToSuppliersAndDeposits_uCAD_zdYsjtpTcwT3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advances
    made to suppliers and deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,105&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,880&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--TotalCurrentPrepaidExpense_uCAD_zwbw4qmzCqR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="color: rgb(204,238,255); font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;648,751&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;689,127&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;/p&gt;

&lt;p id="xdx_8A8_zabEeyprG7x7" style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory>
    <ifrs-full:DisclosureOfExpensesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000602">&lt;p id="xdx_892_eifrs-full--DisclosureOfExpensesExplanatory_zytEmhziE1ya" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B4_zZhmrePEqh58" style="display: none; visibility: hidden"&gt;Schedule of prepaid expenses&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250701__20251231_zU1sLb7Sk8ec" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240701__20250630_zlLmwlHRl9I4" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--PrepaidInsurances_uCAD_zZYDB13dmovg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
    insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;349,509&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;94,960&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--PrepaidProfessionalFees_uCAD_zRPj830oC9Bf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
    professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;157,269&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;434,419&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--PrepaidRents_uCAD_zeMyCyguTDj7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
    rent&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;133,868&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;133,868&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--AdvancesMadeToSuppliersAndDeposits_uCAD_zdYsjtpTcwT3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Advances
    made to suppliers and deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,105&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;25,880&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_ecustom--TotalCurrentPrepaidExpense_uCAD_zwbw4qmzCqR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="color: rgb(204,238,255); font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;648,751&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;689,127&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfExpensesExplanatory>
    <fnuc:PrepaidInsurances
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000604"
      unitRef="CAD">349509</fnuc:PrepaidInsurances>
    <fnuc:PrepaidInsurances
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000605"
      unitRef="CAD">94960</fnuc:PrepaidInsurances>
    <fnuc:PrepaidProfessionalFees
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000607"
      unitRef="CAD">157269</fnuc:PrepaidProfessionalFees>
    <fnuc:PrepaidProfessionalFees
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000608"
      unitRef="CAD">434419</fnuc:PrepaidProfessionalFees>
    <fnuc:PrepaidRents
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000610"
      unitRef="CAD">133868</fnuc:PrepaidRents>
    <fnuc:PrepaidRents
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000611"
      unitRef="CAD">133868</fnuc:PrepaidRents>
    <fnuc:AdvancesMadeToSuppliersAndDeposits
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000613"
      unitRef="CAD">8105</fnuc:AdvancesMadeToSuppliersAndDeposits>
    <fnuc:AdvancesMadeToSuppliersAndDeposits
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000614"
      unitRef="CAD">25880</fnuc:AdvancesMadeToSuppliersAndDeposits>
    <fnuc:TotalCurrentPrepaidExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000616"
      unitRef="CAD">648751</fnuc:TotalCurrentPrepaidExpense>
    <fnuc:TotalCurrentPrepaidExpense
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000617"
      unitRef="CAD">689127</fnuc:TotalCurrentPrepaidExpense>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000619">&lt;p id="xdx_809_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zsxC4d0Bfuph" style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82E_zv9LpkSmoBLh"&gt;Short-term
                                         Loan Receivable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes loans outstanding as at December 31, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--ScheduleOfLoansAndAdvancesToRelatedPartyTableTextBlock_zTQRUVdlW6H" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zVR2PEBkH4I8" style="color: White"&gt;Schedule
of Loan Outstanding&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 2pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.55pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Borrower&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.55pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 13.1pt; text-align: right; text-indent: 14.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Opening
                                         June 30, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Repayments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accrued
                                         Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FX
                                         Movement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.25pt; text-align: right; text-indent: 33pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Closing
                                         December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.25pt; text-align: right; text-indent: 33pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    T.I.M.E. Organization, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zSkl8yG6I4wj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,046,450&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_ziIQXfwZhU7" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zA5IQwSJnmg5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Repayments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(577,023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zOPKXssowfa6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zUB4hmdmHYqe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="FX Movement"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,929&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_znlgoE5nx804" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,481,356&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minglement
    Solutions LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zWNepczgry83" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0634"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zhaGVaAoCh5a" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,430,320&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_ze3iaeE4AFhe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0636"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_z2av6SAItf1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0637"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zi3Plc9cWogl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,820&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zF8l44wjIkQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,426,500&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;AK
    Holdings Group Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zlF8wdNymCW2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0640"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_z3zlkgsS4Tua" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,891,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zR6MHQm3eOK" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zO7ZjUFoP2ia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;98,413&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_z1IdnsL8hQJ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(200,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zFO6wCMwh2i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,789,093&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CV3
    Group, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_za08SUGS7jB" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0646"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_z2NOL3xmpOl8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,480,434&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_z5rfzeDW6b9c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0648"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_zjuWcOTuK8i4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,038&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_z1Cj6n2z58Ij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(25,984&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_zRQ6D7aZIfC7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,473,488&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Starlink
    Capital LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zyjEKlnXlbLd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zElfv2MafHV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,930,033&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zFZePvngFKUl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zLq3T92Q2qQl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,678&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zUpq6uULBsCl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,193&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zbbipQCxOPa8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,924,518&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Summit
    Strategies LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_z2ffr5uD4LLa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zFmsbD5Qb356" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,293,910&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zGk6yFM7FSMf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0660"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zmsgpkDRZk37" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;173,651&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zBzw1Iwd7Rg7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(166,790&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zpOc4xe1LU6a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,300,771&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--LoansAndReceivables_iS_c20250701__20251231_zsbS1TfKTcij" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,046,450&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231_zFTLGMKupvU8" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,026,040&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231_zkvsjlWEsHl9" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(577,023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231_zn2liX6xhm4a" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;296,780&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231_zxYPFRMSJCk1" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(396,521&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--LoansAndReceivables_iE_c20250701__20251231_z5S5HQlyZJTe" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,395,726&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AD_z5msAhs6zvmj" style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;The
T.I.M.E. Organization Inc. &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 16, 2025, the Company advanced $&lt;span id="xdx_904_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20250616__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_z6D24e09hlfg"&gt;2,046,450&lt;/span&gt; (US $&lt;span id="xdx_902_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20250616__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zEh73FQXuOf5"&gt;1,500,000&lt;/span&gt;) to The T.I.M.E. Organization, Inc. under a senior secured term
loan agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
loan is repayable in 39 instalments of US $44,041, and the Company anticipates full repayment by December 31, 2026. The total
expected cash inflow over the term of the loan is approximately US $1,717,600. The effective yield embedded in the amortization
schedule is approximately 43% per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
facility is secured by a first-priority lien over the borrower&#x2019;s present and future accounts receivable, inventory, equipment,
general intangibles, and cash. The loan agreement also contains standard financial and reporting covenants, restrictions on incurrence
of additional debt, and customary events of default provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has designated this loan as a short-term financial asset measured at amortized cost.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Minglement
Solutions LLC.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 14, 2025, the Company advanced $&lt;span id="xdx_90E_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20250714__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zU4DdWNMH4je"&gt;3,430,320&lt;/span&gt; (US$&lt;span id="xdx_90D_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20250714__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zIPUJKaGR6J2"&gt;2,500,000&lt;/span&gt;) to Minglement Solutions LLC (&#x201c;Minglement&#x201d;), a Delaware
limited liability company, pursuant to a Senior Secured Promissory Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Repayment
is structured as a balloon payment of US$2,800,000 in December 2026. The note is senior in priority and secured by a first-priority
security interest in all assets of Minglement pursuant to a Security Agreement. The Company holds a right to demand immediate
repayment of the entire outstanding principal balance at any time upon 60 days' written notice (the &#x201c;Call Back Right&#x201d;),
in which case the borrower is required to repay US$2,625,000 (being US$2,500,000 principal plus a 5% return of US$125,000).&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;














&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;AK
Holdings Group Inc. &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 3, 2025, the Company advanced $&lt;span id="xdx_90B_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20251203__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_z9F9766QJf7i"&gt;10,891,343&lt;/span&gt; (US$&lt;span id="xdx_90A_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20251203__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zs2TlRPS22Jj"&gt;7,800,000&lt;/span&gt;) to AK Holdings Group Inc. (&#x201c;AK Holdings&#x201d;), a company
incorporated in Panama, pursuant to an unsecured promissory note. The note bears interest at 12% per annum, with all principal
and accrued interest due in a single bullet repayment on December 3, 2026. Interest is payable on the maturity date unless otherwise
agreed by the parties in writing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
note contains negative covenants restricting AK Holdings from incurring additional indebtedness, creating encumbrances, altering
its capital structure, making distributions, or disposing of assets outside the ordinary course of business, in each case without
the Company's consent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;CV3
Group, LLC&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 18, 2025, the Company advanced $&lt;span id="xdx_90E_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20251218__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_zgBDag57bTD2"&gt;4,480,434&lt;/span&gt; (US$&lt;span id="xdx_905_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20251218__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_zPvv5Wg8nUzj"&gt;3,250,000&lt;/span&gt;) to CV3 Group, LLC (&#x201c;CV3&#x201d;), a Delaware limited liability
company, pursuant to an unsecured promissory note. The note bears interest at 12% per annum, with all principal and accrued interest
due in a single bullet repayment on December 18, 2026. Interest is payable on the maturity date unless otherwise agreed by the
parties in writing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
note contains negative covenants restricting CV3 from incurring additional indebtedness, creating encumbrances, altering its capital
structure, making distributions, or disposing of assets outside the ordinary course of business, in each case without the Company's
consent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;CV3 is a related party of the Company because
of its relationship with one of the directors of the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Starlink
Capital LLC&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2025, the Company advanced $&lt;span id="xdx_90E_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20251222__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zeFlhmupAtEe"&gt;1,930,033&lt;/span&gt; (US$&lt;span id="xdx_906_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20251222__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zLDUaTYvcFq5"&gt;1,400,000&lt;/span&gt;) to Starlink Capital LLC (&#x201c;Starlink&#x201d;), a Wyoming limited
liability company, pursuant to an unsecured promissory note. The note bears interest at 12% per annum, with all principal and
accrued interest due in a single bullet repayment on December 22, 2026. Interest is payable on the maturity date unless otherwise
agreed by the parties in writing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
note contains negative covenants restricting Starlink from incurring additional indebtedness, creating encumbrances, altering
its capital structure, making distributions, or disposing of assets outside the ordinary course of business, in each case without
the Company's consent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Summit
Strategies LLC&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 3, 2025, the Company advanced $&lt;span id="xdx_905_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20251003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zQgN4RPi2Hh4"&gt;2,374,305&lt;/span&gt; (US$&lt;span id="xdx_909_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20251003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zCCQbWuqT1Jf"&gt;1,700,000&lt;/span&gt;) to Summit Strategies LLC (&#x201c;Summit Strategies&#x201d;), a Wyoming
limited liability company, pursuant to a secured promissory note. On October 30, 2025, the note was amended and a further $&lt;span id="xdx_900_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20251030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zdHnFwQG0sK5"&gt;3,513,375&lt;/span&gt;
(US$&lt;span id="xdx_90A_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20251030__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zXcpICZCNc99"&gt;2,500,000&lt;/span&gt;) was advanced. On November 3, 2025, a Second Note Amending Agreement was entered into and the Company advanced a
further $&lt;span id="xdx_908_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uCAD_c20251103__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zF3StWUl7gqf"&gt;1,406,230&lt;/span&gt; (US$&lt;span id="xdx_90E_eifrs-full--LoansAndAdvancesAtAmortisedCost_iI_uUSD_c20251103__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zBh4U6tnRo5f"&gt;1,000,000&lt;/span&gt;). Interest accrues on each tranche from its respective advance date at 12% per annum. All principal,
accrued interest, and other amounts are due in a single bullet repayment on July 3, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
note is secured by a first-priority lien over all assets of Summit Strategies, including all personal property, accounts, equipment,
investment property, deposit accounts, general intangibles, and proceeds thereof.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
note contains negative covenants restricting Summit Strategies from incurring additional indebtedness, creating encumbrances,
altering its capital structure, making distributions, or disposing of assets outside the ordinary course of business, in each
case without the Company's consent.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <fnuc:ScheduleOfLoansAndAdvancesToRelatedPartyTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000621">&lt;p id="xdx_899_ecustom--ScheduleOfLoansAndAdvancesToRelatedPartyTableTextBlock_zTQRUVdlW6H" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zVR2PEBkH4I8" style="color: White"&gt;Schedule
of Loan Outstanding&lt;/span&gt; &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 2pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.55pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Borrower&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.55pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 13.1pt; text-align: right; text-indent: 14.65pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Opening
                                         June 30, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Repayments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accrued
                                         Interest&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;FX
                                         Movement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.25pt; text-align: right; text-indent: 33pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Closing
                                         December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3.25pt; text-align: right; text-indent: 33pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    T.I.M.E. Organization, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zSkl8yG6I4wj" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,046,450&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_ziIQXfwZhU7" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zA5IQwSJnmg5" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Repayments"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(577,023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zOPKXssowfa6" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Accrued Interest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0629"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_zUB4hmdmHYqe" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="FX Movement"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11,929&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TIMEOrganizationMember_znlgoE5nx804" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,481,356&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Minglement
    Solutions LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zWNepczgry83" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0634"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zhaGVaAoCh5a" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,430,320&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_ze3iaeE4AFhe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0636"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_z2av6SAItf1e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0637"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zi3Plc9cWogl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,820&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--MinglementSolutionsMember_zF8l44wjIkQ7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,426,500&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;AK
    Holdings Group Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zlF8wdNymCW2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0640"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_z3zlkgsS4Tua" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,891,343&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zR6MHQm3eOK" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0642"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zO7ZjUFoP2ia" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;98,413&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_z1IdnsL8hQJ4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(200,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AKHoldingsGroupMember_zFO6wCMwh2i" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10,789,093&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;CV3
    Group, LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_za08SUGS7jB" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0646"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_z2NOL3xmpOl8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,480,434&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_z5rfzeDW6b9c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0648"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_zjuWcOTuK8i4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,038&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_z1Cj6n2z58Ij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(25,984&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CV3GroupMember_zRQ6D7aZIfC7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,473,488&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Starlink
    Capital LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zyjEKlnXlbLd" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0652"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zElfv2MafHV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,930,033&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zFZePvngFKUl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0654"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zLq3T92Q2qQl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;5,678&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zUpq6uULBsCl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(11,193&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--StarlinkCapitalMember_zbbipQCxOPa8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,924,518&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Summit
    Strategies LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--LoansAndReceivables_iS_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_z2ffr5uD4LLa" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0658"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zFmsbD5Qb356" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,293,910&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zGk6yFM7FSMf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0660"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zmsgpkDRZk37" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;173,651&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zBzw1Iwd7Rg7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(166,790&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--LoansAndReceivables_iE_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SummitStrategiesMember_zpOc4xe1LU6a" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,300,771&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--LoansAndReceivables_iS_c20250701__20251231_zsbS1TfKTcij" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2,046,450&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LoansAndAdvancesMadeRelatedPartyTransactions_c20250701__20251231_zFTLGMKupvU8" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;28,026,040&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--RepaymentsOfLoansAndAdvancesToRelatedParties_c20250701__20251231_zkvsjlWEsHl9" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(577,023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--InterestIncomeOnLoansAndAdvances_c20250701__20251231_zn2liX6xhm4a" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;296,780&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_c20250701__20251231_zxYPFRMSJCk1" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(396,521&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--LoansAndReceivables_iE_c20250701__20251231_z5S5HQlyZJTe" style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,395,726&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

</fnuc:ScheduleOfLoansAndAdvancesToRelatedPartyTableTextBlock>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30_custom_TIMEOrganizationMember"
      decimals="0"
      id="Fact000623"
      unitRef="CAD">2046450</ifrs-full:LoansAndReceivables>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-012025-12-31_custom_TIMEOrganizationMember"
      decimals="0"
      id="Fact000627"
      unitRef="CAD">-577023</fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_TIMEOrganizationMember"
      decimals="0"
      id="Fact000631"
      unitRef="CAD">11929</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31_custom_TIMEOrganizationMember"
      decimals="0"
      id="Fact000633"
      unitRef="CAD">1481356</ifrs-full:LoansAndReceivables>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-012025-12-31_custom_MinglementSolutionsMember"
      decimals="0"
      id="Fact000635"
      unitRef="CAD">3430320</fnuc:LoansAndAdvancesMadeRelatedPartyTransactions>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_MinglementSolutionsMember"
      decimals="0"
      id="Fact000638"
      unitRef="CAD">-3820</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31_custom_MinglementSolutionsMember"
      decimals="0"
      id="Fact000639"
      unitRef="CAD">3426500</ifrs-full:LoansAndReceivables>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-012025-12-31_custom_AKHoldingsGroupMember"
      decimals="0"
      id="Fact000641"
      unitRef="CAD">10891343</fnuc:LoansAndAdvancesMadeRelatedPartyTransactions>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-012025-12-31_custom_AKHoldingsGroupMember"
      decimals="0"
      id="Fact000643"
      unitRef="CAD">98413</fnuc:InterestIncomeOnLoansAndAdvances>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_AKHoldingsGroupMember"
      decimals="0"
      id="Fact000644"
      unitRef="CAD">-200663</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31_custom_AKHoldingsGroupMember"
      decimals="0"
      id="Fact000645"
      unitRef="CAD">10789093</ifrs-full:LoansAndReceivables>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-012025-12-31_custom_CV3GroupMember"
      decimals="0"
      id="Fact000647"
      unitRef="CAD">4480434</fnuc:LoansAndAdvancesMadeRelatedPartyTransactions>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-012025-12-31_custom_CV3GroupMember"
      decimals="0"
      id="Fact000649"
      unitRef="CAD">19038</fnuc:InterestIncomeOnLoansAndAdvances>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_CV3GroupMember"
      decimals="0"
      id="Fact000650"
      unitRef="CAD">-25984</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31_custom_CV3GroupMember"
      decimals="0"
      id="Fact000651"
      unitRef="CAD">4473488</ifrs-full:LoansAndReceivables>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-012025-12-31_custom_StarlinkCapitalMember"
      decimals="0"
      id="Fact000653"
      unitRef="CAD">1930033</fnuc:LoansAndAdvancesMadeRelatedPartyTransactions>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-012025-12-31_custom_StarlinkCapitalMember"
      decimals="0"
      id="Fact000655"
      unitRef="CAD">5678</fnuc:InterestIncomeOnLoansAndAdvances>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_StarlinkCapitalMember"
      decimals="0"
      id="Fact000656"
      unitRef="CAD">-11193</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31_custom_StarlinkCapitalMember"
      decimals="0"
      id="Fact000657"
      unitRef="CAD">1924518</ifrs-full:LoansAndReceivables>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-012025-12-31_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000659"
      unitRef="CAD">7293910</fnuc:LoansAndAdvancesMadeRelatedPartyTransactions>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-012025-12-31_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000661"
      unitRef="CAD">173651</fnuc:InterestIncomeOnLoansAndAdvances>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000662"
      unitRef="CAD">-166790</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000663"
      unitRef="CAD">7300771</ifrs-full:LoansAndReceivables>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000664"
      unitRef="CAD">2046450</ifrs-full:LoansAndReceivables>
    <fnuc:LoansAndAdvancesMadeRelatedPartyTransactions
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000665"
      unitRef="CAD">28026040</fnuc:LoansAndAdvancesMadeRelatedPartyTransactions>
    <fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000666"
      unitRef="CAD">-577023</fnuc:RepaymentsOfLoansAndAdvancesToRelatedParties>
    <fnuc:InterestIncomeOnLoansAndAdvances
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000667"
      unitRef="CAD">296780</fnuc:InterestIncomeOnLoansAndAdvances>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000668"
      unitRef="CAD">-396521</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <ifrs-full:LoansAndReceivables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000669"
      unitRef="CAD">29395726</ifrs-full:LoansAndReceivables>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-06-16_custom_TIMEOrganizationMember"
      decimals="0"
      id="Fact000670"
      unitRef="CAD">2046450</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-06-16_custom_TIMEOrganizationMember"
      decimals="0"
      id="Fact000671"
      unitRef="USD">1500000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-07-14_custom_MinglementSolutionsMember"
      decimals="0"
      id="Fact000672"
      unitRef="CAD">3430320</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-07-14_custom_MinglementSolutionsMember"
      decimals="0"
      id="Fact000673"
      unitRef="USD">2500000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-12-03_custom_AKHoldingsGroupMember"
      decimals="0"
      id="Fact000682"
      unitRef="CAD">10891343</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-12-03_custom_AKHoldingsGroupMember"
      decimals="0"
      id="Fact000683"
      unitRef="USD">7800000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-12-18_custom_CV3GroupMember"
      decimals="0"
      id="Fact000684"
      unitRef="CAD">4480434</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-12-18_custom_CV3GroupMember"
      decimals="0"
      id="Fact000685"
      unitRef="USD">3250000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-12-22_custom_StarlinkCapitalMember"
      decimals="0"
      id="Fact000686"
      unitRef="CAD">1930033</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-12-22_custom_StarlinkCapitalMember"
      decimals="0"
      id="Fact000687"
      unitRef="USD">1400000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-10-03_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000688"
      unitRef="CAD">2374305</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-10-03_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000689"
      unitRef="USD">1700000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-10-30_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000690"
      unitRef="CAD">3513375</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-10-30_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000691"
      unitRef="USD">2500000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-11-03_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000692"
      unitRef="CAD">1406230</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <ifrs-full:LoansAndAdvancesAtAmortisedCost
      contextRef="AsOf2025-11-03_custom_SummitStrategiesMember"
      decimals="0"
      id="Fact000693"
      unitRef="USD">1000000</ifrs-full:LoansAndAdvancesAtAmortisedCost>
    <fnuc:DisclousureOfShortTermInvestment contextRef="From2025-07-01to2025-12-31" id="Fact000695">&lt;p id="xdx_802_ecustom--DisclousureOfShortTermInvestment_zx9NlErI7zT3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_821_zErn4OwAdpo"&gt;Short-term
                                         Investments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s short-term investments consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--DisclousureOfCompanysShortTemInvestmentExplanatory_zJwfyfH5rdhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zEaeOUX5wzh2" style="display: none; visibility: hidden"&gt;Schedule of Company&#x2019;s Short-Term Investment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
                                         at June&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30,
                                         2025&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Realized
    gain (loss) on sale of investments&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4pt; text-align: right; text-indent: 6.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized
                                         gain (loss) on change of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4pt; text-align: right; text-indent: 6.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;b&gt;fair
                                         value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;investments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FX
    Movement&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: right; text-indent: 8.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
                                         at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: right; text-indent: 8.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Top
    End Energy Limited (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zE3hO5H3E5Gg" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Beginning Balance Of Short Term Investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;78,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zY08m1lB6x6j" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0700"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zsDhOpcMyZsh" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(36,817&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zS3BJGtPeILf" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,076&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_ztuMYgPXuEM3" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,603&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zJqnjObfXpy6" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,486&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zVuboLfudjRd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Ending Balance Of Short Term Investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,544&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mont
    Royal Resources Limited (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z6TEM1JprYxl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zCLs8fn27chh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,197,644&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z8iRhxBDBdj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(426,106&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zG9PWzE1FBn1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;90,772&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zNUKnqe4Nc15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;269,854&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zaB6WitZEp6e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,375&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zkVzUo1eJG0c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,140,539&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Desert
    Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zKXR9pHfhZm7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0714"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zGd4W0IarRsb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;910,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zjWfgthYpAg3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0716"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zAIEuq7onFS3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0717"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z8hABSVl6Fdh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,470&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zbKpZ7uMQTgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,700&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zIvRT96W9I8c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,006,170&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US1
    Critical Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z8v8qV9ySQff" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0721"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zDQzDmm7h5w" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;914,700&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zy0kx2txDnr5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0723"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z7XLODO63odb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0724"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zXq0CxD6ooij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;274,410&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zJzq6XpyaFEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0726"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z0XBQwm7swI9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,189,110&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pinnacle
    Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zxXcbnygu049" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zGohySPuxQLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;122,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zu2Bktrm8EY2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zo0cGsWMKi48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0731"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zdqHaN184HRl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(87,080&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zoqMQwzvT15f" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(146&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zX0RltHHkHNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Resolution
    Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zdhLFqc5qdO7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,582,184&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z0ICbPG21nu" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,323&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zaN8QHWgNdBb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,262,268&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_ztBtAU8fYi2h" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;619,474&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zWqzg0U2xJqc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0739"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z9htK3e0VE71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,287&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zK69ExqLYnx6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0741"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Resolution
    Minerals Ltd. (Options)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zJ2VMWtsI0bh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z0kvLCbfU19l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0743"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z248k6TOB5Ub" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(154,170&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zE0NLpxUQxNc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;154,170&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zOjZwF5n38Wj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zzMYTZif6j22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0747"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zz7RAbLIVpQf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0748"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zZMeO4cdM4A6" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,660,738&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zRtr9CNvtAQ2" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,173,732&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zgH1tsvxU7Xk" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,879,361&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zYMXrMcJQ9xd" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;861,340&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zefUDlYHVeQg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;540,051&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z3MyDW6Nk54a" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,702&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_ztr3wyTryYw" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,402,202&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;p id="xdx_8AA_zrQWgmSMCbej" style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</fnuc:DisclousureOfShortTermInvestment>
    <fnuc:DisclousureOfCompanysShortTemInvestmentExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000697">&lt;p id="xdx_892_ecustom--DisclousureOfCompanysShortTemInvestmentExplanatory_zJwfyfH5rdhb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zEaeOUX5wzh2" style="display: none; visibility: hidden"&gt;Schedule of Company&#x2019;s Short-Term Investment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Entity&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
                                         at June&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;30,
                                         2025&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Realized
    gain (loss) on sale of investments&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4pt; text-align: right; text-indent: 6.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Unrealized
                                         gain (loss) on change of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.4pt; text-align: right; text-indent: 6.95pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;b&gt;fair
                                         value of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;investments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;FX
    Movement&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: right; text-indent: 8.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
                                         at December 31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 7.35pt; text-align: right; text-indent: 8.3pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Top
    End Energy Limited (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zE3hO5H3E5Gg" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Beginning Balance Of Short Term Investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;78,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zY08m1lB6x6j" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0700"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zsDhOpcMyZsh" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(36,817&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zS3BJGtPeILf" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3,076&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_ztuMYgPXuEM3" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(8,603&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zJqnjObfXpy6" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,486&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--TopEndEnergyLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zVuboLfudjRd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Ending Balance Of Short Term Investment"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,544&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Mont
    Royal Resources Limited (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z6TEM1JprYxl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0707"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zCLs8fn27chh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,197,644&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z8iRhxBDBdj4" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(426,106&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zG9PWzE1FBn1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;90,772&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zNUKnqe4Nc15" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;269,854&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zaB6WitZEp6e" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,375&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--MontRoyalResourcesLimitedMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zkVzUo1eJG0c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,140,539&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Desert
    Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zKXR9pHfhZm7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0714"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zGd4W0IarRsb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;910,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zjWfgthYpAg3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0716"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zAIEuq7onFS3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0717"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z8hABSVl6Fdh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;91,470&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zbKpZ7uMQTgh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;4,700&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--DesertMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zIvRT96W9I8c" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,006,170&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US1
    Critical Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z8v8qV9ySQff" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0721"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zDQzDmm7h5w" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;914,700&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zy0kx2txDnr5" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0723"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z7XLODO63odb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0724"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zXq0CxD6ooij" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;274,410&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zJzq6XpyaFEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0726"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--US1CriticalMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z0XBQwm7swI9" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,189,110&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pinnacle
    Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zxXcbnygu049" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0728"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zGohySPuxQLj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;122,065&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zu2Bktrm8EY2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0730"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zo0cGsWMKi48" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0731"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zdqHaN184HRl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(87,080&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zoqMQwzvT15f" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(146&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--PinnacleMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zX0RltHHkHNg" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;34,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Resolution
    Minerals Ltd. (Shares)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zdhLFqc5qdO7" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,582,184&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z0ICbPG21nu" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;29,323&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zaN8QHWgNdBb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,262,268&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_ztBtAU8fYi2h" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;619,474&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zWqzg0U2xJqc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0739"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z9htK3e0VE71" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;31,287&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zK69ExqLYnx6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0741"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Resolution
    Minerals Ltd. (Options)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zJ2VMWtsI0bh" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0742"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z0kvLCbfU19l" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0743"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z248k6TOB5Ub" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(154,170&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zE0NLpxUQxNc" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;154,170&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zOjZwF5n38Wj" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zzMYTZif6j22" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0747"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__dei--LegalEntityAxis__custom--ResolutionMineralsLtdOptionsMember__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zz7RAbLIVpQf" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0748"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShortTermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zZMeO4cdM4A6" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,660,738&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--AdditionToShortTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zRtr9CNvtAQ2" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,173,732&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DispositionsOfShortTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zgH1tsvxU7Xk" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(2,879,361&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GainLossOnShortTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zYMXrMcJQ9xd" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;861,340&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestments_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_zefUDlYHVeQg" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;540,051&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_z3MyDW6Nk54a" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;45,702&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShortTermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--ShorttermContractsMember_ztr3wyTryYw" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3,402,202&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





&lt;p style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;

</fnuc:DisclousureOfCompanysShortTemInvestmentExplanatory>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000699"
      unitRef="CAD">78554</fnuc:ShortTermInvestment>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000701"
      unitRef="CAD">-36817</fnuc:DispositionsOfShortTermInvestment>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000702"
      unitRef="CAD">-3076</fnuc:GainLossOnShortTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000703"
      unitRef="CAD">-8603</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000704"
      unitRef="CAD">1486</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_TopEndEnergyLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000706"
      unitRef="CAD">31544</fnuc:ShortTermInvestment>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000708"
      unitRef="CAD">1197644</fnuc:AdditionToShortTermInvestment>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000709"
      unitRef="CAD">-426106</fnuc:DispositionsOfShortTermInvestment>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000710"
      unitRef="CAD">90772</fnuc:GainLossOnShortTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000711"
      unitRef="CAD">269854</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000712"
      unitRef="CAD">8375</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_MontRoyalResourcesLimitedMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000713"
      unitRef="CAD">1140539</fnuc:ShortTermInvestment>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000715"
      unitRef="CAD">910000</fnuc:AdditionToShortTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000718"
      unitRef="CAD">91470</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000719"
      unitRef="CAD">4700</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_DesertMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000720"
      unitRef="CAD">1006170</fnuc:ShortTermInvestment>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000722"
      unitRef="CAD">914700</fnuc:AdditionToShortTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000725"
      unitRef="CAD">274410</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_US1CriticalMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000727"
      unitRef="CAD">1189110</fnuc:ShortTermInvestment>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000729"
      unitRef="CAD">122065</fnuc:AdditionToShortTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000732"
      unitRef="CAD">-87080</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000733"
      unitRef="CAD">-146</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_custom_PinnacleMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000734"
      unitRef="CAD">34839</fnuc:ShortTermInvestment>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000735"
      unitRef="CAD">1582184</fnuc:ShortTermInvestment>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000736"
      unitRef="CAD">29323</fnuc:AdditionToShortTermInvestment>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000737"
      unitRef="CAD">-2262268</fnuc:DispositionsOfShortTermInvestment>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000738"
      unitRef="CAD">619474</fnuc:GainLossOnShortTermInvestment>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000740"
      unitRef="CAD">31287</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000744"
      unitRef="CAD">-154170</fnuc:DispositionsOfShortTermInvestment>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_custom_ResolutionMineralsLtdOptionsMember_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000745"
      unitRef="CAD">154170</fnuc:GainLossOnShortTermInvestment>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000749"
      unitRef="CAD">1660738</fnuc:ShortTermInvestment>
    <fnuc:AdditionToShortTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000750"
      unitRef="CAD">3173732</fnuc:AdditionToShortTermInvestment>
    <fnuc:DispositionsOfShortTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000751"
      unitRef="CAD">-2879361</fnuc:DispositionsOfShortTermInvestment>
    <fnuc:GainLossOnShortTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000752"
      unitRef="CAD">861340</fnuc:GainLossOnShortTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments
      contextRef="From2025-07-012025-12-31_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000753"
      unitRef="CAD">540051</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestments>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000754"
      unitRef="CAD">45702</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:ShortTermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_ShorttermContractsMember"
      decimals="0"
      id="Fact000755"
      unitRef="CAD">3402202</fnuc:ShortTermInvestment>
    <ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000757">&lt;p id="xdx_807_eifrs-full--DisclosureOfExplorationAndEvaluationAssetsExplanatory_zbj2b2CvZQQc" style="font: bold 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82E_z53QxNClvgz2"&gt;Exploration
                                         and Evaluation Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the movement of the Company&#x2019;s E&amp;amp;E assets for the six months ended December 31, 2025 and the year
ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfMovementOfTheCompanySEeAssetsTextBlock_zgGOQa8YsoI5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z5itOgQbddk8" style="display: none; visibility: hidden"&gt;Schedule of Movement Of The Company's EE Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IntangibleExplorationAndEvaluationAssets_iS_uCAD_c20250701__20251231_zSTO7soZynG" style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Beginning Intangible exploration and evaluation assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,980,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--IntangibleExplorationAndEvaluationAssets_iS_uCAD_c20240701__20250630_zzFrcR0ZKgYf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,612,758&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exploration
    and evaluation expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationExpenditure_uCAD_c20250701__20251231_zf7oEPmsKHkg" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Exploration and evaluation expenditures"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,514,153&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExplorationAndEvaluationExpenditure_uCAD_c20240701__20250630_zz6F4v35YpG2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,818,048&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions
    per property agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AdditionsPerPropertyAgreements_uCAD_c20250701__20251231_z4AAyT6XPhfb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Additions per property agreements"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AdditionsPerPropertyAgreements_uCAD_c20240701__20250630_zfgtqFCWO45j" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0768"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal
    due to termination of property agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_uCAD_c20250701__20251231_zgR9WFC49uFk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Disposal due to termination of property agreements"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0770"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_uCAD_c20240701__20250630_zmsveRJ9VuX4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,450,319&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--IntangibleExplorationAndEvaluationAssets_iE_uCAD_c20250701__20251231_zv14kllDxiJc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Intangible exploration and evaluation assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,144,640&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IntangibleExplorationAndEvaluationAssets_iE_uCAD_c20240701__20250630_z15pOyyVPhi8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,980,487&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p id="xdx_8AE_zHwhGsR6YMgc" style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;ACME
Option Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 29, 2024, the Company entered &lt;span style="background-color: #FEFEFE"&gt;into &lt;/span&gt;an option agreement (the &#x201c;ACME
Option Agreement&#x201d;) with ACME Lithium Inc. (&#x201c;ACME&#x201d;), pursuant to which ACME has granted the Company the option
to earn up to a 90% undivided interest in the mineral claims held by ACME at its Manitoba lithium project areas, located in south
eastern Manitoba, Canada (the &#x201c;Shatford Lake Lithium Project&#x201d;), which is comprised of 37 mineral claims located over
three project areas - Shatford Lake, Birse Lake, and Cat-Euclid Lake, totaling approximately 17,000 acres.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the ACME Option Agreement, the Company may exercise the option by paying a total of $800,000 and incurring a total of $1,800,000
in exploration and development (&#x201c;E&amp;amp;D&#x201d;) expenditures over a two-year period, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Initial
                                         payment: Cash payment of $20,000 (paid);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
                                         execution: Cash payment of $130,000 (paid);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;First
                                         year: Cash payment of $150,000 (paid) and minimum E&amp;amp;D expenditures of $600,000 (incurred);
                                         and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Second
                                         year: Cash payment of $500,000 and minimum E&amp;amp;D expenditures of $1,200,000.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 26, 2025, the Company entered into a mineral property purchase and sale agreement with ACME pursuant to which the Company
acquired the remaining 49% undivided interest in the Shatford Lake Lithium Project for cash consideration of $650,000. Concurrently,
the option agreement dated January 29, 2024 between the parties, under which the Company had previously earned a 51% undivided
interest in the property, was terminated. As a result of the acquisition, the Company holds a 100% undivided interest in the property.
The property is subject to a 2% gross overriding royalty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Engo
Valley Uranium Project &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 31, 2024, the Company and a British Columbia company (the &#x201c;Vendor&#x201d;) entered into a Share Purchase Agreement (the
&#x201c;SPA&#x201d;) to acquire 100% of Engo Valley Pty Ltd. (&#x201c;Engo Valley&#x201d;), a private Australian company, pursuant
to which Frontier will acquire up to 85% undivided indirect interest in Namibia Minerals and Investment Holdings (Proprietary)
Limited (the &#x201c;Project Company&#x201d;), a private Namibian company, which in turn is the sole registered and beneficial owner
of 100% of the right, title and interest in the Exclusive Prospecting License - 5887 (the &#x201c;License&#x201d;) for the Engo
Valley Uranium Project.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;





&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the SPA, the Company will acquire Engo Valley in two stages, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;First
                                         Stage Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Frontier
acquired an initial 80% undivided interest in Engo Valley, which represents a 68% undivided indirect interest in the Project Company
(the &#x201c;First Stage Interest&#x201d;), upon:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;payment
                                         to the Vendor of US $250,000 in cash (paid);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;incurring
                                         exploration expenditures of a minimum of US $200,000 (incurred); and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;allotting
                                         and issuing to the Vendor 155,730 common shares (issued).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Second
                                         Stage Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company will acquire an additional 20% undivided interest in Engo Valley, which represents a 17% undivided indirect interest in
the Project Company by (the &#x201c;Second Stage Interest&#x201d;), for a total undivided indirect interest of 85% in the Project
Company, upon:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;incurring
                                         additional exploration expenditures of a minimum of US $800,000 on or before June 30,
                                         2025 (incurred), provided, that any expenditures we incurred in excess of the US $200,000
                                         minimum exploration expenditures in connection with our acquisition of the First Stage
                                         Interest will be credited against the expenditure commitment for the Second Stage Interest.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;After
the Company acquires the Second Stage Interest, the Company will be obligated to make the following payments to the Vendor, in
the form of its common shares, upon the achievement of the following milestones:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Milestone Payment No. 1: In the event an SK-1300 compliant technical report determines on or before
July 31, 2027 that there is a uranium mineral resource on the Engo Valley Uranium Project of a minimum of 10 million pounds with
a minimum average grade of 250 parts per million, or ppm, U3O8, the Company will issue an aggregate of 79,302 common shares; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 36pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Milestone Payment No. 2: In the event an SK-1300 compliant technical report determines on or before
July 31, 2029 that there is a uranium mineral resource on the Engo Valley Uranium Project of a minimum of 25 million pounds with
a minimum average grade of 250 ppm U3O8, the Company will issue an aggregate of 79,302 common shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Mound
Lake Property&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 10, 2025, the Company and Free Battery Metal Limited (&#x201c;Free Battery&#x201d;) entered into a Term Sheet pursuant to
which Frontier can earn up to an 80% interest in Free Battery&#x2019;s Mound Lake Property. The Mound Lake Property encompasses
243 single-cell unpatented mineral claims covering over 4,800 hectares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 5, 2025, the Company and Free Battery entered into Amendment No. 1 to the Definitive Agreement, pursuant to which the
timelines for the Second Option and Third Option were each extended by one year in consideration of the Company paying $20,000
and the claim renewal costs for the Mound Lake Property (estimated at approximately $8,000) on or before January 10, 2026 (paid).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms and conditions of the transaction, Frontier can earn up to an 80% interest in the Mound Lake property through the
following option earn-ins:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;First
                                         Option: Upon payment of $20,000 by Frontier to Free Battery (paid), Frontier shall earn
                                         a 10% interest in the Mound Lake Property.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Second
                                         Option: On or before the second anniversary of the effective date, Frontier shall have
                                         the right to acquire an additional 41% interest in the Mound Lake Property upon Frontier:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;having
                                         made work expenditures of at least $1,000,000; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;paying
                                         $500,000 to Free Battery.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Third
                                         Option: On or before the third anniversary of the effective date, Frontier shall have
                                         the right to acquire an additional 29% interest in the Mound Lake Property upon Frontier:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;having
                                         made additional work expenditures of $1,000,000; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;paying
                                         an additional $1,000,000 to Free Battery.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;







&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;











&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the completion of a pre-feasibility study on the Mound Lake Property, Frontier will be the operator of the Mound Lake Property
and be responsible for all costs and expenses associated with exploration and development of the Mound Lake Property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the completion of a pre-feasibility study on the Mound Lake Property, the parties shall diligently and in good faith negotiate
the terms of a joint venture arrangement to advance development of the Mound Lake Property. Such arrangement will include, among
other things, (i) a mechanism by which expenditures on the Mound Lake Property will be funded on a pro rata basis, based upon
the respective parties proportionate interest in the Mound Lake Property; (ii) in the event any one party declines to fund the
expenditures in proportion to their interest, their respective interest in the joint venture shall be reduced accordingly, subject
to the Dilution Conversion (as defined hereinafter); (iii) a mechanism for preparing and approving a budget and work program in
respect of the Mound Lake Property; and (iv) the ongoing management of the joint venture.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the exercise of the First Option, in the event that either party's interest in the Mound Lake Property falls below 10%, such party's
interest shall be converted into a 1% net smelter return royalty on the Mound Lake Property, which shall not be subject to a right
of first refusal or any other pre-emptive rights in favour to such party (the &#x201c;Dilution Conversion&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Black
Lake Uranium Project &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 21, 2024, the Company acquired Global Uranium Acquisition Corp (Pty) Ltd. (&#x201c;Global Uranium&#x201d;) for cash consideration
of $50,000 and the issuance of 76,923 common shares. Global Uranium held an option agreement to acquire a 100% interest in the
Black Lake Uranium Project. On May 8, 2025, the Company defaulted on the option agreement. A loss on termination of the Black
Lake option agreement of $1,379,415 was recorded in the consolidated statements of loss and comprehensive loss, consisting of
previously capitalized E&amp;amp;E assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Buffalo
Uranium Project &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 18, 2025, the Company entered into a binding letter of intent to acquire Bazooka Resources Ltd. (&#x201c;Bazooka&#x201d;).
Bazooka holds the exclusive option to acquire a 100% interest in the Buffalo Uranium Project. The Company made an initial cash
payment of $70,904 (US$50,000) but subsequently made the determination to terminate the binding letter of intent. A loss on termination
of $70,904 was recorded in the consolidated statements of loss and comprehensive loss, consisting of previously capitalized E&amp;amp;E
assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Muskrat
Dam Option Agreement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 5, 2024, the Company &lt;span style="background-color: #FEFEFE"&gt;entered into an option agreement (the &#x201c;Muskrat Dam
Option Agreement&#x201d;) with a private Manitoba company (&#x201c;Manco&#x201d;) to acquire a 90% undivided interest in a group
of mineral claims in the Muskrat Dam Lake area of Western Ontario, near Kenora and the border with Manitoba (the &#x201c;Muskrat
Dam&#160;Project&#x201d;). &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the Muskrat Dam Option Agreement, the Company paid $50,000, issued an aggregate of 38,462 common shares (Note 19), and granted
153,846 2024 Settlement Warrants (each a 2024 Settlement Warrant), whereby each 2024 Settlement Warrant is exercisable for a period
of five years at an exercise price of US $19.50 (see Note 16).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
option agreement was amended and terminated on June 28, 2024, and the Company issued an aggregate of 269,231 shares in consideration
for the termination (see Note 19). The 153,846 2024 Settlement Warrants previously issued were cancelled (see Note 16). A loss
on termination of the Muskrat Dam Option Agreement of $&lt;span id="xdx_905_ecustom--LossOnTerminationOfMuskratDamProject_uCAD_c20250701__20251231_zHyycTSazH3f"&gt;4,652,894&lt;/span&gt; was recorded in the consolidated statements of loss and comprehensive
loss, consisting of $3,415,591 related to the issuance of termination shares, $2,805,780 related to previously capitalized E&amp;amp;E
assets that were written off, net of $1,568,557 related to the derecognition of the derivative liability associated with the cancelled
2024 Settlement Warrants.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory>
    <fnuc:ScheduleOfMovementOfTheCompanySEeAssetsTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000759">&lt;p id="xdx_898_ecustom--ScheduleOfMovementOfTheCompanySEeAssetsTextBlock_zgGOQa8YsoI5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z5itOgQbddk8" style="display: none; visibility: hidden"&gt;Schedule of Movement Of The Company's EE Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IntangibleExplorationAndEvaluationAssets_iS_uCAD_c20250701__20251231_zSTO7soZynG" style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Beginning Intangible exploration and evaluation assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,980,487&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--IntangibleExplorationAndEvaluationAssets_iS_uCAD_c20240701__20250630_zzFrcR0ZKgYf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;26,612,758&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Exploration
    and evaluation expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationExpenditure_uCAD_c20250701__20251231_zf7oEPmsKHkg" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Exploration and evaluation expenditures"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,514,153&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExplorationAndEvaluationExpenditure_uCAD_c20240701__20250630_zz6F4v35YpG2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,818,048&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additions
    per property agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--AdditionsPerPropertyAgreements_uCAD_c20250701__20251231_z4AAyT6XPhfb" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Additions per property agreements"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;650,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AdditionsPerPropertyAgreements_uCAD_c20240701__20250630_zfgtqFCWO45j" style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0768"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Disposal
    due to termination of property agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_uCAD_c20250701__20251231_zgR9WFC49uFk" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Disposal due to termination of property agreements"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0770"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_uCAD_c20240701__20250630_zmsveRJ9VuX4" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,450,319&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--IntangibleExplorationAndEvaluationAssets_iE_uCAD_c20250701__20251231_zv14kllDxiJc" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Intangible exploration and evaluation assets"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,144,640&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--IntangibleExplorationAndEvaluationAssets_iE_uCAD_c20240701__20250630_z15pOyyVPhi8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,980,487&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



</fnuc:ScheduleOfMovementOfTheCompanySEeAssetsTextBlock>
    <ifrs-full:IntangibleExplorationAndEvaluationAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000761"
      unitRef="CAD">32980487</ifrs-full:IntangibleExplorationAndEvaluationAssets>
    <ifrs-full:IntangibleExplorationAndEvaluationAssets
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000762"
      unitRef="CAD">26612758</ifrs-full:IntangibleExplorationAndEvaluationAssets>
    <fnuc:ExplorationAndEvaluationExpenditure
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000764"
      unitRef="CAD">1514153</fnuc:ExplorationAndEvaluationExpenditure>
    <fnuc:ExplorationAndEvaluationExpenditure
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000765"
      unitRef="CAD">7818048</fnuc:ExplorationAndEvaluationExpenditure>
    <fnuc:AdditionsPerPropertyAgreements
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000767"
      unitRef="CAD">650000</fnuc:AdditionsPerPropertyAgreements>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000771"
      unitRef="CAD">-1450319</ifrs-full:DisposalsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleExplorationAndEvaluationAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000773"
      unitRef="CAD">35144640</ifrs-full:IntangibleExplorationAndEvaluationAssets>
    <ifrs-full:IntangibleExplorationAndEvaluationAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000774"
      unitRef="CAD">32980487</ifrs-full:IntangibleExplorationAndEvaluationAssets>
    <fnuc:LossOnTerminationOfMuskratDamProject
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000790"
      unitRef="CAD">4652894</fnuc:LossOnTerminationOfMuskratDamProject>
    <ifrs-full:DisclosureOfJointVenturesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000796">&lt;p id="xdx_80B_eifrs-full--DisclosureOfJointVenturesExplanatory_zcih5jwiETId" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_820_zoH2SOjc80v1"&gt;Investment
                                         in Joint Venture&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 12, 2025, Frontier announced that it has entered into a 50/50 joint venture (the &#x201c;Joint Venture&#x201d;) with Global
Uranium and Enrichment Limited (&#x201c;GUE&#x201d;), to acquire 100% of the Pine Ridge Uranium Project (&#x201c;Pine Ridge&#x201d;) in
the Powder River Basin in Wyoming, United States.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfFinancialInformationInJointVenture_zJYgwFaznZ61" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s interest in the Joint Venture (&#x201c;Powder River Basin LLC&#x201d; or the &#x201c;Buyer&#x201d;) is accounted for
using the equity method in the consolidated financial statements. Summarized financial information of the joint venture are set
out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_z8AZszVRXNgk" style="display: none; visibility: hidden"&gt;Schedule of financial information in Joint Venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20251231_z0GtPYQtYmQ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250630_zDi8XzDTUpI8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--CurrentReceivablesDueFromJointVentures_iI_d0_uCAD_ztX51IRCKKA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;292,144&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,154,723&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--NoncurrentReceivablesDueFromJointVentures_iI_d0_uCAD_zqIgxyp0PNE6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,771,486&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,115,558&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--CurrentLiabilitiesDueFromJointVentures_iI_d0_uCAD_zz50TR7ZiHX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,339,806&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,657,035&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--NonCurrentLiabilitiesDueFromJointVentures_iI_d0_uCAD_z9pFD7Zn8FTd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,297,153&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,232,250&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eifrs-full--CurrentRecognisedAssetsDefinedBenefitPlan_iI_d0_uCAD_z4sMG9GPnbqe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,426,671&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,380,996&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8AE_zSpxqhDolCol" style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfProfitAndLossOfPowderRiverBasinLLCInJointVenture_zWSyglWbTnX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
summarized statement of profit and loss of Powder River Basin LLC for the six months ended December 31, 2025 and 2024 is set out
below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zbOdMvfW8NB7" style="display: none; visibility: hidden"&gt;Schedule
of profit and loss of Powder River Basin LLC in Joint Venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250701__20251231_zEoL4GG3CuVd" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240701__20241231_zgF4Ap6Wyn1b" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eifrs-full--DistributionAndAdministrativeExpense_d0_uCAD_zlCdVCnfMP75" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Administrative
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;117,853&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--AmortizationExpenses_uCAD_zCuzUD6gcBe4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,483&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0821"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--InsuranceExpense_d0_uCAD_zLQ2ZC9bRjt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,384&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--LossForYearJointVentures_d0_uCAD_zx64kDe8ZTz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(165,720&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CompanysShareOfLossForYearJointVentures_d0_uCAD_z6IVEKw96D54" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Company's
    share of loss for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(82,860&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p id="xdx_8A7_zYUbiog5e8Z" style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying value of the investment in the Joint Venture is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfInvestmentInTheJointVentureTableTextBlock_zk8CvxJm9qua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zIIJi0Mc5hhe" style="display: none; visibility: hidden"&gt;Schedule of investment in the Joint Venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"&gt;&lt;div style="border-top: Black 2pt solid; font-size: 1pt; width: 60%"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 45%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CurrentReceivableDueFromJointVentures_iS_c20250701__20251231_z21fbdTIrZul" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Beginning Current Receivable Due From Joint Ventures"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,505,997&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    contributions to JV&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CashContributionsToJv_c20250701__20251231_zlltiJt0nCN6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash contributions to JV"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,502,819&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    of loss in Powder River Basin LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareOfLossInPowderRiverBasinLlc_c20250701__20251231_zZXioLx0sVX9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share of loss in Powder River Basin LLC"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(82,860&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CurrentReceivableDueFromJointVentures_iE_c20250701__20251231_z9C4lO9pFua2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Current Receivable Due From Joint Ventures"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,925,956&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A6_zEh0Kv3tPnx4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Contingent
Liabilities and Commitments: &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Buyer will purchase Pine Ridge from Stakeholder Energy LLC (&#x201c;Seller&#x201d;) upon payment to the Seller of $US22,500,000
cash, to be paid in three equal installments of US$7,500,000, payable as follows:&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21.3pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$7,500,000
                                         to be paid at closing (&#x201c;Closing&#x201d;) of the Acquisition contemplated by the
                                         Purchase and Sale Agreement (&#x201c;Acquisition Agreement&#x201d;) (&#x201c;First Instalment&#x201d;);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21.3pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$7,500,000
                                         to be paid on or before one-year from the date of Closing (&#x201c;Second Instalment&#x201d;);
                                         and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21.3pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;iii.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;US$7,500,000
                                         to be paid on or before two years from the date of Closing (&#x201c;Third Instalment&#x201d;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21.3pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;i.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                         Buyer shall pay the Seller a production royalty based on an applicable royalty percentage
                                         (which will be calculated by a net smelter returns variable between 3.5% and 6%, dependent
                                         on U3O8 realized price) from uranium, vanadium and related minerals produced and sold
                                         or deemed sold by Buyer from any additional property or property interests acquired by
                                         the Buyer, or its affiliates or permitted assigns, within twenty (20) years after the
                                         effective date of March 11, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 21.3pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ii.&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
                                         Buyer shall expend a minimum of US$&lt;span id="xdx_904_ecustom--ExplorationAndDevelopmentCost_uUSD_c20250701__20251231_z0VLivuxZ5e2"&gt;10,000,000&lt;/span&gt; in exploration and development costs by
                                         the three-year anniversary of the Closing.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;




















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is responsible for the 50% payment of the consideration. Deferred liabilities (current) have been recognised for its portion
(US$3.75m) which is payable within 12 months and a further deferred liabilities (non-current) has been recognised for its portion
(US$3.75m) which is payable within 24 months.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfJointVenturesExplanatory>
    <fnuc:ScheduleOfFinancialInformationInJointVenture contextRef="From2025-07-01to2025-12-31" id="Fact000798">&lt;p id="xdx_892_ecustom--ScheduleOfFinancialInformationInJointVenture_zJYgwFaznZ61" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s interest in the Joint Venture (&#x201c;Powder River Basin LLC&#x201d; or the &#x201c;Buyer&#x201d;) is accounted for
using the equity method in the consolidated financial statements. Summarized financial information of the joint venture are set
out below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_z8AZszVRXNgk" style="display: none; visibility: hidden"&gt;Schedule of financial information in Joint Venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20251231_z0GtPYQtYmQ8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250630_zDi8XzDTUpI8" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;June
    30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--CurrentReceivablesDueFromJointVentures_iI_d0_uCAD_ztX51IRCKKA6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;292,144&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,154,723&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--NoncurrentReceivablesDueFromJointVentures_iI_d0_uCAD_zqIgxyp0PNE6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;35,771,486&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;32,115,558&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--CurrentLiabilitiesDueFromJointVentures_iI_d0_uCAD_zz50TR7ZiHX9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,339,806&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,657,035&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_ecustom--NonCurrentLiabilitiesDueFromJointVentures_iI_d0_uCAD_z9pFD7Zn8FTd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,297,153&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(10,232,250&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eifrs-full--CurrentRecognisedAssetsDefinedBenefitPlan_iI_d0_uCAD_z4sMG9GPnbqe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
    Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15,426,671&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12,380,996&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

</fnuc:ScheduleOfFinancialInformationInJointVenture>
    <ifrs-full:CurrentReceivablesDueFromJointVentures
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000800"
      unitRef="CAD">292144</ifrs-full:CurrentReceivablesDueFromJointVentures>
    <ifrs-full:CurrentReceivablesDueFromJointVentures
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000801"
      unitRef="CAD">1154723</ifrs-full:CurrentReceivablesDueFromJointVentures>
    <ifrs-full:NoncurrentReceivablesDueFromJointVentures
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000803"
      unitRef="CAD">35771486</ifrs-full:NoncurrentReceivablesDueFromJointVentures>
    <ifrs-full:NoncurrentReceivablesDueFromJointVentures
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000804"
      unitRef="CAD">32115558</ifrs-full:NoncurrentReceivablesDueFromJointVentures>
    <fnuc:CurrentLiabilitiesDueFromJointVentures
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000806"
      unitRef="CAD">-10339806</fnuc:CurrentLiabilitiesDueFromJointVentures>
    <fnuc:CurrentLiabilitiesDueFromJointVentures
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000807"
      unitRef="CAD">-10657035</fnuc:CurrentLiabilitiesDueFromJointVentures>
    <fnuc:NonCurrentLiabilitiesDueFromJointVentures
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000809"
      unitRef="CAD">-10297153</fnuc:NonCurrentLiabilitiesDueFromJointVentures>
    <fnuc:NonCurrentLiabilitiesDueFromJointVentures
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000810"
      unitRef="CAD">-10232250</fnuc:NonCurrentLiabilitiesDueFromJointVentures>
    <ifrs-full:CurrentRecognisedAssetsDefinedBenefitPlan
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000812"
      unitRef="CAD">15426671</ifrs-full:CurrentRecognisedAssetsDefinedBenefitPlan>
    <ifrs-full:CurrentRecognisedAssetsDefinedBenefitPlan
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000813"
      unitRef="CAD">12380996</ifrs-full:CurrentRecognisedAssetsDefinedBenefitPlan>
    <fnuc:ScheduleOfProfitAndLossOfPowderRiverBasinLLCInJointVenture contextRef="From2025-07-01to2025-12-31" id="Fact000815">&lt;p id="xdx_898_ecustom--ScheduleOfProfitAndLossOfPowderRiverBasinLLCInJointVenture_zWSyglWbTnX5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
summarized statement of profit and loss of Powder River Basin LLC for the six months ended December 31, 2025 and 2024 is set out
below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BE_zbOdMvfW8NB7" style="display: none; visibility: hidden"&gt;Schedule
of profit and loss of Powder River Basin LLC in Joint Venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250701__20251231_zEoL4GG3CuVd" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240701__20241231_zgF4Ap6Wyn1b" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;December
    31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eifrs-full--DistributionAndAdministrativeExpense_d0_uCAD_zlCdVCnfMP75" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Administrative
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;117,853&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_ecustom--AmortizationExpenses_uCAD_zCuzUD6gcBe4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;40,483&lt;/span&gt;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0821"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--InsuranceExpense_d0_uCAD_zLQ2ZC9bRjt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
    expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;7,384&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--LossForYearJointVentures_d0_uCAD_zx64kDe8ZTz5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Loss
    for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(165,720&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CompanysShareOfLossForYearJointVentures_d0_uCAD_z6IVEKw96D54" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Company's
    share of loss for the period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(82,860&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; color: Red; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

</fnuc:ScheduleOfProfitAndLossOfPowderRiverBasinLLCInJointVenture>
    <ifrs-full:DistributionAndAdministrativeExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000817"
      unitRef="CAD">117853</ifrs-full:DistributionAndAdministrativeExpense>
    <ifrs-full:DistributionAndAdministrativeExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000818"
      unitRef="CAD">0</ifrs-full:DistributionAndAdministrativeExpense>
    <fnuc:AmortizationExpenses
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000820"
      unitRef="CAD">40483</fnuc:AmortizationExpenses>
    <ifrs-full:InsuranceExpense
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000823"
      unitRef="CAD">7384</ifrs-full:InsuranceExpense>
    <ifrs-full:InsuranceExpense
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000824"
      unitRef="CAD">0</ifrs-full:InsuranceExpense>
    <fnuc:LossForYearJointVentures
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000826"
      unitRef="CAD">-165720</fnuc:LossForYearJointVentures>
    <fnuc:LossForYearJointVentures
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000827"
      unitRef="CAD">0</fnuc:LossForYearJointVentures>
    <fnuc:CompanysShareOfLossForYearJointVentures
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000829"
      unitRef="CAD">-82860</fnuc:CompanysShareOfLossForYearJointVentures>
    <fnuc:CompanysShareOfLossForYearJointVentures
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact000830"
      unitRef="CAD">0</fnuc:CompanysShareOfLossForYearJointVentures>
    <fnuc:ScheduleOfInvestmentInTheJointVentureTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000832">&lt;p id="xdx_89D_ecustom--ScheduleOfInvestmentInTheJointVentureTableTextBlock_zk8CvxJm9qua" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zIIJi0Mc5hhe" style="display: none; visibility: hidden"&gt;Schedule of investment in the Joint Venture&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"&gt;&lt;div style="border-top: Black 2pt solid; font-size: 1pt; width: 60%"&gt;&#160;&lt;/div&gt;&lt;/div&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: bold 10pt Times New Roman, Times, Serif; width: 45%; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--CurrentReceivableDueFromJointVentures_iS_c20250701__20251231_z21fbdTIrZul" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Beginning Current Receivable Due From Joint Ventures"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16,505,997&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
    contributions to JV&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--CashContributionsToJv_c20250701__20251231_zlltiJt0nCN6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cash contributions to JV"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,502,819&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
    of loss in Powder River Basin LLC&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareOfLossInPowderRiverBasinLlc_c20250701__20251231_zZXioLx0sVX9" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share of loss in Powder River Basin LLC"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(82,860&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; padding-left: 2pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Balance,
    December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--CurrentReceivableDueFromJointVentures_iE_c20250701__20251231_z9C4lO9pFua2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Current Receivable Due From Joint Ventures"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17,925,956&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfInvestmentInTheJointVentureTableTextBlock>
    <fnuc:CurrentReceivableDueFromJointVentures
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000834"
      unitRef="CAD">16505997</fnuc:CurrentReceivableDueFromJointVentures>
    <fnuc:CashContributionsToJv
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000836"
      unitRef="CAD">1502819</fnuc:CashContributionsToJv>
    <fnuc:ShareOfLossInPowderRiverBasinLlc
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000838"
      unitRef="CAD">-82860</fnuc:ShareOfLossInPowderRiverBasinLlc>
    <fnuc:CurrentReceivableDueFromJointVentures
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000840"
      unitRef="CAD">17925956</fnuc:CurrentReceivableDueFromJointVentures>
    <fnuc:ExplorationAndDevelopmentCost
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000841"
      unitRef="USD">10000000</fnuc:ExplorationAndDevelopmentCost>
    <fnuc:DisclosureOfLongTermLoanReceivable contextRef="From2025-07-01to2025-12-31" id="Fact000851">&lt;p id="xdx_809_ecustom--DisclosureOfLongTermLoanReceivable_zs8IorgBF9Qa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;10.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_829_zanyAQpK3SW9"&gt;Long-term
Loan Receivable&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 2, 2025, the Company subscribed to a secured convertible note issued by Commerce Resources Corp. for a principal amount of
$&lt;span id="xdx_903_ecustom--ConvertibleNoteIssued_iI_c20250502_zfNTYxk2Wkyg"&gt;1,100,000&lt;/span&gt; (the &#x201c;Convertible Note&#x201d;). The Convertible Note bears interest at a rate of &lt;span id="xdx_903_ecustom--InterestRate_pid_dp_uPure_c20250701__20251231_zxbpVuGA4FH9"&gt;20&lt;/span&gt;% per annum, accruing until
the earlier of conversion or maturity, and has a contractual maturity of 24 months from issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Convertible Note provides the Company with the option to convert the outstanding principal and accrued interest into common shares
of Commerce Resources Corp. at a fixed price of $0.12 per share, or at the price of a subsequent equity financing (not lower than
$0.10 per share). In addition, if a Liquidity Event (IPO or Merger) occurs within 12 months of issuance, the Convertible Note
will automatically convert into common shares at the price of such financing, subject to a floor equal to the then-prevailing
market price. If no conversion occurs, the obligations are repayable in cash at maturity. The Convertible Note is secured against
the assets of Commerce Resources Corp.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
Liquidity Event occurred during the six months ended December 31, 2025, and the outstanding principal and accrued interest was
converted to common shares of Mont Royal Resources Ltd. (See Note 7).&lt;/span&gt;&lt;/p&gt;

</fnuc:DisclosureOfLongTermLoanReceivable>
    <fnuc:ConvertibleNoteIssued
      contextRef="AsOf2025-05-02"
      decimals="0"
      id="Fact000852"
      unitRef="CAD">1100000</fnuc:ConvertibleNoteIssued>
    <fnuc:InterestRate
      contextRef="From2025-07-01to2025-12-31"
      decimals="INF"
      id="Fact000853"
      unitRef="Pure">0.20</fnuc:InterestRate>
    <fnuc:DisclousureOfLongTermInvestment contextRef="From2025-07-01to2025-12-31" id="Fact000855">&lt;p id="xdx_808_ecustom--DisclousureOfLongTermInvestment_zd9LC4L8fspb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;11.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_827_zqf7So95K1nb"&gt;Long-term
Investments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
Company&#x2019;s long-term investment consists of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--DisclousureOfCompanysLongTemInvestmentExplanatory_zVqIPlckFzna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zXKb4hGkrcr4" style="display: none; visibility: hidden"&gt;Schedule of Company&#x2019;s long-term investment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Balance at June 30, 2025&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Additions&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Dispositions&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Realized gain (loss) on sale of
    investment&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Unrealized gain (loss) on 
    change     of fair value of investment&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;FX Movement&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Balance at December 31, 2025&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Global Uranium and Enrichment Ltd. (Shares)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zRlxkoNZkp39" style="width: 8%; text-align: right" title="Beginning Long Term Investment"&gt;5,203,071&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AdditionsOnLongTermInvestment_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zLZGtUFmtNH1" style="width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0860"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zqHewHpyh8A5" style="width: 8%; text-align: right"&gt;880,520&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_ztsV5RPU9wFe" style="width: 8%; text-align: right"&gt;134,602&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zBkQXFPsAbP1" style="width: 8%; text-align: right" title="Ending Long Term Investment"&gt;6,218,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;American Uranium Limited (Shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_za6e1DqJEAT4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AdditionsOnLongTermInvestment_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zku5JhE42LK4" style="text-align: right"&gt;1,333,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zmRIGSAWNku7" style="text-align: right"&gt;47,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zHmjxqytF1Wj" style="text-align: right"&gt;27,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zwLvCmNOZbB2" style="text-align: right"&gt;1,408,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Nuran Wireless Inc. (Shares)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_ztRdlPKyK5k7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0870"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AdditionsOnLongTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zt1T14S1fHi7" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,584,347&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zZG8A7dx3yXj" style="border-bottom: Black 1pt solid; text-align: right"&gt;(435,560&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_z1uyqgNCHFwc" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,148,787&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_ze64iGenRFCf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;5,203,071&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AdditionsOnLongTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_zZWni4ELugFl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,918,066&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_zuZugNIP6lfi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;492,593&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;162,016&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_z8Xm7eyDGA6h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;10,775,746&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A1_zG6yptNOpoyk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Global
Uranium Enrichment Ltd. &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 16, 2025, the Company entered into a Subscription Agreement with Global Uranium and Enrichment Ltd. (&#x201c;GUE&#x201d;),
an Australian Securities Exchange (ASX) listed entity. Pursuant to the agreement, the Company subscribed for &lt;span id="xdx_905_ecustom--ShareSubscribed_iI_pid_uShares_c20250416__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zIf5aElgjSv6"&gt;89,448,256&lt;/span&gt; shares
of GUE at an aggregate subscription price of $&lt;span id="xdx_904_ecustom--ShareSubscriptionAmount_iI_uCAD_c20251231_zVjTNhwKyNla"&gt;5,132,534&lt;/span&gt;, representing a 19.99% interest in GUE. In addition, the Company was granted
14,000,000 options exercisable at AU $0.13 per share, expiring three years from the date of issue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
subscription shares and any shares issued on exercise of the options are subject to a six-month voluntary escrow period from completion,
subject to certain limited exceptions. The Company is also entitled to appoint one nominee to GUE&#x2019;s board of directors,
conditional upon maintaining at least a 10% equity interest in GUE.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;American
Uranium Limited (formerly GTI Energy Limited)&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 8, 2025, the Company entered into a Subscription Agreement with GTI Energy Limited (&#x201c;GTI&#x201d;), an Australian public
company listed on the ASX. Under the agreement, the Company subscribed for &lt;span id="xdx_90F_ecustom--ShareSubscribed_iI_pid_uShares_c20250808__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zcQGiFlwCbjl"&gt;424,866,286&lt;/span&gt; fully paid ordinary shares in GTI at an
issue price of A$0.0035 per share, for total consideration of $&lt;span id="xdx_902_ecustom--TotalConsiderationPaidReceived_iI_uCAD_c20250808__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zvPhYY1f46D1"&gt;1,333,719&lt;/span&gt; (A$1,487,032). The subscription also included &lt;span id="xdx_908_ecustom--DerivativeFinancialAssetsWarrants_iI_uCAD_c20250808__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zY1HzuVApbd5"&gt;212,433,143&lt;/span&gt;
free-attaching options with an exercise price of A$0.01 per option expiring September 25, 2028.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 29, 2025, GTI changed its name to American Uranium Limited (&#x201c;AMU&#x201d;) and completed a 1-for-40 share consolidation,
bringing the Company&#x2019;s ownership to &lt;span id="xdx_909_ecustom--ShareSubscribed_iI_pid_uShares_c20250829__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zdhAps7pB9sh"&gt;10,621,657&lt;/span&gt; shares and &lt;span id="xdx_904_ecustom--NumberOfWarrantsOrRightsOutstanding_iI_pid_uShares_c20250829__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zjFSS6H4ezml"&gt;5,310,828&lt;/span&gt; options with an exercise price of A$0.40.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Nuran
Wireless Inc.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 22, 2025, the Company entered into a subscription agreement with Nuran Wireless Inc. (&#x201c;Nuran&#x201d;), a Canadian
Securities Exchange (CSE) listed entity. Pursuant to the agreement, the Company subscribed for &lt;span id="xdx_90B_ecustom--ShareSubscribed_iI_pid_uShares_c20251222__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zYunjLrM4UVa"&gt;1,259,515&lt;/span&gt; units of Nuran at an
aggregate subscription price of $&lt;span id="xdx_907_ecustom--ShareSubscriptionAmount_iI_uCAD_c20251222__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zRYqlqrceTYc"&gt;3,584,347&lt;/span&gt; (US $&lt;span id="xdx_906_ecustom--ShareSubscriptionAmount_iI_uUSD_c20251222__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zqQ0zGbBf3mi"&gt;2,600,000&lt;/span&gt;), with each unit comprising one common share and one-half of one common
share purchase warrant. In addition, the Company was granted 629,757 warrants exercisable at 150% of the Issue Price per share,
expiring five years from the closing date.&lt;/span&gt;&lt;/p&gt;

</fnuc:DisclousureOfLongTermInvestment>
    <fnuc:DisclousureOfCompanysLongTemInvestmentExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000857">&lt;p id="xdx_890_ecustom--DisclousureOfCompanysLongTemInvestmentExplanatory_zVqIPlckFzna" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in; text-align: justify; text-indent: -0.3in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zXKb4hGkrcr4" style="display: none; visibility: hidden"&gt;Schedule of Company&#x2019;s long-term investment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Entity&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Balance at June 30, 2025&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Additions&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Dispositions&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Realized gain (loss) on sale of
    investment&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Unrealized gain (loss) on 
    change     of fair value of investment&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;FX Movement&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Balance at December 31, 2025&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 23%; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Global Uranium and Enrichment Ltd. (Shares)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zRlxkoNZkp39" style="width: 8%; text-align: right" title="Beginning Long Term Investment"&gt;5,203,071&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AdditionsOnLongTermInvestment_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zLZGtUFmtNH1" style="width: 8%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0860"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zqHewHpyh8A5" style="width: 8%; text-align: right"&gt;880,520&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_ztsV5RPU9wFe" style="width: 8%; text-align: right"&gt;134,602&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--GlobalUraniumAndEnrichmentLtdMember_zBkQXFPsAbP1" style="width: 8%; text-align: right" title="Ending Long Term Investment"&gt;6,218,193&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;American Uranium Limited (Shares)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_za6e1DqJEAT4" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0865"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--AdditionsOnLongTermInvestment_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zku5JhE42LK4" style="text-align: right"&gt;1,333,719&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zmRIGSAWNku7" style="text-align: right"&gt;47,633&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zHmjxqytF1Wj" style="text-align: right"&gt;27,414&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--AmericanUraniumLimitedMember_zwLvCmNOZbB2" style="text-align: right"&gt;1,408,766&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;Nuran Wireless Inc. (Shares)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_ztRdlPKyK5k7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0870"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AdditionsOnLongTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zt1T14S1fHi7" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,584,347&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_zZG8A7dx3yXj" style="border-bottom: Black 1pt solid; text-align: right"&gt;(435,560&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember__dei--LegalEntityAxis__custom--NuranWirelessIncMember_z1uyqgNCHFwc" style="border-bottom: Black 1pt solid; text-align: right"&gt;3,148,787&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 0.125in; text-indent: -0.125in"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--LongtermInvestment_iS_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_ze64iGenRFCf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;5,203,071&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AdditionsOnLongTermInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_zZWni4ELugFl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;4,918,066&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--UnrealizedGainLossOnChangeOffairValueOfInvestment_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_zuZugNIP6lfi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;492,593&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;162,016&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--LongtermInvestment_iE_uCAD_c20250701__20251231__ifrs-full--ContractDurationAxis__ifrs-full--LongtermContractsMember_z8Xm7eyDGA6h" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;10,775,746&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</fnuc:DisclousureOfCompanysLongTemInvestmentExplanatory>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember"
      decimals="0"
      id="Fact000859"
      unitRef="CAD">5203071</fnuc:LongtermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember"
      decimals="0"
      id="Fact000861"
      unitRef="CAD">880520</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember"
      decimals="0"
      id="Fact000862"
      unitRef="CAD">134602</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_LongtermContractsMember_custom_GlobalUraniumAndEnrichmentLtdMember"
      decimals="0"
      id="Fact000864"
      unitRef="CAD">6218193</fnuc:LongtermInvestment>
    <fnuc:AdditionsOnLongTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember"
      decimals="0"
      id="Fact000866"
      unitRef="CAD">1333719</fnuc:AdditionsOnLongTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember"
      decimals="0"
      id="Fact000867"
      unitRef="CAD">47633</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment>
    <fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember"
      decimals="0"
      id="Fact000868"
      unitRef="CAD">27414</fnuc:IncreaseDecreaseInFairValueOfFinancialInstrumentsDueToExchangeRateChanges>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_LongtermContractsMember_custom_AmericanUraniumLimitedMember"
      decimals="0"
      id="Fact000869"
      unitRef="CAD">1408766</fnuc:LongtermInvestment>
    <fnuc:AdditionsOnLongTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember"
      decimals="0"
      id="Fact000871"
      unitRef="CAD">3584347</fnuc:AdditionsOnLongTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember"
      decimals="0"
      id="Fact000872"
      unitRef="CAD">-435560</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_LongtermContractsMember_custom_NuranWirelessIncMember"
      decimals="0"
      id="Fact000873"
      unitRef="CAD">3148787</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_LongtermContractsMember"
      decimals="0"
      id="Fact000874"
      unitRef="CAD">5203071</fnuc:LongtermInvestment>
    <fnuc:AdditionsOnLongTermInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember"
      decimals="0"
      id="Fact000875"
      unitRef="CAD">4918066</fnuc:AdditionsOnLongTermInvestment>
    <fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment
      contextRef="From2025-07-012025-12-31_ifrs-full_LongtermContractsMember"
      decimals="0"
      id="Fact000876"
      unitRef="CAD">492593</fnuc:UnrealizedGainLossOnChangeOffairValueOfInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_LongtermContractsMember"
      decimals="0"
      id="Fact000877"
      unitRef="CAD">10775746</fnuc:LongtermInvestment>
    <fnuc:ShareSubscribed
      contextRef="AsOf2025-04-16_custom_GlobalUraniumAndEnrichmentLtdMember"
      decimals="INF"
      id="Fact000878"
      unitRef="Shares">89448256</fnuc:ShareSubscribed>
    <fnuc:ShareSubscriptionAmount
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000879"
      unitRef="CAD">5132534</fnuc:ShareSubscriptionAmount>
    <fnuc:ShareSubscribed
      contextRef="AsOf2025-08-08_custom_AmericanUraniumLimitedMember"
      decimals="INF"
      id="Fact000880"
      unitRef="Shares">424866286</fnuc:ShareSubscribed>
    <fnuc:TotalConsiderationPaidReceived
      contextRef="AsOf2025-08-08_custom_AmericanUraniumLimitedMember"
      decimals="0"
      id="Fact000881"
      unitRef="CAD">1333719</fnuc:TotalConsiderationPaidReceived>
    <fnuc:DerivativeFinancialAssetsWarrants
      contextRef="AsOf2025-08-08_custom_AmericanUraniumLimitedMember"
      decimals="0"
      id="Fact000882"
      unitRef="CAD">212433143</fnuc:DerivativeFinancialAssetsWarrants>
    <fnuc:ShareSubscribed
      contextRef="AsOf2025-08-29_custom_AmericanUraniumLimitedMember"
      decimals="INF"
      id="Fact000883"
      unitRef="Shares">10621657</fnuc:ShareSubscribed>
    <fnuc:NumberOfWarrantsOrRightsOutstanding
      contextRef="AsOf2025-08-29_custom_AmericanUraniumLimitedMember"
      decimals="INF"
      id="Fact000884"
      unitRef="Shares">5310828</fnuc:NumberOfWarrantsOrRightsOutstanding>
    <fnuc:ShareSubscribed
      contextRef="AsOf2025-12-22_custom_NuranWirelessIncMember"
      decimals="INF"
      id="Fact000893"
      unitRef="Shares">1259515</fnuc:ShareSubscribed>
    <fnuc:ShareSubscriptionAmount
      contextRef="AsOf2025-12-22_custom_NuranWirelessIncMember"
      decimals="0"
      id="Fact000894"
      unitRef="CAD">3584347</fnuc:ShareSubscriptionAmount>
    <fnuc:ShareSubscriptionAmount
      contextRef="AsOf2025-12-22_custom_NuranWirelessIncMember"
      decimals="0"
      id="Fact000895"
      unitRef="USD">2600000</fnuc:ShareSubscriptionAmount>
    <fnuc:DisclosureOfInvestmentsInAssociatesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000897">&lt;p id="xdx_80B_ecustom--DisclosureOfInvestmentsInAssociatesExplanatory_zgY04baco4u3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;12.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82B_z59y5EevR2Na"&gt;Investment
in Associate&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 17, 2025, the Company, through its wholly owned subsidiary Snow Lake Investments (US) Ltd., entered into a Subscription
and Purchase Agreement with Kadmos Energy Services LLC (&#x201c;Kadmos&#x201d;), a Delaware limited liability company, to acquire
an equity interest in Kadmos.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the agreement, the Company subscribed for &lt;span id="xdx_90C_ecustom--NumberOfClassAMembershipUnitsAcquired_iI_pid_uShares_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zALEpZbxvOkd"&gt;4,900,000&lt;/span&gt; Class A Membership Units of Kadmos for total aggregate consideration of
US$10,000,000. At closing, $2,810,864 (US$2,000,000) was paid in cash. The remaining US$8,000,000 was evidenced by a Secured Promissory
Note (the &#x201c;Note&#x201d;) issued to Kadmos, repayable in six instalments through October 17, 2027.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
investment was completed concurrently with the execution of an Amended and Restated Operating Agreement, the Secured Promissory
Note, and a Unit Pledge Agreement. The resulting capital structure of Kadmos is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfClassAUnitsIssued_iI_pid_uShares_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zwZ2IrnSda99"&gt;4,900,000&lt;/span&gt;
                                         Class A Units issued to Snow Lake Investments (US) Ltd.;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfClassBUnitsIssued_iI_pid_uShares_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zGE2DdQw1ZSe"&gt;5,100,000&lt;/span&gt;
                                         Class B Units issued to Exodys Energy and founding members; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfProfitsInterestUnitsAuthorised_iI_pid_uShares_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zZsOJOUMqHY5"&gt;1,000,000&lt;/span&gt;
                                         Profits Interest Units authorized under a 2025 Equity Incentive Plan and Phantom Equity
                                         Plan for employees and consultants.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that it exercises significant influence over Kadmos within the meaning of &lt;i&gt;IAS 28 Investments in Associates
and Joint Ventures&lt;/i&gt; and accordingly accounts for the investment using the equity method. This conclusion is based on the following
indicators:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Economic
                                         interest: The Company holds 4,900,000 of 10,000,000 total voting units (Class A and Class
                                         B combined), representing approximately 49.0% of the economic and voting interest;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Board
                                         representation: The Company has the right to appoint one member of the initial three-person
                                         Board of Managers, providing direct participation in financial and operating policy decisions;
                                         and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Path
                                         to majority control: Upon contributing an additional US$2,000,000 under the Note, the
                                         Board expands to five members and the Company becomes entitled to appoint a majority
                                         of directors, further evidencing the significance of its influence over Kadmos.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
initial recognition on October 17, 2025, the investment in associate was recorded at $&lt;span id="xdx_903_eifrs-full--InvestmentsInAssociates_iI_uCAD_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zhR1bia8zHcb"&gt;12,530,368&lt;/span&gt;, comprising:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
                                         consideration: $&lt;span id="xdx_903_ecustom--CashConsideration_iI_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zq0Qk2reGfyf" title="Cash consideration"&gt;2,810,864&lt;/span&gt;; and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
                                         value of Secured Promissory Note: The Note was initially recognised as a financial liability
                                         at its fair value of $&lt;span id="xdx_90C_ecustom--FairValueOfPromissoryNoteIssuedForAcquisitionOfAssociate_iI_uCAD_c20251017__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--KadmosEnergyServicesLLCMember_zlfH7delf7e9"&gt;9,719,504&lt;/span&gt;, being the present value of contractual cash flows discounted
                                         at the effective interest rate of 12% per annum.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the movement in the carrying amount of the investment in associate for the six-month period ended December
31, 2025 and year ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--DisclosureOfInvestmentsInAssociatesExplanatoryTableTextBlock_zZB2drNa5wgk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zAmbcPddN5Zf" style="display: none; visibility: hidden"&gt;Schedule
of Company&#x2019;s movement in carrying amount of investment in associate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250701__20251231_zqUN7ktQ7qQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240701__20250630_zJOY2WfJdifl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_uCAD_za4XMROugUkd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--CashAndCashEquivalentsPaidForAcquisitionOfAssociate_uCAD_zHZrhQ4TA6Mj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Initial recognition - cash consideration&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;2,810,864&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0913"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--AcquisitionsInvestmentsAccountedForUsingEquityMethod_uCAD_z9OZL7IeF0qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Initial recognition - Note payable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,719,504&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0916"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_uCAD_zYI69Xii7U2c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Share of net loss of associate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,248&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0919"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--InvestmentsAccountedForUsingEquityMethod_iE_uCAD_zKDJPY9hnEng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;12,502,120&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0922"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AE_zhy8SbK4VUvk" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify; text-indent: -0.25in"&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Note is classified as a financial liability measured at amortized cost in accordance with IFRS 9. Although the Note permits repayment
at the Company&#x2019;s sole discretion in either cash or freely tradable common shares of the Company, the lender is guaranteed receipt
of the fixed principal amount of US$8,000,000 through a true-up mechanism that adjusts the number of shares delivered to equal
the contracted dollar value. Accordingly, the instrument passes the solely payments of principal and interest (&#x201c;SPPI&#x201d;)
criterion and amortized cost classification is appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the movement in the carrying amount of the Note payable for the six-month period ended December 31, 2025
and year ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--DisclosureOfFinancialLiabilitiesExplanatoryTableTextBlock_zPSqz3Z5wmfe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zxLNwa66nbCf" style="display: none; visibility: hidden"&gt;Schedule
of &#160;Company&#x2019;s movement in the carrying amount of the note payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250701__20251231_zHUzQ0lQjDz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240701__20250630_zorUQwIfJTe8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eifrs-full--FinancialLiabilitiesAtAmortisedCost_iS_uCAD_zMSUCY8dYK48" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ProceedsFromBorrowings_uCAD_z7f3LOo9bin5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Initial recognition - Note payable&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;9,719,504&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--InterestOnLoanAndDebentures_uCAD_zT1ahloSbqtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest on loan and debentures&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;223,775&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0941"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--ExchangeDifferencesOnTranslation_uCAD_zUzNuZIM8u0j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Impact of foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(221,411&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eifrs-full--FinancialLiabilitiesAtAmortisedCost_iE_uCAD_zDZP1Sj8W7Vj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,721,868&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0947"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 19pt"&gt;Current portion&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--CurrentFinancialLiabilities_iI_uCAD_c20251231_z66WAruHj3Bf" style="font-weight: bold; text-align: right"&gt;4,111,800&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_iI_uCAD_c20250630_zyPXgamfBqy3" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0949"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 19pt"&gt;Long-term portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NoncurrentFinancialLiabilities_iI_uCAD_c20251231_zxV8d1j3Nyr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;5,610,068&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NoncurrentFinancialLiabilities_iI_uCAD_c20250630_zl1EYcg1UeZi" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AC_zU6DL2xPUSgd" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</fnuc:DisclosureOfInvestmentsInAssociatesExplanatory>
    <fnuc:NumberOfClassAMembershipUnitsAcquired
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="INF"
      id="Fact000898"
      unitRef="Shares">4900000</fnuc:NumberOfClassAMembershipUnitsAcquired>
    <fnuc:NumberOfClassAUnitsIssued
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="INF"
      id="Fact000899"
      unitRef="Shares">4900000</fnuc:NumberOfClassAUnitsIssued>
    <fnuc:NumberOfClassBUnitsIssued
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="INF"
      id="Fact000900"
      unitRef="Shares">5100000</fnuc:NumberOfClassBUnitsIssued>
    <fnuc:NumberOfProfitsInterestUnitsAuthorised
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="INF"
      id="Fact000901"
      unitRef="Shares">1000000</fnuc:NumberOfProfitsInterestUnitsAuthorised>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="0"
      id="Fact000902"
      unitRef="CAD">12530368</ifrs-full:InvestmentsInAssociates>
    <fnuc:CashConsideration
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="0"
      id="Fact000904"
      unitRef="CAD">2810864</fnuc:CashConsideration>
    <fnuc:FairValueOfPromissoryNoteIssuedForAcquisitionOfAssociate
      contextRef="AsOf2025-10-17_custom_KadmosEnergyServicesLLCMember"
      decimals="0"
      id="Fact000905"
      unitRef="CAD">9719504</fnuc:FairValueOfPromissoryNoteIssuedForAcquisitionOfAssociate>
    <fnuc:DisclosureOfInvestmentsInAssociatesExplanatoryTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000907">&lt;p id="xdx_899_ecustom--DisclosureOfInvestmentsInAssociatesExplanatoryTableTextBlock_zZB2drNa5wgk" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B0_zAmbcPddN5Zf" style="display: none; visibility: hidden"&gt;Schedule
of Company&#x2019;s movement in carrying amount of investment in associate&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250701__20251231_zqUN7ktQ7qQa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240701__20250630_zJOY2WfJdifl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iS_uCAD_za4XMROugUkd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--CashAndCashEquivalentsPaidForAcquisitionOfAssociate_uCAD_zHZrhQ4TA6Mj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Initial recognition - cash consideration&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;2,810,864&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0913"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--AcquisitionsInvestmentsAccountedForUsingEquityMethod_uCAD_z9OZL7IeF0qi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Initial recognition - Note payable&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;9,719,504&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0916"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_uCAD_zYI69Xii7U2c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Share of net loss of associate&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(28,248&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0919"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--InvestmentsAccountedForUsingEquityMethod_iE_uCAD_zKDJPY9hnEng" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;12,502,120&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0922"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:DisclosureOfInvestmentsInAssociatesExplanatoryTableTextBlock>
    <fnuc:CashAndCashEquivalentsPaidForAcquisitionOfAssociate
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000912"
      unitRef="CAD">2810864</fnuc:CashAndCashEquivalentsPaidForAcquisitionOfAssociate>
    <fnuc:AcquisitionsInvestmentsAccountedForUsingEquityMethod
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000915"
      unitRef="CAD">9719504</fnuc:AcquisitionsInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000918"
      unitRef="CAD">-28248</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <fnuc:InvestmentsAccountedForUsingEquityMethod
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000921"
      unitRef="CAD">12502120</fnuc:InvestmentsAccountedForUsingEquityMethod>
    <fnuc:DisclosureOfFinancialLiabilitiesExplanatoryTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000932">&lt;p id="xdx_894_ecustom--DisclosureOfFinancialLiabilitiesExplanatoryTableTextBlock_zPSqz3Z5wmfe" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B1_zxLNwa66nbCf" style="display: none; visibility: hidden"&gt;Schedule
of &#160;Company&#x2019;s movement in the carrying amount of the note payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250701__20251231_zHUzQ0lQjDz8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240701__20250630_zorUQwIfJTe8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eifrs-full--FinancialLiabilitiesAtAmortisedCost_iS_uCAD_zMSUCY8dYK48" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0935"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ProceedsFromBorrowings_uCAD_z7f3LOo9bin5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Initial recognition - Note payable&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;9,719,504&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--InterestOnLoanAndDebentures_uCAD_zT1ahloSbqtl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Interest on loan and debentures&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;223,775&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0941"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--ExchangeDifferencesOnTranslation_uCAD_zUzNuZIM8u0j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Impact of foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(221,411&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eifrs-full--FinancialLiabilitiesAtAmortisedCost_iE_uCAD_zDZP1Sj8W7Vj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;9,721,868&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0947"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-left: 19pt"&gt;Current portion&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--CurrentFinancialLiabilities_iI_uCAD_c20251231_z66WAruHj3Bf" style="font-weight: bold; text-align: right"&gt;4,111,800&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--CurrentFinancialLiabilities_iI_uCAD_c20250630_zyPXgamfBqy3" style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0949"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left; padding-left: 19pt"&gt;Long-term portion&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NoncurrentFinancialLiabilities_iI_uCAD_c20251231_zxV8d1j3Nyr" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;5,610,068&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NoncurrentFinancialLiabilities_iI_uCAD_c20250630_zl1EYcg1UeZi" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:DisclosureOfFinancialLiabilitiesExplanatoryTableTextBlock>
    <fnuc:ProceedsFromBorrowings
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000937"
      unitRef="CAD">9719504</fnuc:ProceedsFromBorrowings>
    <fnuc:InterestOnLoanAndDebentures
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000940"
      unitRef="CAD">223775</fnuc:InterestOnLoanAndDebentures>
    <fnuc:ExchangeDifferencesOnTranslation
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000943"
      unitRef="CAD">-221411</fnuc:ExchangeDifferencesOnTranslation>
    <ifrs-full:FinancialLiabilitiesAtAmortisedCost
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000946"
      unitRef="CAD">9721868</ifrs-full:FinancialLiabilitiesAtAmortisedCost>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000948"
      unitRef="CAD">4111800</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000950"
      unitRef="CAD">5610068</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact000953">&lt;p id="xdx_806_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_zFToY2tjD9ne" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;13.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_826_zEX3PuBJGMrd"&gt;Right-of-Use
Assets&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Effective
July 1, 2025, the Company entered into a lease agreement for office space, for a term of seven years. As at December 31, 2025
and June 30, 2025, the Company&#x2019;s right-of-use (&#x201c;ROU&#x201d;) assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfRightOfUseAssetsTextBlock_zrev4QzhgD79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zjl2aRfCcJYf" style="display: none; visibility: hidden"&gt;Schedule of Right of Use Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold; text-align: left"&gt;Cost, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CostOfRightOfUseOfAssetsValue_iS_uCAD_c20240701__20250630_zPrrq2dqOn26" style="width: 14%; text-align: right" title="Cost, beginning of period"&gt;63,360&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Additions for right-of-use assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsToRightofuseAssets_d0_c20250701__20251231_zyTIr9bQQRi6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Additions for right-of-use assets"&gt;1,266,281&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AdditionsToRightofuseAssets_d0_c20240701__20250630_zx4Wausi1dA7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--CostOfRightOfUseOfAssetsValue_iE_uCAD_c20250701__20251231_z1ihWdZtErAi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,266,281&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--CostOfRightOfUseOfAssetsValue_iE_uCAD_c20240701__20250630_zfB8B355zFal" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, ending of period"&gt;63,360&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"&gt;&lt;b&gt;Accumulated
Amortization, beginning of period&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--FinanceLeaseRightOfUseAssetAccumulatedAmortizations_iS_uCAD_c20240701__20250630_zmfCbTGkqE2j" style="text-align: right" title="Accumulated Amortization, beginning of period"&gt;34,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DepreciationRightofuseAssets_c20250701__20251231_zAl7wyymgS5j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Depreciation"&gt;90,449&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20240701__20250630_zZxEx7EZ42k1" style="border-bottom: Black 1pt solid; text-align: right"&gt;29,040&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Accumulated Amortization, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FinanceLeaseRightOfUseAssetAccumulatedAmortizations_iE_uCAD_c20250701__20251231_zpgP3jXOswZh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Accumulated Amortization, end of year"&gt;90,449&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FinanceLeaseRightOfUseAssetAccumulatedAmortizations_iE_uCAD_c20240701__20250630_zlnHC4B1Rs35" style="border-bottom: Black 1pt solid; text-align: right"&gt;63,360&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Net Book Value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iTI_uCAD_c20251231_zYSvvRjJxBA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Net Book Value"&gt;1,175,832&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--RightofuseAssets_iTI_d0_uCAD_c20250630_zI2cWSrohUZk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_znGZowXQObV3" style="margin: 0"&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <fnuc:ScheduleOfRightOfUseAssetsTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000955">&lt;p id="xdx_89D_ecustom--ScheduleOfRightOfUseAssetsTextBlock_zrev4QzhgD79" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span id="xdx_8B6_zjl2aRfCcJYf" style="display: none; visibility: hidden"&gt;Schedule of Right of Use Assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold; text-align: left"&gt;Cost, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--CostOfRightOfUseOfAssetsValue_iS_uCAD_c20240701__20250630_zPrrq2dqOn26" style="width: 14%; text-align: right" title="Cost, beginning of period"&gt;63,360&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Additions for right-of-use assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsToRightofuseAssets_d0_c20250701__20251231_zyTIr9bQQRi6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Additions for right-of-use assets"&gt;1,266,281&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AdditionsToRightofuseAssets_d0_c20240701__20250630_zx4Wausi1dA7" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--CostOfRightOfUseOfAssetsValue_iE_uCAD_c20250701__20251231_z1ihWdZtErAi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,266,281&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--CostOfRightOfUseOfAssetsValue_iE_uCAD_c20240701__20250630_zfB8B355zFal" style="border-bottom: Black 1pt solid; text-align: right" title="Cost, ending of period"&gt;63,360&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"&gt;&lt;b&gt;Accumulated
Amortization, beginning of period&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--FinanceLeaseRightOfUseAssetAccumulatedAmortizations_iS_uCAD_c20240701__20250630_zmfCbTGkqE2j" style="text-align: right" title="Accumulated Amortization, beginning of period"&gt;34,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DepreciationRightofuseAssets_c20250701__20251231_zAl7wyymgS5j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Depreciation"&gt;90,449&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20240701__20250630_zZxEx7EZ42k1" style="border-bottom: Black 1pt solid; text-align: right"&gt;29,040&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Accumulated Amortization, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--FinanceLeaseRightOfUseAssetAccumulatedAmortizations_iE_uCAD_c20250701__20251231_zpgP3jXOswZh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Accumulated Amortization, end of year"&gt;90,449&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--FinanceLeaseRightOfUseAssetAccumulatedAmortizations_iE_uCAD_c20240701__20250630_zlnHC4B1Rs35" style="border-bottom: Black 1pt solid; text-align: right"&gt;63,360&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Net Book Value&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iTI_uCAD_c20251231_zYSvvRjJxBA8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Net Book Value"&gt;1,175,832&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--RightofuseAssets_iTI_d0_uCAD_c20250630_zI2cWSrohUZk" style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfRightOfUseAssetsTextBlock>
    <fnuc:CostOfRightOfUseOfAssetsValue
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000957"
      unitRef="CAD">63360</fnuc:CostOfRightOfUseOfAssetsValue>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000959"
      unitRef="CAD">1266281</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000960"
      unitRef="CAD">0</ifrs-full:AdditionsToRightofuseAssets>
    <fnuc:CostOfRightOfUseOfAssetsValue
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000961"
      unitRef="CAD">1266281</fnuc:CostOfRightOfUseOfAssetsValue>
    <fnuc:CostOfRightOfUseOfAssetsValue
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000963"
      unitRef="CAD">63360</fnuc:CostOfRightOfUseOfAssetsValue>
    <fnuc:FinanceLeaseRightOfUseAssetAccumulatedAmortizations
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000965"
      unitRef="CAD">34320</fnuc:FinanceLeaseRightOfUseAssetAccumulatedAmortizations>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000967"
      unitRef="CAD">90449</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000968"
      unitRef="CAD">29040</ifrs-full:DepreciationRightofuseAssets>
    <fnuc:FinanceLeaseRightOfUseAssetAccumulatedAmortizations
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000970"
      unitRef="CAD">90449</fnuc:FinanceLeaseRightOfUseAssetAccumulatedAmortizations>
    <fnuc:FinanceLeaseRightOfUseAssetAccumulatedAmortizations
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000971"
      unitRef="CAD">63360</fnuc:FinanceLeaseRightOfUseAssetAccumulatedAmortizations>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000973"
      unitRef="CAD">1175832</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000974"
      unitRef="CAD">0</ifrs-full:RightofuseAssets>
    <fnuc:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock1TextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000976">&lt;p id="xdx_809_ecustom--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock1TextBlock_z2B4Qrod0zKj" style="margin: 0"&gt;&lt;/p&gt;

&lt;p style="margin: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;14.&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_820_zjWrx92EkqX1"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;



&lt;p id="xdx_897_ecustom--ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock_zheGN6bIKEl8" style="margin: 0"&gt;&lt;span id="xdx_8B6_zQ76B3Be9mOh" style="display: none; visibility: hidden"&gt;Schedule of Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; vertical-align: bottom"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&lt;span style="font-size: 10pt"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; width: 66%"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right; width: 14%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_uCAD_c20251231_zM2SajwOv4dl" style="font-weight: bold; text-align: right"&gt;722,161&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_uCAD_c20250630_zuX4eLdw95gi" style="text-align: right"&gt;1,408,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Accrued liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iI_uCAD_c20251231_zF7kMEhomVJb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;347,994&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iI_uCAD_c20250630_z0pzgHs0fQTj" style="border-bottom: Black 1pt solid; text-align: right"&gt;237,942&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--TradeAndOtherCurrentPayables_iI_uCAD_c20251231_z4ID59cnw1f9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Accounts payable and accrued liabilities"&gt;1,070,155&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--TradeAndOtherCurrentPayables_iI_uCAD_c20250630_z4PB9boffFCf" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,646,662&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p id="xdx_8A5_zyT757riYBO" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

</fnuc:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock1TextBlock>
    <fnuc:ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000978">&lt;p id="xdx_897_ecustom--ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock_zheGN6bIKEl8" style="margin: 0"&gt;&lt;span id="xdx_8B6_zQ76B3Be9mOh" style="display: none; visibility: hidden"&gt;Schedule of Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; vertical-align: bottom"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&lt;span style="font-size: 10pt"&gt;June 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; width: 66%"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right; width: 14%"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 14%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Trade payables&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_uCAD_c20251231_zM2SajwOv4dl" style="font-weight: bold; text-align: right"&gt;722,161&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_uCAD_c20250630_zuX4eLdw95gi" style="text-align: right"&gt;1,408,720&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Accrued liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iI_uCAD_c20251231_zF7kMEhomVJb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;347,994&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--CurrentAccruedExpensesAndOtherCurrentLiabilities_iI_uCAD_c20250630_z0pzgHs0fQTj" style="border-bottom: Black 1pt solid; text-align: right"&gt;237,942&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--TradeAndOtherCurrentPayables_iI_uCAD_c20251231_z4ID59cnw1f9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Accounts payable and accrued liabilities"&gt;1,070,155&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--TradeAndOtherCurrentPayables_iI_uCAD_c20250630_z4PB9boffFCf" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,646,662&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
</fnuc:ScheduleOfAccountsPayableAndAccruedLiabilitiesTextBlock>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000979"
      unitRef="CAD">722161</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000980"
      unitRef="CAD">1408720</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000981"
      unitRef="CAD">347994</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000982"
      unitRef="CAD">237942</ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact000984"
      unitRef="CAD">1070155</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact000985"
      unitRef="CAD">1646662</ifrs-full:TradeAndOtherCurrentPayables>
    <fnuc:DisclosureOfLeaseLiabilitiesTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000987">&lt;p id="xdx_80C_ecustom--DisclosureOfLeaseLiabilitiesTextBlock_zjVEWelARxf9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;15.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_828_z41P7k6NhJVk"&gt;Lease
Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
movements and carrying amounts of the Company&#x2019;s ROU assets under lease as per disclosed in Note 13, are summarized as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfLeaseLiabilitiesTextBlock_zJXfhwEoF1D4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B8_zrB7fTetB6l8" style="display: none; visibility: hidden"&gt;Schedule of Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_uCAD_c20250701__20251231_zStEHc4JAHSl" style="width: 14%; font-weight: bold; text-align: right" title="Balance, beginning of period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0991"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--LeaseLiabilities_iS_uCAD_c20240701__20250630_z7oG0WyMrj76" style="width: 14%; text-align: right"&gt;31,107&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions of lease liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_uCAD_c20250701__20251231_z0g816Q2NLy1" style="font-weight: bold; text-align: right" title="Additions of lease liabilities"&gt;1,266,281&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsToRightofuseAssets_d0_uCAD_c20240701__20250630_zQorqgOEPyR5" style="text-align: right" title="Additions of lease liabilities"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease payments&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RepaymentOfDebtAndCapitalLeaseObligations_uCAD_c20250701__20251231_zyBQFGpkFC3a" style="font-weight: bold; text-align: right" title="Lease payments"&gt;(133,298&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RepaymentOfDebtAndCapitalLeaseObligations_uCAD_c20240701__20250630_zAQhVZxtA4Yi" style="text-align: right" title="Lease payments"&gt;(32,842&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accretion on lease liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccretionExpense1_uCAD_c20250701__20251231_z5b23LxnIU0j" style="font-weight: bold; text-align: right" title="Accretion on lease liabilities"&gt;87,798&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccretionExpense1_uCAD_c20240701__20250630_zgshLqEL48Ji" style="text-align: right" title="Accretion on lease liabilities"&gt;1,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Impact of foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ImpactOfForeignExchange_uCAD_c20250701__20251231_zoKAcBOFm08j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impact of foreign exchange"&gt;6,101&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ImpactOfForeignExchange_uCAD_c20240701__20250630_z0WBuJJk2QLb" style="border-bottom: Black 1pt solid; text-align: right" title="Impact of foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iNE_di_uCAD_c20250701__20251231_z15IVcNYHtK3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,226,882&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--LeaseLiabilities_iNE_di_uCAD_c20240701__20250630_zWw3TxUUVC8k" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1010"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AA_zM3NfloslsO8" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</fnuc:DisclosureOfLeaseLiabilitiesTextBlock>
    <fnuc:ScheduleOfLeaseLiabilitiesTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact000989">&lt;p id="xdx_894_ecustom--ScheduleOfLeaseLiabilitiesTextBlock_zJXfhwEoF1D4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B8_zrB7fTetB6l8" style="display: none; visibility: hidden"&gt;Schedule of Lease Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_uCAD_c20250701__20251231_zStEHc4JAHSl" style="width: 14%; font-weight: bold; text-align: right" title="Balance, beginning of period"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0991"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--LeaseLiabilities_iS_uCAD_c20240701__20250630_z7oG0WyMrj76" style="width: 14%; text-align: right"&gt;31,107&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Additions of lease liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AdditionsToRightofuseAssets_uCAD_c20250701__20251231_z0g816Q2NLy1" style="font-weight: bold; text-align: right" title="Additions of lease liabilities"&gt;1,266,281&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--AdditionsToRightofuseAssets_d0_uCAD_c20240701__20250630_zQorqgOEPyR5" style="text-align: right" title="Additions of lease liabilities"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease payments&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RepaymentOfDebtAndCapitalLeaseObligations_uCAD_c20250701__20251231_zyBQFGpkFC3a" style="font-weight: bold; text-align: right" title="Lease payments"&gt;(133,298&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--RepaymentOfDebtAndCapitalLeaseObligations_uCAD_c20240701__20250630_zAQhVZxtA4Yi" style="text-align: right" title="Lease payments"&gt;(32,842&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accretion on lease liabilities&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--AccretionExpense1_uCAD_c20250701__20251231_z5b23LxnIU0j" style="font-weight: bold; text-align: right" title="Accretion on lease liabilities"&gt;87,798&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccretionExpense1_uCAD_c20240701__20250630_zgshLqEL48Ji" style="text-align: right" title="Accretion on lease liabilities"&gt;1,735&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Impact of foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ImpactOfForeignExchange_uCAD_c20250701__20251231_zoKAcBOFm08j" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Impact of foreign exchange"&gt;6,101&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ImpactOfForeignExchange_uCAD_c20240701__20250630_z0WBuJJk2QLb" style="border-bottom: Black 1pt solid; text-align: right" title="Impact of foreign exchange"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1008"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iNE_di_uCAD_c20250701__20251231_z15IVcNYHtK3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1,226,882&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--LeaseLiabilities_iNE_di_uCAD_c20240701__20250630_zWw3TxUUVC8k" style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1010"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfLeaseLiabilitiesTextBlock>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact000992"
      unitRef="CAD">31107</ifrs-full:LeaseLiabilities>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000994"
      unitRef="CAD">1266281</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact000996"
      unitRef="CAD">0</ifrs-full:AdditionsToRightofuseAssets>
    <fnuc:RepaymentOfDebtAndCapitalLeaseObligations
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact000998"
      unitRef="CAD">-133298</fnuc:RepaymentOfDebtAndCapitalLeaseObligations>
    <fnuc:RepaymentOfDebtAndCapitalLeaseObligations
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001000"
      unitRef="CAD">-32842</fnuc:RepaymentOfDebtAndCapitalLeaseObligations>
    <fnuc:AccretionExpense1
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001002"
      unitRef="CAD">87798</fnuc:AccretionExpense1>
    <fnuc:AccretionExpense1
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001004"
      unitRef="CAD">1735</fnuc:AccretionExpense1>
    <fnuc:ImpactOfForeignExchange
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001006"
      unitRef="CAD">6101</fnuc:ImpactOfForeignExchange>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001009"
      unitRef="CAD">-1226882</ifrs-full:LeaseLiabilities>
    <ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities contextRef="From2025-07-01to2025-12-31" id="Fact001013">&lt;p id="xdx_80D_eifrs-full--MaturityAnalysisForDerivativeFinancialLiabilities_zhAxStk1OCk9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;16.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_824_ztKA7JbqYdDg"&gt;Derivative
Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
changes to the derivative liabilities are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfChangesToDerivativeLiabilitiesTextBlock_zUBBT74Pc5L6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zjA1TShGceWe" style="display: none; visibility: hidden"&gt;Schedule of Changes to Derivative Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250701__20251231_zEjtIawYz2R5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240701__20250630_zXkeMRkRNwBl" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_uCAD_z2cMYis8ERd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;111,913&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;305,025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--FairValueOfDerivativeLiabilityOnDateOfIssuance_uCAD_zDpSUIw6AMtd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value of derivative liability on date of issuance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1020"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;129,440&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--FairValueChangesOfDerivativeLiabilityFindersWarrants_uCAD_zUiPlbcLuHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Finders&#x2019; Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,527&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38,060&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--FairValueChangesOfDerivativeLiabilityIncentiveWarrants_uCAD_zc0g3dFEW6qc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Incentive Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1026"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,754&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--FairValueChangesOfDerivativeLiabilitySettlementWarrants_uCAD_zT9X8lDq4wlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Settlement Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(30,164&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(160,622&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--FairValueChangesOfDerivativeLiabilityAgentsWarrants_uCAD_zjzqK8uRfnha" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Agents&#x2019; Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,735&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,803&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--FairValueChangesOfDerivativeLiabilityPerformanceWarrants_uCAD_zaf6BUqiZWRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Performance Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1035"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(946&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--FairValueChangesOfDerivativeLiabilityOctagonWarrants_uCAD_zo5R5vIPCMDf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Fair value changes of derivative liability &#x2013; Octagon Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(55,745&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(73,367&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_uCAD_zRdOWa6vHibf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;24,796&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;111,913&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A4_zj314yjC9Pxf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;IPO
Finders&#x2019; Warrants &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the IPO which closed on November 23, 2021, the Company issued 14,154 finders&#x2019; warrants (each a &#x201c;Finders&#x2019;
Warrant&#x201d;) exercisable at US $121.875 before November 19, 2026. The fair value of these Finders&#x2019; Warrants &lt;span style="color: windowtext"&gt;was
estimated at $1,237,681 using the &lt;/span&gt;Black-Scholes valuation model (&#x201c;Black-Scholes&#x201d;) &lt;span style="color: windowtext"&gt;with
the following assumptions: expected volatility of 100% based on comparable companies, expected dividend yield of 0%, risk-free
interest rate of 1.58%, and an expected life of five years.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the derivative liability related to the Finders&#x2019; Warrants was measured at a fair value of $8,752 (June
30, 2025 - $7,225) using Black-Scholes with the following assumptions: share price of US $3.000, exercise price of US $121.875,
&lt;span style="color: windowtext"&gt;expected volatility of 226.56%&lt;/span&gt;, expected dividend yield of 0%, risk-free interest rate
of 2.57% and an estimated remaining life of 0.89 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, the Company recorded a fair value increase of $1,527 on the derivative liability related
to the Finders&#x2019; Warrants (December 31, 2024 &#x2013; fair value gain of $4,279).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Incentive
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 17, 2023, the Company issued 17,307 incentive warrants (each a &#x201c;Incentive Warrant&#x201d;) to a third-party pursuant
to an engagement agreement between the parties, whereby each Incentive Warrant is exercisable for a period of two years at an
exercise price of: (i) US $39.00 for 5,769 Incentive Warrants; (ii) US $52.00 for 5,769 Incentive Warrants; and (iii) US $65.00
for 5,769 Incentive Warrants. On initial recognition, the fair value of these Incentive Warrants &lt;span style="color: windowtext"&gt;was
estimated at $409,496 using Black-Scholes with the following assumptions: expected volatility of 148% based on comparable companies,
expected dividend yield of 0%, risk-free interest rate of 4.15%, and an expected life of two years. The fair value of the Incentive
Warrants was recorded as consulting fees on the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the derivative liability related to the Incentive Warrants was measured at a fair value of $nil as the Incentive
Warrants expired on February 17, 2025 (June 30, 2025 - $nil).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, the Company recorded a fair value change of $nil (2024 &#x2013; fair value decrease of
$10,913) on the derivative liability related to the Incentive Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Settlement
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2023, the Company issued 38,462 settlement warrants (each a &#x201c;Settlement Warrant&#x201d;) to two additional third-parties
pursuant to an agreement for release and settlement of claims advanced against the Company, whereby each Settlement Warrant is
exercisable for a period of three years at an exercise price of US $32.50. On initial recognition, the fair value of these Settlement
Warrants &lt;span style="color: windowtext"&gt;was estimated at $979,294 using Black-Scholes with the following assumptions: expected
volatility of 140% based on comparable companies, expected dividend yield of 0%, risk-free interest rate of 3.51%, and an expected
life of three years. The fair value of the Settlement Warrants was recorded as professional fees on the consolidated statements
of loss and comprehensive loss.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the derivative liability related to the Settlement Warrants was measured at a fair value of $1,074 (June
30, 2025 - $31,238) using Black-Scholes with the following assumptions: share price of US $3.00, exercise price of US $32.50,
&lt;span style="color: windowtext"&gt;expected volatility of 195.53%&lt;/span&gt;, expected dividend yield of 0%, risk-free interest rate of
2.15% and an estimated remaining life of 0.25 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, the Company recorded a fair value decrease of $&lt;span id="xdx_904_ecustom--FairValueChangesOfDerivativeLiability_uCAD_c20250701__20251231__custom--DerivativeLiabilities1Axis__custom--SettlementWarrantsMember_zgf5eKTJKug2" title="Fair value changes of derivative liability"&gt;30,164&lt;/span&gt; (2024 &#x2013; fair value increase
of $&lt;span id="xdx_903_ecustom--FairValueChangesOfDerivativeLiability_uCAD_c20240701__20241231__custom--DerivativeLiabilities1Axis__custom--SettlementWarrantsMember_zAGvnUXeXlo9" title="Fair value changes of derivative liability"&gt;32,656&lt;/span&gt;) on the derivative liability related to the Settlement Warrants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Agents&#x2019;
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 21, 2023, the Company issued 6,615 agents&#x2019; warrants (each an &#x201c;Agents&#x2019; Warrant&#x201d;) in connection
to the flow-through financing, whereby each Agents&#x2019; Warrant is exercisable for a period of five years at an exercise price
of US $34.71. On initial recognition, the fair value of these Agents&#x2019; Warrants was estimated at $139,639 using Black-Scholes
with the following assumptions: expected volatility of 139% based on comparable companies, expected dividend yield of 0%, risk-free
interest rate of 4.25%, and an expected life of five years. The fair value of the Agents&#x2019; Warrants was recorded as share
issuance costs and netted against share capital on the consolidated statements of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the derivative liability related to the Agents&#x2019; Warrants was measured at a fair value of $14,642 (June
30, 2025 - $17,377) using Black-Scholes with the following assumptions: share price of US $3.00, exercise price of US $34.71,
expected volatility of 162.92%, expected dividend yield of 0%, risk-free interest rate of 2.57% and an estimated remaining life
of 2.73 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, the Company recorded a fair value decrease of $&lt;span id="xdx_908_ecustom--FairValueChangesOfDerivativeLiability_uCAD_c20250701__20251231__custom--DerivativeLiabilities1Axis__custom--AgentsWarrantsMember_zCFj4wP6jUD7" title="Fair value changes of derivative liability"&gt;2,735&lt;/span&gt; on the derivative liability related
to the Agents&#x2019; Warrants (December 31, 2024 &#x2013; fair value increase of $&lt;span id="xdx_909_ecustom--FairValueChangesOfDerivativeLiability_uCAD_c20240701__20241231__custom--DerivativeLiabilities1Axis__custom--AgentsWarrantsMember_zsItE5dlsiqf" title="Fair value changes of derivative liability"&gt;22,336&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Performance
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 2, 2023, the Company issued 23,076 performance warrants (each a &#x201c;Performance Warrant&#x201d;) to a third-party pursuant
to a marketing services agreement between the parties, whereby each Performance Warrant is exercisable for a period of one year
at an exercise price of: (i) US $26.00 for 7,692 Performance Warrants; (ii) US $32.50 for 7,692 Performance Warrants; and (iii)
US $39.00 for 7,692 Performance Warrants. On initial recognition, the fair value of these Performance Warrants was estimated
at $171,631 using Black-Scholes with the following assumptions: expected volatility of 137% based on comparable companies, expected
dividend yield of 0%, risk-free interest rate of 4.83%, and an expected life of one year. The fair value of the Performance Warrants
was recorded as consulting fees on the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the derivative liability related to the Performance Warrants was measured at a fair value of $nil as the
Performance Warrants expired on October 2, 2024 (June 30, 2025 - $nil)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, the Company recorded a fair value change of $nil on the derivative liability related to
the Performance Warrants (December 31, 2024 &#x2013; fair value decrease of $946).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Octagon
Warrants&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;On
April 1, 2025, the Company issued 19,231 performance warrants (each an &#x201c;Octagon Warrant&#x201d;) &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to
a third-party pursuant to the marketing agreement between the parties, whereby each Octagon Warrant is exercisable for a period
of one year at an exercise price of US $13.00. On initial recognition, the fair value of these Octagon Warrants was estimated
at $129,440 using Black-Scholes with the following assumptions: expected volatility of 238.19%, expected dividend yield of 0%,
risk-free interest rate of 2.49%, and an expected life of one year. The fair value of the Octagon Warrants was recorded as consulting
fees on the consolidated statements of loss and comprehensive loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the derivative liability related to the Octagon Warrants was measured at a fair value of $328 (June 30,
2025 - $56,073) using Black-Scholes with the following assumptions: share price of US $3.00, exercise price of US $13.00, expected
volatility of 113.47%, expected dividend yield of 0%, risk-free interest rate of 2.15% and an estimated remaining life of 0.30
years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ending December 31, 2025, the Company recorded a fair value decrease of $&lt;span id="xdx_90A_ecustom--FairValueChangesOfDerivativeLiability_uCAD_c20250701__20251231__custom--DerivativeLiabilities1Axis__custom--OctagonWarrantsMember_zeUlbTtDs2zk" title="Fair value changes of derivative liability"&gt;55,745&lt;/span&gt; on the derivative liability related
to the Octagon Warrants (December 31, 2024 - $nil).&lt;/span&gt;&lt;/p&gt;

</ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities>
    <fnuc:ScheduleOfChangesToDerivativeLiabilitiesTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001015">&lt;p id="xdx_894_ecustom--ScheduleOfChangesToDerivativeLiabilitiesTextBlock_zUBBT74Pc5L6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zjA1TShGceWe" style="display: none; visibility: hidden"&gt;Schedule of Changes to Derivative Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250701__20251231_zEjtIawYz2R5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240701__20250630_zXkeMRkRNwBl" style="border-bottom: Black 1pt solid; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_uCAD_z2cMYis8ERd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;111,913&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;305,025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_ecustom--FairValueOfDerivativeLiabilityOnDateOfIssuance_uCAD_zDpSUIw6AMtd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value of derivative liability on date of issuance&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1020"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;129,440&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_ecustom--FairValueChangesOfDerivativeLiabilityFindersWarrants_uCAD_zUiPlbcLuHHf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Finders&#x2019; Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,527&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(38,060&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--FairValueChangesOfDerivativeLiabilityIncentiveWarrants_uCAD_zc0g3dFEW6qc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Incentive Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1026"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(11,754&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--FairValueChangesOfDerivativeLiabilitySettlementWarrants_uCAD_zT9X8lDq4wlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Settlement Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(30,164&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(160,622&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--FairValueChangesOfDerivativeLiabilityAgentsWarrants_uCAD_zjzqK8uRfnha" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Agents&#x2019; Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(2,735&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(37,803&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_ecustom--FairValueChangesOfDerivativeLiabilityPerformanceWarrants_uCAD_zaf6BUqiZWRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Fair value changes of derivative liability &#x2013; Performance Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1035"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(946&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_ecustom--FairValueChangesOfDerivativeLiabilityOctagonWarrants_uCAD_zo5R5vIPCMDf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Fair value changes of derivative liability &#x2013; Octagon Warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(55,745&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(73,367&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_uCAD_zRdOWa6vHibf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;24,796&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;111,913&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfChangesToDerivativeLiabilitiesTextBlock>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001017"
      unitRef="CAD">111913</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2024-06-30"
      decimals="0"
      id="Fact001018"
      unitRef="CAD">305025</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <fnuc:FairValueOfDerivativeLiabilityOnDateOfIssuance
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001021"
      unitRef="CAD">129440</fnuc:FairValueOfDerivativeLiabilityOnDateOfIssuance>
    <fnuc:FairValueChangesOfDerivativeLiabilityFindersWarrants
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001023"
      unitRef="CAD">1527</fnuc:FairValueChangesOfDerivativeLiabilityFindersWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityFindersWarrants
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001024"
      unitRef="CAD">-38060</fnuc:FairValueChangesOfDerivativeLiabilityFindersWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityIncentiveWarrants
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001027"
      unitRef="CAD">-11754</fnuc:FairValueChangesOfDerivativeLiabilityIncentiveWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilitySettlementWarrants
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001029"
      unitRef="CAD">-30164</fnuc:FairValueChangesOfDerivativeLiabilitySettlementWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilitySettlementWarrants
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001030"
      unitRef="CAD">-160622</fnuc:FairValueChangesOfDerivativeLiabilitySettlementWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityAgentsWarrants
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001032"
      unitRef="CAD">-2735</fnuc:FairValueChangesOfDerivativeLiabilityAgentsWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityAgentsWarrants
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001033"
      unitRef="CAD">-37803</fnuc:FairValueChangesOfDerivativeLiabilityAgentsWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityPerformanceWarrants
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001036"
      unitRef="CAD">-946</fnuc:FairValueChangesOfDerivativeLiabilityPerformanceWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityOctagonWarrants
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001038"
      unitRef="CAD">-55745</fnuc:FairValueChangesOfDerivativeLiabilityOctagonWarrants>
    <fnuc:FairValueChangesOfDerivativeLiabilityOctagonWarrants
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001039"
      unitRef="CAD">-73367</fnuc:FairValueChangesOfDerivativeLiabilityOctagonWarrants>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001041"
      unitRef="CAD">24796</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001042"
      unitRef="CAD">111913</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <fnuc:FairValueChangesOfDerivativeLiability
      contextRef="From2025-07-012025-12-31_custom_SettlementWarrantsMember"
      decimals="0"
      id="Fact001052"
      unitRef="CAD">30164</fnuc:FairValueChangesOfDerivativeLiability>
    <fnuc:FairValueChangesOfDerivativeLiability
      contextRef="From2024-07-012024-12-31_custom_SettlementWarrantsMember"
      decimals="0"
      id="Fact001054"
      unitRef="CAD">32656</fnuc:FairValueChangesOfDerivativeLiability>
    <fnuc:FairValueChangesOfDerivativeLiability
      contextRef="From2025-07-012025-12-31_custom_AgentsWarrantsMember"
      decimals="0"
      id="Fact001056"
      unitRef="CAD">2735</fnuc:FairValueChangesOfDerivativeLiability>
    <fnuc:FairValueChangesOfDerivativeLiability
      contextRef="From2024-07-012024-12-31_custom_AgentsWarrantsMember"
      decimals="0"
      id="Fact001058"
      unitRef="CAD">22336</fnuc:FairValueChangesOfDerivativeLiability>
    <fnuc:FairValueChangesOfDerivativeLiability
      contextRef="From2025-07-012025-12-31_custom_OctagonWarrantsMember"
      decimals="0"
      id="Fact001060"
      unitRef="CAD">55745</fnuc:FairValueChangesOfDerivativeLiability>
    <fnuc:OtherLiabilitiyDisclosureTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001067">&lt;p id="xdx_80A_ecustom--OtherLiabilitiyDisclosureTextBlock_zu1o6jeN2AEf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;17.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_828_zpMOzUMAJ5w"&gt;Other
Liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
Company grants RSUs which contained a put right option (the &#x201c;Put Right Option&#x201d;) where the holders can elect to settle
in cash or in equity. These RSUs vest at various stages pending conditions of certain milestones. These RSUs with the Put Right
Option are classified as other liabilities on the consolidated statements of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;On
January 30, 2023, the Company granted &lt;span id="xdx_909_ecustom--RestrictedShareUnitsGranted_iI_pid_uShares_c20230130__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zCU0exeCkxz1"&gt;30,769&lt;/span&gt; RSUs to various directors which contained a put right option (the &#x201c;Put Right
Option&#x201d;) where the directors can elect to settle in cash or in equity. These RSUs vest at various stages pending conditions
of certain milestones. As at August 9, 2023, &lt;span id="xdx_901_ecustom--RestrictedShareUnitsVested_iI_pid_uShares_c20230809__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zfJh61Be43ff"&gt;12,308&lt;/span&gt; RSUs with the Put Right Option had met certain milestones required to vest.
On September 26, 2023, the Company paid $&lt;span id="xdx_900_ecustom--CashPaidToSettleLiabilityForShareBasedPayment_iI_uCAD_c20230926__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zu1SJlRvlhAh"&gt;534,240&lt;/span&gt; (US $&lt;span id="xdx_903_ecustom--CashPaidToSettleLiabilityForShareBasedPayment_iI_uUSD_c20230926__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zjx28VsC4ST6"&gt;400,000&lt;/span&gt;) to redeem these 12,308 RSUs at the Put Purchase Price. On January
10, 2025, the remaining &lt;span id="xdx_903_ecustom--RestrictedShareUnitsExercised_iI_pid_uShares_c20250110__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zwv5qXD4JlY6"&gt;18,461&lt;/span&gt; RSUs with the Put Right Option were exercised. The Company paid $&lt;span id="xdx_901_ecustom--CashPaidToSettleLiabilityForShareBasedPayment_iI_uCAD_c20250110__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zU29goXkacKl"&gt;863,280&lt;/span&gt; (US $&lt;span id="xdx_906_ecustom--CashPaidToSettleLiabilityForShareBasedPayment_iI_uUSD_c20250110__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zZoJFvOPc4fl"&gt;600,000&lt;/span&gt;) to redeem
these 18,461 RSUs at the Put Right Exercise Price.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;On
July 21, 2025, in connection with the adoption of the Company&#x2019;s RSU Plan, the board of directors approved the transition
of all previously issued RSUs into the RSU Plan, with vesting accelerated to the earlier of (i) the date following such adoption
at which the applicable participant elects to vest, provided such date is within 30 months of the adoption date, and (ii) June
30, 2026, or such earlier date as the market capitalization of the Corporation exceeds US $150,000,000 for 10 consecutive trading
days. Accordingly, 3,846 RSUs originally granted on July 14, 2023 and 890,375 RSUs originally granted on January 9, 2025 were
recognized as liabilities at their respective fair values on the transition date, being US $30.90 for the July 14, 2023 grants
and US $9.72 for the January 9, 2025 grants, based on the 30-day volume weighted average price of the Company&#x2019;s common
shares on the original grant date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Concurrently,
the Company granted 107,125 new RSUs to directors, officers, and a consultant of the Company at a grant date fair value of US
$3.91 per RSU, based on the 30-day volume weighted average price of the Company&#x2019;s common shares on July 21, 2025. Of these,
12,000 RSUs vested immediately on the grant date, with the remaining 95,125 RSUs vesting on the earlier of June 30, 2026, or the
market capitalization of the Corporation exceeding US $150,000,000 for 10 consecutive trading days. Share-based compensation
is recognized on a straight-line basis over the vesting period from July 21, 2025, to June 30, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;On
July 21, 2025, &lt;span id="xdx_90C_ecustom--RestrictedShareUnitsGranted_iI_pid_uShares_c20250721__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zb4kEKSJiZp1"&gt;6,807&lt;/span&gt; RSUs were redeemed for cash consideration of $&lt;span id="xdx_907_ecustom--CashConsideration_iI_uCAD_c20250721__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z0jZ74L5chzi" title="Cash consideration"&gt;54,779&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfMovementInRSULiabilityTableTextBlock_zhWd3iFxKFRa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes the movement in the RSU liability during the six-month period ended December 31, 2025 and the year
ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zhQ2dIlk6rpc" style="display: none; visibility: hidden"&gt;Schedule
Of &#160;The Company&#x2019;s Movement In RSU &#160;Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zETGrfgqEpR8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_znUFmB5CW0eb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--LiabilitiesArisingFromShareBasedPaymentTransactions_iS_uCAD_zrQf4jn9uN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1081"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;773,891&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ExpenseArisingFromShareBasedPaymentTransactions_uCAD_zJtaGfjZr3Y3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share based compensation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;12,315,277&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CashPaidToSettleLiabilityForShareBasedPayments_uCAD_zsseCDBwY39a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;RSUs redeemed in cash&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(54,779&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(863,280&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--ImpactOfForeignExchange_zfyWlspDkDEb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Impact of foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,373&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(60&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--LiabilitiesArisingFromShareBasedPaymentTransactions_iE_uCAD_zAo87qKmtAe3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A3_zggg5UiMOFzl" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</fnuc:OtherLiabilitiyDisclosureTextBlock>
    <fnuc:RestrictedShareUnitsGranted
      contextRef="AsOf2023-01-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001068"
      unitRef="Shares">30769</fnuc:RestrictedShareUnitsGranted>
    <fnuc:RestrictedShareUnitsVested
      contextRef="AsOf2023-08-09_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001069"
      unitRef="Shares">12308</fnuc:RestrictedShareUnitsVested>
    <fnuc:CashPaidToSettleLiabilityForShareBasedPayment
      contextRef="AsOf2023-09-26_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001070"
      unitRef="CAD">534240</fnuc:CashPaidToSettleLiabilityForShareBasedPayment>
    <fnuc:CashPaidToSettleLiabilityForShareBasedPayment
      contextRef="AsOf2023-09-26_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001071"
      unitRef="USD">400000</fnuc:CashPaidToSettleLiabilityForShareBasedPayment>
    <fnuc:RestrictedShareUnitsExercised
      contextRef="AsOf2025-01-10_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001072"
      unitRef="Shares">18461</fnuc:RestrictedShareUnitsExercised>
    <fnuc:CashPaidToSettleLiabilityForShareBasedPayment
      contextRef="AsOf2025-01-10_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001073"
      unitRef="CAD">863280</fnuc:CashPaidToSettleLiabilityForShareBasedPayment>
    <fnuc:CashPaidToSettleLiabilityForShareBasedPayment
      contextRef="AsOf2025-01-10_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001074"
      unitRef="USD">600000</fnuc:CashPaidToSettleLiabilityForShareBasedPayment>
    <fnuc:RestrictedShareUnitsGranted
      contextRef="AsOf2025-07-21_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001075"
      unitRef="Shares">6807</fnuc:RestrictedShareUnitsGranted>
    <fnuc:CashConsideration
      contextRef="AsOf2025-07-21_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001077"
      unitRef="CAD">54779</fnuc:CashConsideration>
    <fnuc:ScheduleOfMovementInRSULiabilityTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001079">&lt;p id="xdx_89C_ecustom--ScheduleOfMovementInRSULiabilityTableTextBlock_zhWd3iFxKFRa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
following table summarizes the movement in the RSU liability during the six-month period ended December 31, 2025 and the year
ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zhQ2dIlk6rpc" style="display: none; visibility: hidden"&gt;Schedule
Of &#160;The Company&#x2019;s Movement In RSU &#160;Liability&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zETGrfgqEpR8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_znUFmB5CW0eb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_ecustom--LiabilitiesArisingFromShareBasedPaymentTransactions_iS_uCAD_zrQf4jn9uN3k" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, beginning of period&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1081"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;773,891&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_ecustom--ExpenseArisingFromShareBasedPaymentTransactions_uCAD_zJtaGfjZr3Y3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share based compensation&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;12,315,277&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;89,449&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--CashPaidToSettleLiabilityForShareBasedPayments_uCAD_zsseCDBwY39a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;RSUs redeemed in cash&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(54,779&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(863,280&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_ecustom--ImpactOfForeignExchange_zfyWlspDkDEb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Impact of foreign exchange&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;11,373&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(60&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--LiabilitiesArisingFromShareBasedPaymentTransactions_iE_uCAD_zAo87qKmtAe3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, end of period&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1094"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfMovementInRSULiabilityTableTextBlock>
    <fnuc:LiabilitiesArisingFromShareBasedPaymentTransactions
      contextRef="AsOf2024-06-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001082"
      unitRef="CAD">773891</fnuc:LiabilitiesArisingFromShareBasedPaymentTransactions>
    <fnuc:ExpenseArisingFromShareBasedPaymentTransactions
      contextRef="From2025-07-012025-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001084"
      unitRef="CAD">12315277</fnuc:ExpenseArisingFromShareBasedPaymentTransactions>
    <fnuc:ExpenseArisingFromShareBasedPaymentTransactions
      contextRef="From2024-07-012025-06-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001085"
      unitRef="CAD">89449</fnuc:ExpenseArisingFromShareBasedPaymentTransactions>
    <fnuc:CashPaidToSettleLiabilityForShareBasedPayments
      contextRef="From2025-07-012025-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001087"
      unitRef="CAD">-54779</fnuc:CashPaidToSettleLiabilityForShareBasedPayments>
    <fnuc:CashPaidToSettleLiabilityForShareBasedPayments
      contextRef="From2024-07-012025-06-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001088"
      unitRef="CAD">-863280</fnuc:CashPaidToSettleLiabilityForShareBasedPayments>
    <fnuc:ImpactOfForeignExchange
      contextRef="From2025-07-012025-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001090"
      unitRef="CAD">11373</fnuc:ImpactOfForeignExchange>
    <fnuc:ImpactOfForeignExchange
      contextRef="From2024-07-012025-06-30_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001091"
      unitRef="CAD">-60</fnuc:ImpactOfForeignExchange>
    <fnuc:LiabilitiesArisingFromShareBasedPaymentTransactions
      contextRef="AsOf2025-12-31_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001093"
      unitRef="CAD">12271871</fnuc:LiabilitiesArisingFromShareBasedPaymentTransactions>
    <fnuc:FlowThroughShareLiabilityDisclosureTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001096">&lt;p id="xdx_802_ecustom--FlowThroughShareLiabilityDisclosureTextBlock_z9BhIKbv04u1" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;18.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_828_zxuwuYJsRFv4"&gt;Flow-Through
Share Liability&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Flow-through
share liability includes the liability portion of the flow-through shares issued. The flow-through common shares issued in the
offering completed on September 21, 2023 were issued at a premium to the market price in recognition of the tax benefits accruing
to subscribers. The flow-through premium was calculated to be $&lt;span id="xdx_906_ecustom--FlowThroughShareLiability_iI_uCAD_c20230921_zvcCMDqBuYMd"&gt;3,637,149&lt;/span&gt; and was derecognized through income as eligible expenditures
were incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended June 30, 2025, the Company incurred eligible expenditures of $&lt;span id="xdx_903_ecustom--EligibleExpendituresIncurred_iI_uCAD_c20250630_znRYkXexTfxc"&gt;4,273,151&lt;/span&gt;, satisfying $&lt;span id="xdx_909_ecustom--DecreaseInFlowThroughPremiumRecognised_iI_uCAD_c20250630_zGu5CTxkAQrj"&gt;2,016,543&lt;/span&gt; of such premium.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of June 30, 2025, the Company had not fully spent the required amount, resulting in potential tax penalties and investor compensation
obligations. As a result, the Company has recorded a provision of $&lt;span id="xdx_909_ecustom--ProvisionsOfCompensationForTaxBenefit_iI_uCAD_c20250630_zne0xXq4vWE2"&gt;1,059,721&lt;/span&gt; for estimated Part XII.6 tax payable to the Canada
Revenue Agency and for potential investor compensation related to tax benefit adjustments.&lt;/span&gt;&lt;/p&gt;

</fnuc:FlowThroughShareLiabilityDisclosureTextBlock>
    <fnuc:FlowThroughShareLiability
      contextRef="AsOf2023-09-21"
      decimals="0"
      id="Fact001097"
      unitRef="CAD">3637149</fnuc:FlowThroughShareLiability>
    <fnuc:EligibleExpendituresIncurred
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001098"
      unitRef="CAD">4273151</fnuc:EligibleExpendituresIncurred>
    <fnuc:DecreaseInFlowThroughPremiumRecognised
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001099"
      unitRef="CAD">2016543</fnuc:DecreaseInFlowThroughPremiumRecognised>
    <fnuc:ProvisionsOfCompensationForTaxBenefit
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001100"
      unitRef="CAD">1059721</fnuc:ProvisionsOfCompensationForTaxBenefit>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001102">&lt;p id="xdx_806_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zpEyqXipYRFa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19.&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_822_zr7DMvcXrxzl" style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Share
Capital&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Authorized
share capital&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
Company is authorized to issue an unlimited number of common shares without par value. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;On
May 2, 2025, the Company completed a 1-for-13 reverse stock split of its outstanding common shares. All references to the number
of common shares, earnings per share, and per share information in these consolidated financial statements have been retroactively
adjusted to reflect the impact of the share split for all periods presented. The total number of common shares outstanding decreased
from &lt;span id="xdx_905_eifrs-full--NumberOfSharesOutstanding_iI_pid_uShares_c20250501_ztq0jtHe17Z7" title="Shares outstanding before the reverse split"&gt;101,406,557&lt;/span&gt; to &lt;span id="xdx_907_eifrs-full--NumberOfSharesOutstanding_iI_pid_uShares_c20250502_zFMbYRN1e8p8" title="Shares outstanding after the reverse split"&gt;7,800,497&lt;/span&gt;, with no change in total share capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zCVWPt858h72" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Common
shares issued and outstanding from June 30, 2024 to December 31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span id="xdx_8B6_zkWk7JMEDOA4" style="display: none; visibility: hidden"&gt;Schedule of common shares issued and outstanding&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; font-weight: bold; text-align: right"&gt;Number of common shares&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; font-weight: bold; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;#&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iS_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zvdQQiq9F5P2" style="width: 14%; font-weight: bold; text-align: right" title="Number of shares outstanding"&gt;1,982,003&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--Equity_iS_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z53HqS2b0G14" style="width: 14%; font-weight: bold; text-align: right" title="Total Shareholders' Equity"&gt;50,127,974&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shares issued on ATM financings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharesIssuedOnAtmFinancingsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zLfOmoNHaBMe" style="text-align: right" title="Shares issued on ATM financings, shares"&gt;5,842,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharesIssuedOnAtmFinancingsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zisnZFg6JWre" style="text-align: right" title="Shares issued on ATM financings, value"&gt;63,274,574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share issue costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareIssueCostsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zHmkXnYdkX86" style="text-align: right" title="Share issue costs, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1118"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareIssueCostsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zXuutkQJU22g" style="text-align: right" title="Share issue costs, value"&gt;(16,672,731&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Shares issued per agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharesIssuedPerAgreementsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zsXGvjVRHoFl" style="text-align: right" title="Shares issued per agreements, shares"&gt;776,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SharesIssuedPerAgreementsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zDvZNC33tpc" style="text-align: right" title="Shares issued per agreements, value"&gt;8,325,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Shares issued per option agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharesIssuedPerOptionAgreementsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z8ww1PQ82Auf" style="text-align: right" title="Shares issued per option agreements, shares"&gt;155,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharesIssuedPerOptionAgreementsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zVoae5lGfVAa" style="text-align: right" title="Shares issued per option agreements, value"&gt;1,490,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z1XzAxBtVra4" style="text-align: right" title="Share based compensation, shares"&gt;14,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zD5DC5FVPqTb" style="text-align: right" title="Share based compensation, value"&gt;186,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Treasury shares held for cancellation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--TreasurySharesHeldForCancellationShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zNtLiPmq6yH9" style="text-align: right" title="Treasury shares held for cancellation, shares"&gt;(22,919&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--TreasurySharesHeldForCancellationValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z6zlK3qinpec" style="text-align: right" title="Treasury shares held for cancellation, value"&gt;(191,898&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Cash paid in lieu on shares consolidation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--CashPaidInLieuOnSharesConsolidationShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z2jjWwLKmeNd" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid in lieu on shares consolidation, shares"&gt;(689&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CashPaidInLieuOnSharesConsolidationValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zCH2cB8amCqg" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid in lieu on shares consolidation, value"&gt;(3,740&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zg9m2Y6AFIXb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of shares outstanding"&gt;8,748,167&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--Equity_iS_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zzESLf4hm7Fg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total Shareholders' Equity"&gt;106,536,406&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shares issued on ATM financings&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharesIssuedOnAtmFinancingsShares_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z3UkwXjw6JXa" style="font-weight: bold; text-align: right" title="Shares issued on ATM financings, shares"&gt;6,755,183&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SharesIssuedOnAtmFinancingsValue_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zJLO03HkCSyh" style="font-weight: bold; text-align: right" title="Shares issued on ATM financings, value"&gt;50,685,642&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Share issue costs&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareIssueCostsShares_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zU8Md6SKmFG1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Share issue costs, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1150"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareIssueCostsValue_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z5eZ2qg3rlef" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Share issue costs, value"&gt;(9,269,409&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iE_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zBN26wXeyuM7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of shares outstanding"&gt;15,503,350&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--Equity_iE_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z0B7V3MrBmIe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total Shareholders' Equity"&gt;147,952,639&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A2_zXDvPBWdBE6f" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Share
capital transactions for the six months ended December 31, 2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 17, 2025, the Company entered into an ATM Sales Agreement with ThinkEquity LLC (the &#x201c;Agent&#x201d;), pursuant to which
the Company may offer and sell, from time to time through the Agent, up to US$&lt;span id="xdx_907_ecustom--MaximumAggregateOfferingAmountUnderATMFacility_iI_uUSD_c20250417_zqG7srxxv2Gj" title="Maximum Aggregate Offering Amount Under ATM Sales Agreement"&gt;50,000,000&lt;/span&gt; of common shares of the Company. During
the six months ending December 31, 2025, the Company had sold &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ATMSalesAgreementWithThinkEquityLLCMember_z74JES6Rrzta" title="Common shares sold during the period"&gt;6,755,183&lt;/span&gt; common shares for gross proceeds of $&lt;span id="xdx_90A_eifrs-full--ProceedsFromIssuingShares_uCAD_c20250701__20251231_z49mZfEBq9Dl" title="Gross proceeds from shares issuance"&gt;50,685,642&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the equity financings above, the Company paid fees and expenses for marketing, commissions, and professional services
in the amount of $&lt;span id="xdx_900_eifrs-full--PaymentsForShareIssueCosts_uCAD_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ATMSalesAgreementWithThinkEquityLLCMember_zLmSTA86XTJb" title="Fees and expenses for marketing, commissions, and professional services"&gt;9,269,409&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Share
capital transactions for the year ended June 30, 2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 7, 2024, the Company issued &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20240807_zEHYgjERdkPk" title="Common shares issued for acquisition"&gt;155,730&lt;/span&gt; common shares in connection with the acquisition of the First Stage Interest with respect
to the Engo Valley Uranium Project. These common shares were valued at $&lt;span id="xdx_90E_ecustom--FairValueOfSharesIssuedAsConsiderationForAcquisition_iI_uCAD_c20240807_zjIgKnNaHtM9" title="Fair value of shares issued as consideration for acquisition"&gt;1,490,860&lt;/span&gt; based on the Company&#x2019;s closing share price
on the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 22, 2024, the Company entered into an ATM Sales Agreement, as amended on October 18, 2024, with the Agent, as sales agent,
pursuant to which the Company may offer and sell, from time to time through the Agent, up to US$&lt;span id="xdx_905_ecustom--ShareIssueAmount_iI_uUSD_c20240822__20241018_zF8iv2cFWo19" title="ATM facility maximum authorized issuance"&gt;2,900,000&lt;/span&gt; of common shares of
the Company. During the year ended June 30, 2025, the Company has sold &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250630_zk8JfHAZIYch" title="Common shares sold through ATM"&gt;1,009,919&lt;/span&gt; common shares for gross proceeds of $4,081,551
(US $2,897,622).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 20, 2024, the Company issued &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20241220_zsySDxOavp8g" title="Common shares issued"&gt;1,211,538&lt;/span&gt; common shares at a price of US $&lt;span id="xdx_905_ecustom--PublicOfferingPricePerShare_iI_pid_uUSDPShares_c20241220_zG23DtfD9cHg" title="Public offering price per share"&gt;5.33&lt;/span&gt; per share in a best-efforts public offering,
for gross proceeds of $&lt;span id="xdx_90E_eifrs-full--ProceedsFromIssuingShares_uCAD_c20241201__20241220_zQfi0SxLOJBe" title="Gross proceeds from shares issuance"&gt;9,276,199&lt;/span&gt; (US $6,457,500).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 31, 2024, the Company issued &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20241231_zsKTFvoTX9Lg" title="Common shares issued"&gt;1,442,307&lt;/span&gt; common shares at a price of US $&lt;span id="xdx_90E_ecustom--PublicOfferingPricePerShare_iI_pid_uUSDPShares_c20241231_zSFEzAYxhaGl" title="Public offering price per share"&gt;10.40&lt;/span&gt; per share in a best-efforts public offering,
for gross proceeds of $&lt;span id="xdx_906_eifrs-full--ProceedsFromIssuingShares_uCAD_c20241201__20241231_z0swvTeYsN53" title="Gross proceeds from shares issuance"&gt;21,583,500&lt;/span&gt; (US $15,000,000).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 27, 2025, the Company issued &lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250127_ziVs6cyBA0fe" title="Common shares issued"&gt;1,230,769&lt;/span&gt; common shares at a price of US $&lt;span id="xdx_909_ecustom--PublicOfferingPricePerShare_iI_pid_uUSDPShares_c20250127_zxqdt61X1JLa" title="Public offering price per share"&gt;13.00&lt;/span&gt; per share in a best-efforts public offering
for gross proceeds of $&lt;span id="xdx_90E_eifrs-full--ProceedsFromIssuingShares_uCAD_c20250101__20250127_z3EyFid9Ky71" title="Gross proceeds from shares issuance"&gt;23,009,600&lt;/span&gt; (US $16,000,000).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 17, 2025, the Company entered into an ATM Sales Agreement with the Agent, pursuant to which the Company may offer and sell,
from time to time through the Agent, up to US$&lt;span id="xdx_901_ecustom--MaximumAggregateOfferingAmountUnderATMFacility_iI_uUSD_c20250417_zeX8zrM1PkNk" title="Maximum Aggregate Offering Amount Under ATM Sales Agreement"&gt;50,000,000&lt;/span&gt; of common shares of the Company.
During the year ended June 30, 2025, the Company had sold 948,359 common shares for gross proceeds of $&lt;span id="xdx_906_eifrs-full--ProceedsFromIssuingShares_uCAD_c20240701__20250630_zlKyS5u1CEkd" title="Gross proceeds from shares issuance"&gt;5,323,724&lt;/span&gt; (US$3,858,666).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/span&gt;&lt;/p&gt;



















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the equity financings above, the Company paid fees and expenses for marketing, commissions, and professional services
in the amount of $&lt;span id="xdx_90A_eifrs-full--PaymentsForShareIssueCosts_uCAD_c20240701__20250630_zVccNR4iB6e9" title="Fees and expenses for marketing, commissions, and professional services"&gt;16,672,731&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
November 18, 2024, the Company issued &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20241118_zx5xcYZFuTj3" title="Common shares issued to settle legal expense debt"&gt;76,923&lt;/span&gt; common shares to 10152300 Manitoba LTD. pursuant to a debt settlement agreement for
legal expenses between the parties. These common shares were valued at $&lt;span id="xdx_905_ecustom--FairValueOfSharesIssuedForDebtSettlement_iI_uCAD_c20241118_zzIL7KvXFPs9" title="Fair value of shares issued for debt settlement"&gt;308,924&lt;/span&gt; based on the Company&#x2019;s closing share price
on the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board of Directors approved the issuance of up to &lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250110_zksKuSv4Z3V4" title="Shares issued to settle creditor balances"&gt;38,461&lt;/span&gt; shares to settle debts owed to various creditors under a Debt Settlement
Agreement. The shares were issued on January 10, 2025. These common shares were valued at $&lt;span id="xdx_90D_ecustom--FairValueOfSharesIssuedForDebtSettlement_iI_uCAD_c20250110_z0NR5Bqk2J3f" title="Fair value of shares issued for debt settlement"&gt;489,627&lt;/span&gt; based on the Company&#x2019;s
closing share price on the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2025, the Company issued &lt;span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10183923ManitobaLtdMember_zUE7OK4bzlTd" title="Common shares issued to settle legal expense debt"&gt;378,461&lt;/span&gt; common shares to 10183923 Manitoba Ltd. and &lt;span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10152300ManitobaLTDMember_zSmnSaF6zJsa" title="Common shares issued to settle legal expense debt"&gt;38,461&lt;/span&gt; common shares to 10152300 Manitoba
LTD. pursuant to a debt settlement agreement between the respective parties. These common shares were valued at $&lt;span id="xdx_903_ecustom--FairValueOfSharesIssuedForDebtSettlement_iI_uCAD_c20250228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10183923ManitobaLtdMember_zNVuokznxKCc" title="Fair value of shares issued for debt settlement"&gt;5,358,848&lt;/span&gt; and
$&lt;span id="xdx_902_ecustom--FairValueOfSharesIssuedForDebtSettlement_iI_uCAD_c20250228__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10152300ManitobaLTDMember_ztAW0b0Aevc5" title="Fair value of shares issued for debt settlement"&gt;544,598&lt;/span&gt;, respectively, based on the Company&#x2019;s closing share price on the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 12, 2025, the Company issued &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250312__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10223254ManitobaLtdMember_z2ZBdaT8Zfue" title="Common shares issued to settle legal expense debt"&gt;123,076&lt;/span&gt; common shares to 10223254 Manitoba Ltd. pursuant to a debt settlement agreement between
the parties. These common shares were valued at $&lt;span id="xdx_90B_ecustom--FairValueOfSharesIssuedForDebtSettlement_iI_uCAD_c20250312__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10223254ManitobaLtdMember_zerG8aQQubAk" title="Fair value of shares issued for debt settlement"&gt;838,126&lt;/span&gt; based on the Company&#x2019;s closing share price on the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 13, 2025, the Company issued &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250313__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10223778ManitobaLtdMember_z9qgAvXe1UMe" title="Common shares issued to settle legal expense debt"&gt;121,153&lt;/span&gt; common shares to 10223778 Manitoba Ltd. pursuant to a debt settlement agreement between
the parties. These common shares were valued at $&lt;span id="xdx_90C_ecustom--FairValueOfSharesIssuedForDebtSettlement_iI_uCAD_c20250312__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DebtSettlementTo10223778ManitobaLtdMember_zYEgrRNWtivi" title="Fair value of shares issued for debt settlement"&gt;785,213&lt;/span&gt; based on the Company&#x2019;s closing share price on the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 10, 2025, &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250110__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsAndCommitteeMember_zy8Dht3mU7Jb" title="Common shares granted to directors and committee members"&gt;6,923&lt;/span&gt; common shares were granted to directors and committee members. These common shares were valued at $&lt;span id="xdx_909_ecustom--FairValueOfSharesGrantedToDirectorsAndCommitteeMembers_iI_uCAD_c20250110_zzhUWVqWSj14" title="Fair value of shares granted to directors and committee members"&gt;88,120&lt;/span&gt;
based on the Company&#x2019;s closing share price on the date of issuance. The Company also issued &lt;span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20250110__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ChiefExecutiveOfficerMember_znDdcreusQ35" title="Common shares issued to CEO upon exercise of RSUs"&gt;7,692&lt;/span&gt; common shares to the CEO
on the exercise of RSUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended June 30, 2025, the Company bought back 22,919 shares for $191,898.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-05-01"
      decimals="INF"
      id="Fact001104"
      unitRef="Shares">101406557</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-05-02"
      decimals="INF"
      id="Fact001106"
      unitRef="Shares">7800497</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001108">&lt;p id="xdx_894_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zCVWPt858h72" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Common
shares issued and outstanding from June 30, 2024 to December 31, 2025 are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span id="xdx_8B6_zkWk7JMEDOA4" style="display: none; visibility: hidden"&gt;Schedule of common shares issued and outstanding&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-top: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; font-weight: bold; text-align: right"&gt;Number of common shares&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; font-weight: bold; text-align: right"&gt;Amount&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;#&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; font-weight: bold"&gt;Balance, June 30, 2024&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iS_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zvdQQiq9F5P2" style="width: 14%; font-weight: bold; text-align: right" title="Number of shares outstanding"&gt;1,982,003&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--Equity_iS_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z53HqS2b0G14" style="width: 14%; font-weight: bold; text-align: right" title="Total Shareholders' Equity"&gt;50,127,974&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shares issued on ATM financings&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharesIssuedOnAtmFinancingsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zLfOmoNHaBMe" style="text-align: right" title="Shares issued on ATM financings, shares"&gt;5,842,892&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SharesIssuedOnAtmFinancingsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zisnZFg6JWre" style="text-align: right" title="Shares issued on ATM financings, value"&gt;63,274,574&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Share issue costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareIssueCostsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zHmkXnYdkX86" style="text-align: right" title="Share issue costs, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1118"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareIssueCostsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zXuutkQJU22g" style="text-align: right" title="Share issue costs, value"&gt;(16,672,731&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Shares issued per agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--SharesIssuedPerAgreementsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zsXGvjVRHoFl" style="text-align: right" title="Shares issued per agreements, shares"&gt;776,535&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--SharesIssuedPerAgreementsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zDvZNC33tpc" style="text-align: right" title="Shares issued per agreements, value"&gt;8,325,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Shares issued per option agreements&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharesIssuedPerOptionAgreementsShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z8ww1PQ82Auf" style="text-align: right" title="Shares issued per option agreements, shares"&gt;155,730&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SharesIssuedPerOptionAgreementsValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zVoae5lGfVAa" style="text-align: right" title="Shares issued per option agreements, value"&gt;1,490,860&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Share based compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z1XzAxBtVra4" style="text-align: right" title="Share based compensation, shares"&gt;14,615&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zD5DC5FVPqTb" style="text-align: right" title="Share based compensation, value"&gt;186,031&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Treasury shares held for cancellation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--TreasurySharesHeldForCancellationShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zNtLiPmq6yH9" style="text-align: right" title="Treasury shares held for cancellation, shares"&gt;(22,919&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--TreasurySharesHeldForCancellationValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z6zlK3qinpec" style="text-align: right" title="Treasury shares held for cancellation, value"&gt;(191,898&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Cash paid in lieu on shares consolidation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--CashPaidInLieuOnSharesConsolidationShares_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z2jjWwLKmeNd" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid in lieu on shares consolidation, shares"&gt;(689&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--CashPaidInLieuOnSharesConsolidationValue_uCAD_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zCH2cB8amCqg" style="border-bottom: Black 1pt solid; text-align: right" title="Cash paid in lieu on shares consolidation, value"&gt;(3,740&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfSharesOutstanding_iS_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zg9m2Y6AFIXb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of shares outstanding"&gt;8,748,167&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--Equity_iS_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zzESLf4hm7Fg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total Shareholders' Equity"&gt;106,536,406&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Shares issued on ATM financings&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--SharesIssuedOnAtmFinancingsShares_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z3UkwXjw6JXa" style="font-weight: bold; text-align: right" title="Shares issued on ATM financings, shares"&gt;6,755,183&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SharesIssuedOnAtmFinancingsValue_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zJLO03HkCSyh" style="font-weight: bold; text-align: right" title="Shares issued on ATM financings, value"&gt;50,685,642&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Share issue costs&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareIssueCostsShares_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zU8Md6SKmFG1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Share issue costs, shares"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1150"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareIssueCostsValue_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z5eZ2qg3rlef" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Share issue costs, value"&gt;(9,269,409&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Balance, December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iE_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zBN26wXeyuM7" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of shares outstanding"&gt;15,503,350&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--Equity_iE_uCAD_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z0B7V3MrBmIe" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Total Shareholders' Equity"&gt;147,952,639&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001110"
      unitRef="Shares">1982003</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2024-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001112"
      unitRef="CAD">50127974</ifrs-full:Equity>
    <fnuc:SharesIssuedOnAtmFinancingsShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001114"
      unitRef="Shares">5842892</fnuc:SharesIssuedOnAtmFinancingsShares>
    <fnuc:SharesIssuedOnAtmFinancingsValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001116"
      unitRef="CAD">63274574</fnuc:SharesIssuedOnAtmFinancingsValue>
    <fnuc:ShareIssueCostsValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001120"
      unitRef="CAD">-16672731</fnuc:ShareIssueCostsValue>
    <fnuc:SharesIssuedPerAgreementsShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001122"
      unitRef="Shares">776535</fnuc:SharesIssuedPerAgreementsShares>
    <fnuc:SharesIssuedPerAgreementsValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001124"
      unitRef="CAD">8325336</fnuc:SharesIssuedPerAgreementsValue>
    <fnuc:SharesIssuedPerOptionAgreementsShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001126"
      unitRef="Shares">155730</fnuc:SharesIssuedPerOptionAgreementsShares>
    <fnuc:SharesIssuedPerOptionAgreementsValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001128"
      unitRef="CAD">1490860</fnuc:SharesIssuedPerOptionAgreementsValue>
    <fnuc:ShareBasedCompensationShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001130"
      unitRef="Shares">14615</fnuc:ShareBasedCompensationShares>
    <fnuc:ShareBasedCompensationValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001132"
      unitRef="CAD">186031</fnuc:ShareBasedCompensationValue>
    <fnuc:TreasurySharesHeldForCancellationShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001134"
      unitRef="Shares">-22919</fnuc:TreasurySharesHeldForCancellationShares>
    <fnuc:TreasurySharesHeldForCancellationValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001136"
      unitRef="CAD">-191898</fnuc:TreasurySharesHeldForCancellationValue>
    <fnuc:CashPaidInLieuOnSharesConsolidationShares
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001138"
      unitRef="Shares">-689</fnuc:CashPaidInLieuOnSharesConsolidationShares>
    <fnuc:CashPaidInLieuOnSharesConsolidationValue
      contextRef="From2024-07-012025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001140"
      unitRef="CAD">-3740</fnuc:CashPaidInLieuOnSharesConsolidationValue>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001142"
      unitRef="Shares">8748167</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2025-06-30_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001144"
      unitRef="CAD">106536406</ifrs-full:Equity>
    <fnuc:SharesIssuedOnAtmFinancingsShares
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001146"
      unitRef="Shares">6755183</fnuc:SharesIssuedOnAtmFinancingsShares>
    <fnuc:SharesIssuedOnAtmFinancingsValue
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001148"
      unitRef="CAD">50685642</fnuc:SharesIssuedOnAtmFinancingsValue>
    <fnuc:ShareIssueCostsValue
      contextRef="From2025-07-012025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001152"
      unitRef="CAD">-9269409</fnuc:ShareIssueCostsValue>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="INF"
      id="Fact001154"
      unitRef="Shares">15503350</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:Equity
      contextRef="AsOf2025-12-31_ifrs-full_IssuedCapitalMember"
      decimals="0"
      id="Fact001156"
      unitRef="CAD">147952639</ifrs-full:Equity>
    <fnuc:MaximumAggregateOfferingAmountUnderATMFacility
      contextRef="AsOf2025-04-17"
      decimals="0"
      id="Fact001158"
      unitRef="USD">50000000</fnuc:MaximumAggregateOfferingAmountUnderATMFacility>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-12-31_custom_ATMSalesAgreementWithThinkEquityLLCMember"
      decimals="INF"
      id="Fact001160"
      unitRef="Shares">6755183</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001162"
      unitRef="CAD">50685642</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2025-07-012025-12-31_custom_ATMSalesAgreementWithThinkEquityLLCMember"
      decimals="0"
      id="Fact001164"
      unitRef="CAD">9269409</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-08-07"
      decimals="INF"
      id="Fact001166"
      unitRef="Shares">155730</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesIssuedAsConsiderationForAcquisition
      contextRef="AsOf2024-08-07"
      decimals="0"
      id="Fact001168"
      unitRef="CAD">1490860</fnuc:FairValueOfSharesIssuedAsConsiderationForAcquisition>
    <fnuc:ShareIssueAmount
      contextRef="From2024-08-222024-10-18"
      decimals="0"
      id="Fact001170"
      unitRef="USD">2900000</fnuc:ShareIssueAmount>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-06-30"
      decimals="INF"
      id="Fact001172"
      unitRef="Shares">1009919</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-20"
      decimals="INF"
      id="Fact001174"
      unitRef="Shares">1211538</ifrs-full:NumberOfSharesIssued>
    <fnuc:PublicOfferingPricePerShare
      contextRef="AsOf2024-12-20"
      decimals="INF"
      id="Fact001176"
      unitRef="USDPShares">5.33</fnuc:PublicOfferingPricePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-12-012024-12-20"
      decimals="0"
      id="Fact001178"
      unitRef="CAD">9276199</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001180"
      unitRef="Shares">1442307</ifrs-full:NumberOfSharesIssued>
    <fnuc:PublicOfferingPricePerShare
      contextRef="AsOf2024-12-31"
      decimals="INF"
      id="Fact001182"
      unitRef="USDPShares">10.40</fnuc:PublicOfferingPricePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-12-012024-12-31"
      decimals="0"
      id="Fact001184"
      unitRef="CAD">21583500</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-27"
      decimals="INF"
      id="Fact001186"
      unitRef="Shares">1230769</ifrs-full:NumberOfSharesIssued>
    <fnuc:PublicOfferingPricePerShare
      contextRef="AsOf2025-01-27"
      decimals="INF"
      id="Fact001188"
      unitRef="USDPShares">13.00</fnuc:PublicOfferingPricePerShare>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2025-01-012025-01-27"
      decimals="0"
      id="Fact001190"
      unitRef="CAD">23009600</ifrs-full:ProceedsFromIssuingShares>
    <fnuc:MaximumAggregateOfferingAmountUnderATMFacility
      contextRef="AsOf2025-04-17"
      decimals="0"
      id="Fact001192"
      unitRef="USD">50000000</fnuc:MaximumAggregateOfferingAmountUnderATMFacility>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001194"
      unitRef="CAD">5323724</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001204"
      unitRef="CAD">16672731</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2024-11-18"
      decimals="INF"
      id="Fact001206"
      unitRef="Shares">76923</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesIssuedForDebtSettlement
      contextRef="AsOf2024-11-18"
      decimals="0"
      id="Fact001208"
      unitRef="CAD">308924</fnuc:FairValueOfSharesIssuedForDebtSettlement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-10"
      decimals="INF"
      id="Fact001210"
      unitRef="Shares">38461</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesIssuedForDebtSettlement
      contextRef="AsOf2025-01-10"
      decimals="0"
      id="Fact001212"
      unitRef="CAD">489627</fnuc:FairValueOfSharesIssuedForDebtSettlement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_DebtSettlementTo10183923ManitobaLtdMember"
      decimals="INF"
      id="Fact001214"
      unitRef="Shares">378461</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-02-28_custom_DebtSettlementTo10152300ManitobaLTDMember"
      decimals="INF"
      id="Fact001216"
      unitRef="Shares">38461</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesIssuedForDebtSettlement
      contextRef="AsOf2025-02-28_custom_DebtSettlementTo10183923ManitobaLtdMember"
      decimals="0"
      id="Fact001218"
      unitRef="CAD">5358848</fnuc:FairValueOfSharesIssuedForDebtSettlement>
    <fnuc:FairValueOfSharesIssuedForDebtSettlement
      contextRef="AsOf2025-02-28_custom_DebtSettlementTo10152300ManitobaLTDMember"
      decimals="0"
      id="Fact001220"
      unitRef="CAD">544598</fnuc:FairValueOfSharesIssuedForDebtSettlement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-03-12_custom_DebtSettlementTo10223254ManitobaLtdMember"
      decimals="INF"
      id="Fact001222"
      unitRef="Shares">123076</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesIssuedForDebtSettlement
      contextRef="AsOf2025-03-12_custom_DebtSettlementTo10223254ManitobaLtdMember"
      decimals="0"
      id="Fact001224"
      unitRef="CAD">838126</fnuc:FairValueOfSharesIssuedForDebtSettlement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-03-13_custom_DebtSettlementTo10223778ManitobaLtdMember"
      decimals="INF"
      id="Fact001226"
      unitRef="Shares">121153</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesIssuedForDebtSettlement
      contextRef="AsOf2025-03-12_custom_DebtSettlementTo10223778ManitobaLtdMember"
      decimals="0"
      id="Fact001228"
      unitRef="CAD">785213</fnuc:FairValueOfSharesIssuedForDebtSettlement>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-10_custom_DirectorsAndCommitteeMember"
      decimals="INF"
      id="Fact001230"
      unitRef="Shares">6923</ifrs-full:NumberOfSharesIssued>
    <fnuc:FairValueOfSharesGrantedToDirectorsAndCommitteeMembers
      contextRef="AsOf2025-01-10"
      decimals="0"
      id="Fact001232"
      unitRef="CAD">88120</fnuc:FairValueOfSharesGrantedToDirectorsAndCommitteeMembers>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2025-01-10_custom_ChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact001234"
      unitRef="Shares">7692</ifrs-full:NumberOfSharesIssued>
    <fnuc:DisclosureOfReserveForShareBasedPaymentsTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001236">&lt;p id="xdx_80B_ecustom--DisclosureOfReserveForShareBasedPaymentsTextBlock_zXq01YUQRAZ9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;20.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_82A_zpZuq9RjAKX2"&gt;Reserve
for Share-Based Payments&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains the Option Plan whereby certain key officers, directors and consultants may be granted stock options for common
shares of the Company. The maximum number of common shares that are issuable under the Option Plan is limited to 185,133 common
shares. &lt;span style="color: windowtext"&gt;Under the Option Plan, the exercise price of each option may not be lower than the greater
of the closing price of the Company&#x2019;s shares on the trading day prior to the grant date or the grant date itself, whichever
is higher. Vesting of options is determined at the discretion of the Board. &lt;/span&gt;As at December 31, 2025, the Company had 118,996
common shares available for issuance under the Option Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the stock option activity for the six months ended December 31, 2025, and the year ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfStockOptionActivityTableTextBlock_zZlGXwj06t0i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_zmNTdKvoFwC7" style="display: none; visibility: hidden"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; font-weight: bold; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOptionsOutstanding_iS_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zuCavSXsls7h" style="width: 14%; font-weight: bold; text-align: right" title="Number of Options, Opening Balance"&gt;62,137&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90B_ecustom--WeightedAverageExercisePriceOutstandingAtBeginning_pid_uUSDPShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zhLzigCxai2a"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfOptionsOutstanding_iS_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zIEoKjaP2GNe" style="width: 14%; text-align: right" title="Number of Options, Opening Balance"&gt;62,137&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOutstandingAtBeginning_pid_uUSDPShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zcWafHuHVnEj"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Granted&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NumberOfOptionsGranted_pid_d0_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zEXRTgYFJzTh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of Options, Granted"&gt;4,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90B_ecustom--WeightedAverageExercisePriceGranted_iI_pid_uUSDPShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zgTBuI6novcg"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Ending Balance&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfOptionsOutstanding_iE_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zaobQpPfvw48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of Options, Ending Balance"&gt;66,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_908_ecustom--WeightedAverageExercisePriceOutstandingAtEnding_pid_uUSDPShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zbZBVYxxYedb"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfOptionsOutstanding_iE_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_ztueEWDbpeO" style="border-bottom: Black 1pt solid; text-align: right"&gt;62,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_905_ecustom--WeightedAverageExercisePriceOutstandingAtEnding_pid_uUSDPShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zoHC9sNkSNsd"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_8A8_zwkj5z7N0UCb" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Option
activities for the six months ended December 31, 2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 21, 2025, the Board of Directors approved the repricing of all outstanding stock options to a revised exercise price of US
$&lt;span id="xdx_905_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uUSDPShares_c20250721_zqnGOELNI4Zc"&gt;5.00&lt;/span&gt; per option. The repricing applied to all option holders on a consistent basis. Management assessed the impact of the repricing
and determined that the revised exercise price did not result in any incremental fair value being conveyed to option holders.
Accordingly, no additional share-based payment expense has been recognized in relation to this repricing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 21, 2025, the Company granted &lt;span id="xdx_90E_ecustom--OptionsGrantedShares_pid_uShares_c20250721__20250721_znHIeq8M0oLa"&gt;4,000&lt;/span&gt; options to a director. The options are exercisable at a price of US $&lt;span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uUSDPShares_c20250721_z4dwLPYptycj"&gt;5.00&lt;/span&gt; per common
share until January 30, 2028 and vested immediately on grant. The options were valued using Black-Scholes with the following assumptions:
expected volatility of &lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20250721__20250721_zzlcn46uiTwe"&gt;422.48&lt;/span&gt;%, expected dividend yield of &lt;span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20250721__20250721_zveTuR1VTlZ5"&gt;0&lt;/span&gt;%, risk-free interest rate of &lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20250721__20250721_zQgwc9Oa8xW3"&gt;2.81&lt;/span&gt;%, and an expected life of &lt;span id="xdx_903_ecustom--ExpectedLife_dtY_c20250721__20250721_z4ZraFwxkruf"&gt;2.53&lt;/span&gt;
years. The grant date fair value attributable to these options of $&lt;span id="xdx_90C_ecustom--FairValueAttributable_uCAD_c20250721__20250721_zRzEpwXsJTdf"&gt;23,095&lt;/span&gt; was recorded as stock-based compensation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Option
activities for the year ended June 30, 2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 9, 2025, the Board of Directors approved the repricing of all outstanding stock options to a revised exercise price of
US $&lt;span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uUSDPShares_c20250109_z7TMxNFYWIS8"&gt;19.50&lt;/span&gt; per option (subsequently repriced to US $5.00). The repricing applied to all option holders on a consistent basis.
Management assessed the impact of the repricing and determined that the revised exercise price did not result in any incremental
fair value being conveyed to option holders. Accordingly, no additional share-based payment expense has been recognized in relation
to this repricing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes information of stock options outstanding and exercisable as at December 31, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfInformationOfStockOptionsOutstandingTableTextBlock_zqAaXe32YVwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zOlXllJ8Nawa" style="display: none; visibility: hidden"&gt;Schedule of stock options outstanding and exercisable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Date of expiry&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;outstanding&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;contractual life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 31%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;July 17, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_zO9h4mmgi50g" style="width: 14%; text-align: right"&gt;19,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_zgwGSXiWE9Ml" style="width: 14%; text-align: right"&gt;19,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_zKjIu12DKwq4"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_z4my3RI2kzq4" title="Weighted Averages Remaining Contractual Life"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 18, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_z7Ha8qxm0Egc" style="text-align: right"&gt;7,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_zwEFos3ySB6h" style="text-align: right"&gt;7,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90D_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_zO2S7m5FqHJ"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_zEbOXHdkTmK7" title="Weighted Averages Remaining Contractual Life"&gt;0.88&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 30, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_zgImOvJUuddl" style="text-align: right"&gt;27,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_zerjZxysunph" style="text-align: right"&gt;27,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_zdQhmAafGyb5"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_znKoRnt1hwG" title="Weighted Averages Remaining Contractual Life"&gt;2.08&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May 24, 2029&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zIvzG8eRRNc6" style="border-bottom: Black 1pt solid; text-align: right"&gt;12,308&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zlhPytEomIPi" style="border-bottom: Black 1pt solid; text-align: right"&gt;12,308&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90C_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zMS4Pcwz9jy2"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zU1TVtuUKCuf" title="Weighted Averages Remaining Contractual Life"&gt;3.40&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zlcOqdQFwria" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;66,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zQWIDnPCMYxd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;66,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90C_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zuliPPelrnEf"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zEQMQjj4ERj1" title="Weighted Averages Remaining Contractual Life"&gt;1.74&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A9_zhve7Ht4p5D8" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</fnuc:DisclosureOfReserveForShareBasedPaymentsTextBlock>
    <fnuc:ScheduleOfStockOptionActivityTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001238">&lt;p id="xdx_89D_ecustom--ScheduleOfStockOptionActivityTableTextBlock_zZlGXwj06t0i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;span id="xdx_8BC_zmNTdKvoFwC7" style="display: none; visibility: hidden"&gt;Schedule of stock option activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; font-weight: bold; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOptionsOutstanding_iS_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zuCavSXsls7h" style="width: 14%; font-weight: bold; text-align: right" title="Number of Options, Opening Balance"&gt;62,137&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90B_ecustom--WeightedAverageExercisePriceOutstandingAtBeginning_pid_uUSDPShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zhLzigCxai2a"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfOptionsOutstanding_iS_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zIEoKjaP2GNe" style="width: 14%; text-align: right" title="Number of Options, Opening Balance"&gt;62,137&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOutstandingAtBeginning_pid_uUSDPShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zcWafHuHVnEj"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Granted&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--NumberOfOptionsGranted_pid_d0_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zEXRTgYFJzTh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of Options, Granted"&gt;4,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90B_ecustom--WeightedAverageExercisePriceGranted_iI_pid_uUSDPShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zgTBuI6novcg"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Ending Balance&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfOptionsOutstanding_iE_pid_uShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zaobQpPfvw48" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of Options, Ending Balance"&gt;66,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_908_ecustom--WeightedAverageExercisePriceOutstandingAtEnding_pid_uUSDPShares_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zbZBVYxxYedb"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--NumberOfOptionsOutstanding_iE_pid_uShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_ztueEWDbpeO" style="border-bottom: Black 1pt solid; text-align: right"&gt;62,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_905_ecustom--WeightedAverageExercisePriceOutstandingAtEnding_pid_uUSDPShares_c20240701__20250630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zoHC9sNkSNsd"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</fnuc:ScheduleOfStockOptionActivityTableTextBlock>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-06-30_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001240"
      unitRef="Shares">62137</fnuc:NumberOfOptionsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstandingAtBeginning
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001241"
      unitRef="USDPShares">5.00</fnuc:WeightedAverageExercisePriceOutstandingAtBeginning>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2024-06-30_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001243"
      unitRef="Shares">62137</fnuc:NumberOfOptionsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstandingAtBeginning
      contextRef="From2024-07-012025-06-30_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001244"
      unitRef="USDPShares">5.00</fnuc:WeightedAverageExercisePriceOutstandingAtBeginning>
    <fnuc:NumberOfOptionsGranted
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001246"
      unitRef="Shares">4000</fnuc:NumberOfOptionsGranted>
    <fnuc:WeightedAverageExercisePriceGranted
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001247"
      unitRef="USDPShares">5.00</fnuc:WeightedAverageExercisePriceGranted>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001249"
      unitRef="Shares">66137</fnuc:NumberOfOptionsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstandingAtEnding
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001250"
      unitRef="USDPShares">5.00</fnuc:WeightedAverageExercisePriceOutstandingAtEnding>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-06-30_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001251"
      unitRef="Shares">62137</fnuc:NumberOfOptionsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstandingAtEnding
      contextRef="From2024-07-012025-06-30_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001252"
      unitRef="USDPShares">5.00</fnuc:WeightedAverageExercisePriceOutstandingAtEnding>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="AsOf2025-07-21"
      decimals="INF"
      id="Fact001260"
      unitRef="USDPShares">5.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <fnuc:OptionsGrantedShares
      contextRef="From2025-07-212025-07-21"
      decimals="INF"
      id="Fact001261"
      unitRef="Shares">4000</fnuc:OptionsGrantedShares>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="AsOf2025-07-21"
      decimals="INF"
      id="Fact001262"
      unitRef="USDPShares">5.00</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2025-07-212025-07-21"
      decimals="INF"
      id="Fact001263"
      unitRef="Pure">4.2248</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2025-07-212025-07-21"
      decimals="INF"
      id="Fact001264"
      unitRef="Pure">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2025-07-212025-07-21"
      decimals="INF"
      id="Fact001265"
      unitRef="Pure">0.0281</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <fnuc:ExpectedLife contextRef="From2025-07-212025-07-21" id="Fact001266">P2Y6M10D</fnuc:ExpectedLife>
    <fnuc:FairValueAttributable
      contextRef="From2025-07-212025-07-21"
      decimals="0"
      id="Fact001267"
      unitRef="CAD">23095</fnuc:FairValueAttributable>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="AsOf2025-01-09"
      decimals="INF"
      id="Fact001268"
      unitRef="USDPShares">19.50</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <fnuc:ScheduleOfInformationOfStockOptionsOutstandingTableTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001270">&lt;p id="xdx_897_ecustom--ScheduleOfInformationOfStockOptionsOutstandingTableTextBlock_zqAaXe32YVwb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zOlXllJ8Nawa" style="display: none; visibility: hidden"&gt;Schedule of stock options outstanding and exercisable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of options&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Date of expiry&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;outstanding&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;contractual life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 31%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;July 17, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_zO9h4mmgi50g" style="width: 14%; text-align: right"&gt;19,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_zgwGSXiWE9Ml" style="width: 14%; text-align: right"&gt;19,231&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_zKjIu12DKwq4"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--July172026Member_z4my3RI2kzq4" title="Weighted Averages Remaining Contractual Life"&gt;0.54&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 18, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_z7Ha8qxm0Egc" style="text-align: right"&gt;7,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_zwEFos3ySB6h" style="text-align: right"&gt;7,521&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90D_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_zO2S7m5FqHJ"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--November182026Member_zEbOXHdkTmK7" title="Weighted Averages Remaining Contractual Life"&gt;0.88&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;January 30, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_zgImOvJUuddl" style="text-align: right"&gt;27,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_zerjZxysunph" style="text-align: right"&gt;27,077&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_zdQhmAafGyb5"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--January302028Member_znKoRnt1hwG" title="Weighted Averages Remaining Contractual Life"&gt;2.08&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;May 24, 2029&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zIvzG8eRRNc6" style="border-bottom: Black 1pt solid; text-align: right"&gt;12,308&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zlhPytEomIPi" style="border-bottom: Black 1pt solid; text-align: right"&gt;12,308&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90C_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zMS4Pcwz9jy2"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_904_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember__custom--StatementScenariosAxis__custom--May242029Member_zU1TVtuUKCuf" title="Weighted Averages Remaining Contractual Life"&gt;3.40&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zlcOqdQFwria" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;66,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOptionsExercisable_iI_pid_uShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zQWIDnPCMYxd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;66,137&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90C_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zuliPPelrnEf"&gt;5.00&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_900_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionsMember_zEQMQjj4ERj1" title="Weighted Averages Remaining Contractual Life"&gt;1.74&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfInformationOfStockOptionsOutstandingTableTextBlock>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_July172026Member"
      decimals="INF"
      id="Fact001271"
      unitRef="Shares">19231</fnuc:NumberOfOptionsOutstanding>
    <fnuc:NumberOfOptionsExercisable
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_July172026Member"
      decimals="INF"
      id="Fact001272"
      unitRef="Shares">19231</fnuc:NumberOfOptionsExercisable>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_July172026Member"
      decimals="INF"
      id="Fact001273"
      unitRef="USDPShares">5.00</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember_custom_July172026Member"
      id="Fact001275">P0Y6M14D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_November182026Member"
      decimals="INF"
      id="Fact001276"
      unitRef="Shares">7521</fnuc:NumberOfOptionsOutstanding>
    <fnuc:NumberOfOptionsExercisable
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_November182026Member"
      decimals="INF"
      id="Fact001277"
      unitRef="Shares">7521</fnuc:NumberOfOptionsExercisable>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_November182026Member"
      decimals="INF"
      id="Fact001278"
      unitRef="USDPShares">5.00</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember_custom_November182026Member"
      id="Fact001280">P0Y10M17D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_January302028Member"
      decimals="INF"
      id="Fact001281"
      unitRef="Shares">27077</fnuc:NumberOfOptionsOutstanding>
    <fnuc:NumberOfOptionsExercisable
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_January302028Member"
      decimals="INF"
      id="Fact001282"
      unitRef="Shares">27077</fnuc:NumberOfOptionsExercisable>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_January302028Member"
      decimals="INF"
      id="Fact001283"
      unitRef="USDPShares">5.00</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember_custom_January302028Member"
      id="Fact001285">P2Y29D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_May242029Member"
      decimals="INF"
      id="Fact001286"
      unitRef="Shares">12308</fnuc:NumberOfOptionsOutstanding>
    <fnuc:NumberOfOptionsExercisable
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_May242029Member"
      decimals="INF"
      id="Fact001287"
      unitRef="Shares">12308</fnuc:NumberOfOptionsExercisable>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_StockOptionsMember_custom_May242029Member"
      decimals="INF"
      id="Fact001288"
      unitRef="USDPShares">5.00</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember_custom_May242029Member"
      id="Fact001290">P3Y4M24D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001291"
      unitRef="Shares">66137</fnuc:NumberOfOptionsOutstanding>
    <fnuc:NumberOfOptionsExercisable
      contextRef="AsOf2025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001292"
      unitRef="Shares">66137</fnuc:NumberOfOptionsExercisable>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_StockOptionsMember"
      decimals="INF"
      id="Fact001293"
      unitRef="USDPShares">5.00</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_StockOptionsMember"
      id="Fact001295">P1Y8M26D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:DisclosureOfReserveForWarrantsTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001297">&lt;p id="xdx_800_ecustom--DisclosureOfReserveForWarrantsTextBlock_zxDabX2d6IYh" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;21.&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_824_zxMorSt1xR0h"&gt;Reserve
for Warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following summarizes the warrant activity for the six months ended December 31, 2025, and the year ended June 30, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleSummarizesTheWarrantActivityTextBlock_zSIFY8ClQzcd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zHwJcBnsg8Qg" style="display: none"&gt;Schedule
of  summarizes the warrants activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;Number of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; font-weight: bold; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfWarrantsOutstanding_iS_pid_uShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zg4nNUNgudNh" style="width: 14%; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, Beginning Balance"&gt;78,462&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90F_ecustom--WeightedAverageExercisePriceOutstanding_iS_pid_uUSDPShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zq1OpbbRJcw" title="Weighted Average Exercise Price, Beginning Balance"&gt;44.03&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfWarrantsOutstanding_iS_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z0fpn4bHKWBk" style="width: 14%; text-align: right" title="Number of Warrants Outstanding, Beginning Balance"&gt;99,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--WeightedAverageExercisePriceOutstanding_iS_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4erzqLxbR4l" title="Weighted Average Exercise Price, Beginning Balance"&gt;48.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Octagon Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfOctagonWarrantsIssued_pid_uShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zkMae8Z6eHdc" style="font-weight: bold; text-align: right" title="Issuance of Octagon Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1309"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfOctagonWarrantsIssuedPerShare_pid_uUSDPShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zTPfWMG4RC6i" title="Issuance of Octagon Warrants Per Share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfOctagonWarrantsIssued_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zWRPJRFO4Rtc" style="text-align: right" title="Issuance of Octagon Warrants"&gt;19,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_909_ecustom--NumberOfOctagonWarrantsIssuedPerShare_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zAp0Xk5WmqXc" title="Issuance of Octagon Warrants Per Share"&gt;13.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfWarrantsExpired_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zXof9LoMPB64" style="text-align: right" title="Expired"&gt;(7,692&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90A_ecustom--NumberOfWarrantsExpiredPerShare_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zhRFyFC7b6a2" title="Expired, Per Share"&gt;26.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfWarrantsExpired1_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zkkPZQgzz7lh" style="text-align: right" title="Expired"&gt;(7,692&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_908_ecustom--NumberOfWarrantsExpiredPerShare1_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zLysCcGUNgH3" title="Expired, Per Share"&gt;32.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfWarrantsExpired2_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zqpP9jW9zMDg" style="text-align: right" title="Expired"&gt;(7,692&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_907_ecustom--NumberOfWarrantsExpiredPerShare2_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zgNqKJCoPaM4" title="Expired, Per Share"&gt;39.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfWarrantsExpired3_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zEZjwO7Jhkf3" style="text-align: right" title="Expired"&gt;(5,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_904_ecustom--NumberOfWarrantsExpiredPerShare3_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zmpyIgh32geb" title="Expired, Per Share"&gt;39.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfWarrantsExpired4_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z2xQRCh8GmDe" style="text-align: right" title="Expired"&gt;(5,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_907_ecustom--NumberOfWarrantsExpiredPerShare4_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zLUwMtJ6Eog8" title="Expired, Per Share"&gt;52.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NumberOfWarrantsExpired5_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z7RbFAM5dh71" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(5,769&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_906_ecustom--NumberOfWarrantsExpiredPerShare5_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z6bVwIuqjS71" title="Expired, Per Share"&gt;65.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Ending Balance&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfWarrantsOutstanding_iE_pid_uShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zFaUvvEoYwYa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, Ending Balance"&gt;78,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOutstanding_iE_pid_uUSDPShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zFUgo4YPUKag" title="Weighted Average Exercise Price, Ending Balance"&gt;44.03&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NumberOfWarrantsOutstanding_iE_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zzjjY18F14Of" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Outstanding, Ending Balance"&gt;78,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOutstanding_iE_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zbWh2jDEFsQ8" title="Weighted Average Exercise Price, Ending Balance"&gt;44.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_z4PNa4uMIIk2" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
more information on the warrant issuances, see Note 16.&lt;/span&gt;&lt;/p&gt;





















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes information of warrants outstanding as at December 31, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eifrs-full--DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_zaYplKoP5MTf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zZnwyANAWlIc" style="display: none"&gt;Schedule
of  information of warrants outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Date of expiry&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;outstanding&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;contractual life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;#&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Years&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 24%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--March312026Member_zOGYNzwwTDAd" style="width: 22%; text-align: right" title="Number of warrants outstanding"&gt;38,462&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_900_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--March312026Member_z3e5lNOqIFn2" title="Exercise Price"&gt;32.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--March312026Member_zNbiZr1CZ1fb" title="Weighted Averages Remaining Contractual Life"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--April12026Member_zizbt7waofkb" style="text-align: right" title="Number of warrants outstanding"&gt;19,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--April12026Member_zTOkEYJnvmE7" title="Exercise Price"&gt;13.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--April12026Member_zcEGFoRjkpOc" title="Weighted Averages Remaining Contractual Life"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 19, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--November192026Member_zkBFl4QeIWdi" style="text-align: right" title="Number of warrants outstanding"&gt;14,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90C_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--November192026Member_zOsTuEVFHK0f" title="Exercise Price"&gt;121.88&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--November192026Member_z2cY7nPnbcv2" title="Weighted Averages Remaining Contractual Life"&gt;0.89&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 21, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--September212028Member_zn4WYOHNIXIg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants outstanding"&gt;6,615&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90B_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--September212028Member_z6sFlUcR3dt1" title="Exercise Price"&gt;34.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--September212028Member_zSoZAOMcHMyk" title="Weighted Averages Remaining Contractual Life"&gt;2.73&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231_zYjj4vHs8AN1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of warrants outstanding"&gt;78,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90F_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231_zxS7RBp1nBP" title="Exercise Price"&gt;44.03&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231_zeN8z76goBE1" title="Weighted Averages Remaining Contractual Life"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A8_z3KiGN2vzwZh" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

</fnuc:DisclosureOfReserveForWarrantsTextBlock>
    <fnuc:ScheduleSummarizesTheWarrantActivityTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001299">&lt;p id="xdx_89C_ecustom--ScheduleSummarizesTheWarrantActivityTextBlock_zSIFY8ClQzcd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zHwJcBnsg8Qg" style="display: none"&gt;Schedule
of  summarizes the warrants activity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;Number of&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;warrants&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;#&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;#&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; font-weight: bold; text-align: left"&gt;Opening Balance&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfWarrantsOutstanding_iS_pid_uShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zg4nNUNgudNh" style="width: 14%; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, Beginning Balance"&gt;78,462&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90F_ecustom--WeightedAverageExercisePriceOutstanding_iS_pid_uUSDPShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zq1OpbbRJcw" title="Weighted Average Exercise Price, Beginning Balance"&gt;44.03&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfWarrantsOutstanding_iS_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z0fpn4bHKWBk" style="width: 14%; text-align: right" title="Number of Warrants Outstanding, Beginning Balance"&gt;99,614&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--WeightedAverageExercisePriceOutstanding_iS_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z4erzqLxbR4l" title="Weighted Average Exercise Price, Beginning Balance"&gt;48.73&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Issuance of Octagon Warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfOctagonWarrantsIssued_pid_uShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zkMae8Z6eHdc" style="font-weight: bold; text-align: right" title="Issuance of Octagon Warrants"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1309"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span id="xdx_906_ecustom--NumberOfOctagonWarrantsIssuedPerShare_pid_uUSDPShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zTPfWMG4RC6i" title="Issuance of Octagon Warrants Per Share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfOctagonWarrantsIssued_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zWRPJRFO4Rtc" style="text-align: right" title="Issuance of Octagon Warrants"&gt;19,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_909_ecustom--NumberOfOctagonWarrantsIssuedPerShare_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zAp0Xk5WmqXc" title="Issuance of Octagon Warrants Per Share"&gt;13.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfWarrantsExpired_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zXof9LoMPB64" style="text-align: right" title="Expired"&gt;(7,692&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90A_ecustom--NumberOfWarrantsExpiredPerShare_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zhRFyFC7b6a2" title="Expired, Per Share"&gt;26.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfWarrantsExpired1_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zkkPZQgzz7lh" style="text-align: right" title="Expired"&gt;(7,692&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_908_ecustom--NumberOfWarrantsExpiredPerShare1_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zLysCcGUNgH3" title="Expired, Per Share"&gt;32.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--NumberOfWarrantsExpired2_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zqpP9jW9zMDg" style="text-align: right" title="Expired"&gt;(7,692&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_907_ecustom--NumberOfWarrantsExpiredPerShare2_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zgNqKJCoPaM4" title="Expired, Per Share"&gt;39.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--NumberOfWarrantsExpired3_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zEZjwO7Jhkf3" style="text-align: right" title="Expired"&gt;(5,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_904_ecustom--NumberOfWarrantsExpiredPerShare3_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zmpyIgh32geb" title="Expired, Per Share"&gt;39.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Expired&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfWarrantsExpired4_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z2xQRCh8GmDe" style="text-align: right" title="Expired"&gt;(5,769&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_907_ecustom--NumberOfWarrantsExpiredPerShare4_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zLUwMtJ6Eog8" title="Expired, Per Share"&gt;52.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NumberOfWarrantsExpired5_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z7RbFAM5dh71" style="border-bottom: Black 1pt solid; text-align: right" title="Expired"&gt;(5,769&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_906_ecustom--NumberOfWarrantsExpiredPerShare5_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z6bVwIuqjS71" title="Expired, Per Share"&gt;65.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Ending Balance&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfWarrantsOutstanding_iE_pid_uShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zFaUvvEoYwYa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of Warrants Outstanding, Ending Balance"&gt;78,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90A_ecustom--WeightedAverageExercisePriceOutstanding_iE_pid_uUSDPShares_c20250701__20251231__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zFUgo4YPUKag" title="Weighted Average Exercise Price, Ending Balance"&gt;44.03&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NumberOfWarrantsOutstanding_iE_pid_uShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zzjjY18F14Of" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Warrants Outstanding, Ending Balance"&gt;78,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90D_ecustom--WeightedAverageExercisePriceOutstanding_iE_pid_uUSDPShares_c20240701__20250630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zbWh2jDEFsQ8" title="Weighted Average Exercise Price, Ending Balance"&gt;44.03&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleSummarizesTheWarrantActivityTextBlock>
    <fnuc:NumberOfWarrantsOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001301"
      unitRef="Shares">78462</fnuc:NumberOfWarrantsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001303"
      unitRef="USDPShares">44.03</fnuc:WeightedAverageExercisePriceOutstanding>
    <fnuc:NumberOfWarrantsOutstanding
      contextRef="AsOf2024-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001305"
      unitRef="Shares">99614</fnuc:NumberOfWarrantsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstanding
      contextRef="AsOf2024-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001307"
      unitRef="USDPShares">48.73</fnuc:WeightedAverageExercisePriceOutstanding>
    <fnuc:NumberOfOctagonWarrantsIssued
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001313"
      unitRef="Shares">19231</fnuc:NumberOfOctagonWarrantsIssued>
    <fnuc:NumberOfOctagonWarrantsIssuedPerShare
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001315"
      unitRef="USDPShares">13.00</fnuc:NumberOfOctagonWarrantsIssuedPerShare>
    <fnuc:NumberOfWarrantsExpired
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001317"
      unitRef="Shares">-7692</fnuc:NumberOfWarrantsExpired>
    <fnuc:NumberOfWarrantsExpiredPerShare
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001319"
      unitRef="USDPShares">26.00</fnuc:NumberOfWarrantsExpiredPerShare>
    <fnuc:NumberOfWarrantsExpired1
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001321"
      unitRef="Shares">-7692</fnuc:NumberOfWarrantsExpired1>
    <fnuc:NumberOfWarrantsExpiredPerShare1
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001323"
      unitRef="USDPShares">32.50</fnuc:NumberOfWarrantsExpiredPerShare1>
    <fnuc:NumberOfWarrantsExpired2
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001325"
      unitRef="Shares">-7692</fnuc:NumberOfWarrantsExpired2>
    <fnuc:NumberOfWarrantsExpiredPerShare2
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001327"
      unitRef="USDPShares">39.00</fnuc:NumberOfWarrantsExpiredPerShare2>
    <fnuc:NumberOfWarrantsExpired3
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001329"
      unitRef="Shares">-5769</fnuc:NumberOfWarrantsExpired3>
    <fnuc:NumberOfWarrantsExpiredPerShare3
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001331"
      unitRef="USDPShares">39.00</fnuc:NumberOfWarrantsExpiredPerShare3>
    <fnuc:NumberOfWarrantsExpired4
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001333"
      unitRef="Shares">-5769</fnuc:NumberOfWarrantsExpired4>
    <fnuc:NumberOfWarrantsExpiredPerShare4
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001335"
      unitRef="USDPShares">52.00</fnuc:NumberOfWarrantsExpiredPerShare4>
    <fnuc:NumberOfWarrantsExpired5
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001337"
      unitRef="Shares">-5769</fnuc:NumberOfWarrantsExpired5>
    <fnuc:NumberOfWarrantsExpiredPerShare5
      contextRef="From2024-07-012025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001339"
      unitRef="USDPShares">65.00</fnuc:NumberOfWarrantsExpiredPerShare5>
    <fnuc:NumberOfWarrantsOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001341"
      unitRef="Shares">78462</fnuc:NumberOfWarrantsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstanding
      contextRef="AsOf2025-12-31_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001343"
      unitRef="USDPShares">44.03</fnuc:WeightedAverageExercisePriceOutstanding>
    <fnuc:NumberOfWarrantsOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001345"
      unitRef="Shares">78462</fnuc:NumberOfWarrantsOutstanding>
    <fnuc:WeightedAverageExercisePriceOutstanding
      contextRef="AsOf2025-06-30_ifrs-full_WarrantsMember"
      decimals="INF"
      id="Fact001347"
      unitRef="USDPShares">44.03</fnuc:WeightedAverageExercisePriceOutstanding>
    <ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001358">&lt;p id="xdx_89E_eifrs-full--DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_zaYplKoP5MTf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_zZnwyANAWlIc" style="display: none"&gt;Schedule
of  information of warrants outstanding&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Number of&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Weighted average&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;warrants&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;remaining&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;Date of expiry&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;outstanding&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;contractual life&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;#&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="font-weight: bold; text-align: right"&gt;Years&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 24%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--March312026Member_zOGYNzwwTDAd" style="width: 22%; text-align: right" title="Number of warrants outstanding"&gt;38,462&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_900_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--March312026Member_z3e5lNOqIFn2" title="Exercise Price"&gt;32.50&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 22%; text-align: right"&gt;&lt;span id="xdx_90E_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--March312026Member_zNbiZr1CZ1fb" title="Weighted Averages Remaining Contractual Life"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;April 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--April12026Member_zizbt7waofkb" style="text-align: right" title="Number of warrants outstanding"&gt;19,231&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_902_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--April12026Member_zTOkEYJnvmE7" title="Exercise Price"&gt;13.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--April12026Member_zcEGFoRjkpOc" title="Weighted Averages Remaining Contractual Life"&gt;0.25&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;November 19, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--November192026Member_zkBFl4QeIWdi" style="text-align: right" title="Number of warrants outstanding"&gt;14,154&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90C_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--November192026Member_zOsTuEVFHK0f" title="Exercise Price"&gt;121.88&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_909_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--November192026Member_z2cY7nPnbcv2" title="Weighted Averages Remaining Contractual Life"&gt;0.89&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;September 21, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231__custom--StatementScenariosAxis__custom--September212028Member_zn4WYOHNIXIg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants outstanding"&gt;6,615&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;USD &lt;span id="xdx_90B_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231__custom--StatementScenariosAxis__custom--September212028Member_z6sFlUcR3dt1" title="Exercise Price"&gt;34.71&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231__custom--StatementScenariosAxis__custom--September212028Member_zSoZAOMcHMyk" title="Weighted Averages Remaining Contractual Life"&gt;2.73&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfOptionsOutstanding_iI_pid_uShares_c20251231_zYjj4vHs8AN1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Number of warrants outstanding"&gt;78,462&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;USD &lt;span id="xdx_90F_ecustom--ExercisePrice_iI_pid_uUSDPShares_c20251231_zxS7RBp1nBP" title="Exercise Price"&gt;44.03&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_901_ecustom--WeightedAveragesRemainingContractualLife_dtY_c20250701__20251231_zeN8z76goBE1" title="Weighted Averages Remaining Contractual Life"&gt;0.58&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_March312026Member"
      decimals="INF"
      id="Fact001360"
      unitRef="Shares">38462</fnuc:NumberOfOptionsOutstanding>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_March312026Member"
      decimals="INF"
      id="Fact001362"
      unitRef="USDPShares">32.50</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_March312026Member"
      id="Fact001364">P0Y3M</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_April12026Member"
      decimals="INF"
      id="Fact001366"
      unitRef="Shares">19231</fnuc:NumberOfOptionsOutstanding>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_April12026Member"
      decimals="INF"
      id="Fact001368"
      unitRef="USDPShares">13.00</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_April12026Member"
      id="Fact001370">P0Y3M</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_November192026Member"
      decimals="INF"
      id="Fact001372"
      unitRef="Shares">14154</fnuc:NumberOfOptionsOutstanding>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_November192026Member"
      decimals="INF"
      id="Fact001374"
      unitRef="USDPShares">121.88</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_November192026Member"
      id="Fact001376">P0Y10M20D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31_custom_September212028Member"
      decimals="INF"
      id="Fact001378"
      unitRef="Shares">6615</fnuc:NumberOfOptionsOutstanding>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31_custom_September212028Member"
      decimals="INF"
      id="Fact001380"
      unitRef="USDPShares">34.71</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife
      contextRef="From2025-07-012025-12-31_custom_September212028Member"
      id="Fact001382">P2Y8M23D</fnuc:WeightedAveragesRemainingContractualLife>
    <fnuc:NumberOfOptionsOutstanding
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact001384"
      unitRef="Shares">78462</fnuc:NumberOfOptionsOutstanding>
    <fnuc:ExercisePrice
      contextRef="AsOf2025-12-31"
      decimals="INF"
      id="Fact001386"
      unitRef="USDPShares">44.03</fnuc:ExercisePrice>
    <fnuc:WeightedAveragesRemainingContractualLife contextRef="From2025-07-01to2025-12-31" id="Fact001388">P0Y6M29D</fnuc:WeightedAveragesRemainingContractualLife>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001390">&lt;p id="xdx_808_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zGkr2Q4I2ye3" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;22.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_828_zwnQtJCcrZq"&gt;Basic
and Diluted Loss per Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculations of basic and diluted loss per share for the six months ended December 31, 2025, were based on the net loss of $&lt;span id="xdx_901_eifrs-full--ProfitLoss_dxL_c20250701__20251231_zhSWkUIAjDVb" title="::XDX::-14954249"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1391"&gt;14,954,249&lt;/span&gt;&lt;/span&gt;
(2024 &#x2013;$&lt;span id="xdx_907_eifrs-full--ProfitLoss_dxL_c20240701__20241231_zNpTlBTAM1bg" title="::XDX::-2357257"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1392"&gt;2,357,257&lt;/span&gt;&lt;/span&gt;) and the weighted average number of basic and diluted common shares outstanding of &lt;span id="xdx_90B_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_c20250701__20251231_zMwwgxv9jVdh" title="Diluted weighted-average number of shares outstanding"&gt;12,417,745&lt;/span&gt; (2024 &#x2013;
&lt;span id="xdx_903_eifrs-full--AdjustedWeightedAverageShares_pid_uShares_c20240701__20241231_zxi7c34KAxU9" title="Diluted weighted-average number of shares outstanding"&gt;2,354,785&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2025-07-01to2025-12-31"
      decimals="INF"
      id="Fact001394"
      unitRef="Shares">12417745</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2024-07-012024-12-31"
      decimals="INF"
      id="Fact001396"
      unitRef="Shares">2354785</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001398">&lt;p id="xdx_800_eifrs-full--DisclosureOfRelatedPartyExplanatory_zHylXwlepmsj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;23.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_826_zFW4PBGjsUH4"&gt;Related
Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with IAS 24 &#x2013; Related Party Disclosures, key management personnel, including companies controlled by them, are
those persons having authority and responsibility for planning, directing and controlling the activities of the Company directly
or indirectly, including any directors (executive and non-executive) of the Company. The remuneration of directors and key executives
is determined by the compensation committee of the Board.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfRemunerationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTextBlock_zMdoQrPYSDyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
remuneration of directors and other members of key management personnel during the six months ended December 31, 2025 and 2024
were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zTC9g1rJIri3" style="display: none"&gt;Schedule Of Remuneration Of Directors And Other Members Of Key Management Personnel&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;December 31, 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Directors&#x2019; and Officers&#x2019; consulting fees&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WagesAndSalaries_uCAD_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsAndOfficersConsultingFeesMember_zjBcNf6Tluy8" style="width: 14%; font-weight: bold; text-align: right" title="Directors' and officers' consulting fees"&gt;509,395&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WagesAndSalaries_uCAD_c20240701__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsAndOfficersConsultingFeesMember_zZ96r5b9ZJT9" style="width: 14%; text-align: right" title="Directors' and officers' consulting fees"&gt;462,154&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Exploration and evaluation expenditures&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WagesAndSalaries_uCAD_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExplorationAndEvaluationExpendituresMember_zbGjc0EjL74i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Exploration and evaluation expenditures"&gt;60,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WagesAndSalaries_uCAD_c20240701__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExplorationAndEvaluationExpendituresMember_zfUQPdxWmVL" style="border-bottom: Black 1pt solid; text-align: right" title="Exploration and evaluation expenditures"&gt;60,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WagesAndSalaries_uCAD_c20250701__20251231_zlJjWn6Em62k" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total remuneration"&gt;569,395&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WagesAndSalaries_uCAD_c20240701__20241231_znrRITwtbBea" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remuneration"&gt;522,154&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AB_zJorsjTnu0r1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Exploration
and evaluation expenditures&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, fees of $&lt;span id="xdx_906_eifrs-full--TangibleExplorationAndEvaluationAssets_iI_uCAD_c20251231_zcsG651tNQRg"&gt;60,000&lt;/span&gt; (2024 &#x2013; $&lt;span id="xdx_904_eifrs-full--TangibleExplorationAndEvaluationAssets_iI_uCAD_c20241231_zID3bw0fyfT9"&gt;60,000&lt;/span&gt;) for services rendered by the Company&#x2019;s VP
of Exploration and its former VP of Resources Development, had been capitalized as E&amp;amp;E assets on the consolidated statements
of financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Share-based
compensation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the six months ended December 31, 2025, the Company had granted certain RSUs and options to various directors and officers. Total
stock-based compensation of $&lt;span id="xdx_902_ecustom--StockBasedCompensations_uCAD_c20250701__20251231_zkM87OJbOoXh"&gt;12,307,676&lt;/span&gt; (2024 &#x2013; $&lt;span id="xdx_905_ecustom--StockBasedCompensations_uCAD_c20240701__20241231_zFibwBUpThNi"&gt;169,066&lt;/span&gt;) was recorded in connection with the vesting of these securities.
See notes 17 and 20 for more information.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Related
party balances&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfAllRelatedPartyBalancesPayableForServicesAndBusinessExpenseReimbursementsRenderedTextBlock_z0DkZw82qfF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
related party balances, for services and business expense reimbursements rendered as at December 31, 2025 and June 30, 2025 are
non-interest bearing and payable on demand, and are comprised of the following&lt;span style="color: windowtext"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zXRwHdmAIvy8" style="display: none"&gt;Schedule Of All Related Party Balances Payable For Services And Business Expense Reimbursements Rendered&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 66%; text-align: left"&gt;Payable to officers and directors&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PayableToOfficersAndDirectors_uCAD_c20250701__20251231_z9EqKQ04RlSj" style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: right" title="Payable to officers and directors"&gt;111,230&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PayableToOfficersAndDirectors_uCAD_c20240701__20250630_zElVPmM2dbOk" style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: right" title="Payable to officers and directors"&gt;127,925&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_uCAD_c20251231_zAemkkHA2Wcl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;111,230&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_uCAD_c20250630_zRD1bn6GfXmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;127,925&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8AD_zGANtbLSQ9E9" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <fnuc:ScheduleOfRemunerationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001400">&lt;p id="xdx_897_ecustom--ScheduleOfRemunerationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTextBlock_zMdoQrPYSDyi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
remuneration of directors and other members of key management personnel during the six months ended December 31, 2025 and 2024
were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zTC9g1rJIri3" style="display: none"&gt;Schedule Of Remuneration Of Directors And Other Members Of Key Management Personnel&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;December 31, 2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 66%; text-align: left"&gt;Directors&#x2019; and Officers&#x2019; consulting fees&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WagesAndSalaries_uCAD_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsAndOfficersConsultingFeesMember_zjBcNf6Tluy8" style="width: 14%; font-weight: bold; text-align: right" title="Directors' and officers' consulting fees"&gt;509,395&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WagesAndSalaries_uCAD_c20240701__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsAndOfficersConsultingFeesMember_zZ96r5b9ZJT9" style="width: 14%; text-align: right" title="Directors' and officers' consulting fees"&gt;462,154&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Exploration and evaluation expenditures&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WagesAndSalaries_uCAD_c20250701__20251231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExplorationAndEvaluationExpendituresMember_zbGjc0EjL74i" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right" title="Exploration and evaluation expenditures"&gt;60,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WagesAndSalaries_uCAD_c20240701__20241231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExplorationAndEvaluationExpendituresMember_zfUQPdxWmVL" style="border-bottom: Black 1pt solid; text-align: right" title="Exploration and evaluation expenditures"&gt;60,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 2.5pt double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WagesAndSalaries_uCAD_c20250701__20251231_zlJjWn6Em62k" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Total remuneration"&gt;569,395&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WagesAndSalaries_uCAD_c20240701__20241231_znrRITwtbBea" style="border-bottom: Black 2.5pt double; text-align: right" title="Total remuneration"&gt;522,154&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfRemunerationOfDirectorsAndOtherMembersOfKeyManagementPersonnelTextBlock>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-07-012025-12-31_custom_DirectorsAndOfficersConsultingFeesMember"
      decimals="0"
      id="Fact001402"
      unitRef="CAD">509395</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2024-07-012024-12-31_custom_DirectorsAndOfficersConsultingFeesMember"
      decimals="0"
      id="Fact001404"
      unitRef="CAD">462154</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-07-012025-12-31_custom_ExplorationAndEvaluationExpendituresMember"
      decimals="0"
      id="Fact001406"
      unitRef="CAD">60000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2024-07-012024-12-31_custom_ExplorationAndEvaluationExpendituresMember"
      decimals="0"
      id="Fact001408"
      unitRef="CAD">60000</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001410"
      unitRef="CAD">569395</ifrs-full:WagesAndSalaries>
    <ifrs-full:WagesAndSalaries
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact001412"
      unitRef="CAD">522154</ifrs-full:WagesAndSalaries>
    <ifrs-full:TangibleExplorationAndEvaluationAssets
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001413"
      unitRef="CAD">60000</ifrs-full:TangibleExplorationAndEvaluationAssets>
    <ifrs-full:TangibleExplorationAndEvaluationAssets
      contextRef="AsOf2024-12-31"
      decimals="0"
      id="Fact001414"
      unitRef="CAD">60000</ifrs-full:TangibleExplorationAndEvaluationAssets>
    <fnuc:StockBasedCompensations
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001415"
      unitRef="CAD">12307676</fnuc:StockBasedCompensations>
    <fnuc:StockBasedCompensations
      contextRef="From2024-07-012024-12-31"
      decimals="0"
      id="Fact001416"
      unitRef="CAD">169066</fnuc:StockBasedCompensations>
    <fnuc:ScheduleOfAllRelatedPartyBalancesPayableForServicesAndBusinessExpenseReimbursementsRenderedTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001418">&lt;p id="xdx_894_ecustom--ScheduleOfAllRelatedPartyBalancesPayableForServicesAndBusinessExpenseReimbursementsRenderedTextBlock_z0DkZw82qfF4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;All
related party balances, for services and business expense reimbursements rendered as at December 31, 2025 and June 30, 2025 are
non-interest bearing and payable on demand, and are comprised of the following&lt;span style="color: windowtext"&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zXRwHdmAIvy8" style="display: none"&gt;Schedule Of All Related Party Balances Payable For Services And Business Expense Reimbursements Rendered&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 66%; text-align: left"&gt;Payable to officers and directors&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PayableToOfficersAndDirectors_uCAD_c20250701__20251231_z9EqKQ04RlSj" style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: right" title="Payable to officers and directors"&gt;111,230&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PayableToOfficersAndDirectors_uCAD_c20240701__20250630_zElVPmM2dbOk" style="border-bottom: Black 1pt solid; width: 14%; font-weight: bold; text-align: right" title="Payable to officers and directors"&gt;127,925&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_uCAD_c20251231_zAemkkHA2Wcl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;111,230&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AmountsPayableRelatedPartyTransactions_iI_uCAD_c20250630_zRD1bn6GfXmi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;127,925&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfAllRelatedPartyBalancesPayableForServicesAndBusinessExpenseReimbursementsRenderedTextBlock>
    <fnuc:PayableToOfficersAndDirectors
      contextRef="From2025-07-01to2025-12-31"
      decimals="0"
      id="Fact001420"
      unitRef="CAD">111230</fnuc:PayableToOfficersAndDirectors>
    <fnuc:PayableToOfficersAndDirectors
      contextRef="From2024-07-012025-06-30"
      decimals="0"
      id="Fact001422"
      unitRef="CAD">127925</fnuc:PayableToOfficersAndDirectors>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001423"
      unitRef="CAD">111230</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001424"
      unitRef="CAD">127925</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <fnuc:DisclosureOfCapitalManagementTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001426">&lt;p id="xdx_800_ecustom--DisclosureOfCapitalManagementTextBlock_zOOTmvAcjp5h" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;24.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_821_zXbKuIWm6T7"&gt;Capital
                                         Management&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s objective when managing capital is to safeguard its ability to continue as a going concern such that it can provide
returns for shareholders and benefits for other stakeholders. The management of the capital structure is based on the funds available
to the Company in order to support the acquisition, exploration and development of mineral properties and to maintain the Company
in good standing with the various regulatory authorities. In order to maintain or adjust its capital structure, the Company may
issue new shares, sell assets to settle liabilities, issue debt instruments or return capital to its shareholders. The Company
monitors its capital structure and makes adjustments in light of changes in economic conditions and the risk characteristics of
the underlying assets&lt;span style="color: windowtext"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is not subject to any capital requirements imposed by a lending institution or regulatory body, other than the flow-through
obligations from the Offering.&lt;/span&gt;&lt;/p&gt;

</fnuc:DisclosureOfCapitalManagementTextBlock>
    <ifrs-full:DisclosureOfFinancialRiskManagementExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001428">&lt;p id="xdx_80D_eifrs-full--DisclosureOfFinancialRiskManagementExplanatory_zZRkKCYfrmW3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;25.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82D_zcSUrc5AFm53"&gt;Financial
Risks&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is exposed to various risks as it relates to financial instruments. Management, in conjunction with the Board, mitigates
these risks by assessing, monitoring and approving the Company&#x2019;s risk management process. There have not been any changes
in the nature of these risks or the process of managing these risks from the previous reporting periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Credit
risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;Credit
risk is the risk of loss associated with a counterparty&#x2019;s inability to fulfill its payment obligations. The Company&#x2019;s
credit risk is primarily attributable to cash and short-term receivables&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
&lt;span style="color: windowtext"&gt;Cash is held with reputable chartered bank in Canada, which is closely monitored by management.
Management believes that the credit risk concentration with respect to financial instruments included in cash and short-term receivables
is minimal.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidity
risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Liquidity
risk is the risk that the Company will not have sufficient cash resources to meet its financial obligations as they come due.
The Company&#x2019;s liquidity and operating results may be adversely affected if the Company&#x2019;s access to the capital market
is hindered, whether as a result of a downturn in stock market conditions generally or related to matters specific to the Company.
The Company generates cash flow primarily from its financing and investing activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;As
at December 31, 2025, the Company had a cash balance of $&lt;span id="xdx_90D_eifrs-full--CashAndCashEquivalents_iI_uCAD_c20251231_zBRYboP38AB8" title="Cash"&gt;16,141,406&lt;/span&gt; (June 30, 2025 &#x2013; $&lt;span id="xdx_909_eifrs-full--CashAndCashEquivalents_iI_uCAD_c20250630_zYndfd0egaH8" title="Cash"&gt;17,829,149&lt;/span&gt;) to settle current liabilities
of $&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_905_eifrs-full--CurrentLiabilities_iI_uCAD_c20251231_zn3pFZTTPh37"&gt;22,973,079&lt;/span&gt; &lt;span style="color: windowtext"&gt;(June
30, 2025 - $&lt;span id="xdx_904_eifrs-full--CurrentLiabilities_iI_uCAD_c20250630_z0EUKgVhJJUj"&gt;7,002,625&lt;/span&gt;).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eifrs-full--MaturityAnalysisForNonderivativeFinancialLiabilities_ztKTKPnSvoT5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the Company had the following undiscounted contractual obligations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zaMvWRWadqw8" style="display: none; visibility: hidden"&gt;Schedule of contractual obligations&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zYivS4uCgoB3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Less than 1 year&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zA1eKf1EjAKc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1 to 3 years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z5qINbf2ADk2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3 to 5 years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20251231_zX6TBDltexTk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--TradeAndOtherCurrentPayables_iI_d0_uCAD_zCpawnJQNOmi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,070,155&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;1,070,155&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iNI_di0_uCAD_zevZmyi2KRpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,230&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;111,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--LeaseLiabilities1_iI_d0_uCAD_zc6VvaRxlau3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;267,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;850,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;767,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,884,766&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eifrs-full--OtherPayables_iI_d0_uCAD_zNDRD4GFsy8j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,111,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,853,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;10,964,800&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredLiabilities_iI_d0_uCAD_zPqGa2FGv1Ai" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,116,125&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,116,125&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;10,232,250&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eifrs-full--OtherNoncurrentLiabilities_iI_d0_uCAD_zWDjFVQoaJE" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--UndiscountedFinancialLiabilities_iI_d0_uCAD_zc26X7n8bJrb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;22,948,283&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,819,453&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;767,336&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;36,535,072&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A5_zDfJawIrepN7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company manages liquidity risk by maintaining adequate cash reserves and by continuously monitoring forecasts and actual cash
flows for a rolling period of 12 months to identify financial requirements. Where insufficient liquidity may exist, the Company
may pursue various debt and equity instruments for short or long-term financing of its operations. Management believes there is
sufficient capital to meet short-term business obligations, after taking into account cash flow requirements from operations and
the Company&#x2019;s cash position as at December 31, 2025.&lt;/span&gt;&lt;/p&gt;





















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Interest
rate risk &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in
market interest rates. As at December 31, 2025, the Company had no hedging agreements in place with respect to floating interest
rates. Management believes that the interest rate risk concentration with respect to financial instruments is minimal.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Foreign
exchange risk &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Foreign
exchange risk is the risk that the Company will be subject to foreign currency fluctuations in satisfying obligations related
to its foreign activities. The Company has financial instruments and transactions denominated in foreign currencies, notably in
USD. The Company&#x2019;s primary exposure to foreign exchange risk is that transactions denominated in foreign currency may expose
the Company to the risk of exchange rate fluctuations. Based on its current operations, management believes that the foreign exchange
risk is not significant; however, the Company monitors its USD-denominated balances and transactions on an ongoing basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Fair
value &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value estimates of financial instruments are made at a specific point in time based on relevant information about financial markets
and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant
judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair values.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the Company&#x2019;s financial instruments consisted of cash, &lt;span style="color: windowtext"&gt;short-term
and long-term loans receivable, short-term and long-term investments, accounts payable, due to related parties, lease liabilities,
loan payable, derivative liabilities, deferred liabilities, and other liabilities. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of &lt;span style="color: windowtext"&gt;accounts payable, loan payable, short-term and long-term loans receivable, deferred
liabilities and due to related parties &lt;/span&gt;are approximately equal to their carrying value due to their short-term nature.
The fair values of the lease liabilities approximate their carrying amounts as they were measured taking into consideration comparable
instruments with similar risks in determining the rates at which to discount their amount in applying their respective measurement
models.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: windowtext"&gt;The
Company classifies fair value measurements using a fair value hierarchy that reflects the significance of the inputs used in making
the measurements&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. The fair value hierarchy has
the following levels:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                         1 &#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 17.85pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13.6pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                         2 &#x2013; Inputs other than quoted prices included in Level 1 that are observable for
                                         the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived
                                         from prices); and&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
                                         3 &#x2013; Inputs for the asset or liability that are not based on observable market data
                                         (unobservable inputs).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfFairValueMeasurementOfLiabilitiesTextBlock_zbkQKDxQ5pt4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_z2SiKpLkYes7" style="display: none; visibility: hidden"&gt;Schedule of Fair Value Measurements&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: italic"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_z4ILiaEVPl63" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zNiKza7GPGpl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zw9Ptxj4iQkf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 3&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zaj24ITegCzi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--OtherCashAndCashEquivalents_iI_d0_uCAD_zhLZbbm1Dxwi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;16,141,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;16,141,406&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eifrs-full--CurrentInterestReceivable_iI_d0_uCAD_z8JItqFEZuxh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term loan receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,395,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,395,726&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eifrs-full--ShorttermInvestmentsClassifiedAsCashEquivalents_iI_d0_uCAD_zRuXnDMMug04" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,402,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,402,202&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--LongtermInvestment_iI_d0_uCAD_zdCrMKVRz8Yl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Long-term investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,775,746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;10,775,746&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--AccountsPayableAndAccruedLiabilities_iI_d0_uCAD_zCTC3f2XB9fc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,070,155&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(1,070,155&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_d0_uCAD_zSBebhQLNzj3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(111,230&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(111,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eifrs-full--LeaseLiabilities_iI_d0_uCAD_z7qnZycDfpe1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,226,882&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(1,226,882&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--LoanPayable_iI_d0_uCAD_z1n25mscaJq9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,721,868&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(9,721,868&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--DeferredTaxLiabilities_iNI_di0_uCAD_zREfbST98GL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iNI_di0_uCAD_zKWSh69zpkKb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Derivative liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,796&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(24,796&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eifrs-full--OtherNoncurrentLiabilities_iNI_di0_uCAD_zG8dTX7ZQWUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--TotalCashAndCashEquivalents_iI_d0_uCAD_zwdOMAYgam06" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;29,137,969&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(4,081,941&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;25,056,028&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: italic"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20250630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zkLKBzIrlQxf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZa9CRsRWwKf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVPt4C1zbqi3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 3&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250630_zijftdAYuHR1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--OtherCashAndCashEquivalents_iI_d0_uCAD_zKPzBJjuaYQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;17,829,149&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;17,829,149&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eifrs-full--CurrentInterestReceivable_iI_d0_uCAD_zFLwdlfC40l8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term loan receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,046,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,046,450&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eifrs-full--ShorttermInvestmentsClassifiedAsCashEquivalents_iI_d0_uCAD_zQ2Yb5BDRLKa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,660,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,660,738&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eifrs-full--InterestReceivable_iIP3ifrs-full--ShorttermInvestmentsClassifiedAsCashEquivalents_d0_uCAD_zuMAUrTeqFA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Long-term loan receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,128,932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,128,932&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--LongtermInvestment_iI_d0_uCAD_zAhHnwH5h7El" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Long-term investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,203,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;5,203,071&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--AccountsPayableAndAccruedLiabilities_iI_d0_uCAD_z5zl1omP1SRa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,646,662&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(1,646,662&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_d0_uCAD_z6NeohOHLgje" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(127,925&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(127,925&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--DeferredTaxLiabilities_iNI_di0_uCAD_zSDgI0bDuyu1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iNI_di0_uCAD_zXuqERxRLnR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Derivative liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(111,913&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(111,913&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--TotalCashAndCashEquivalents_iI_d0_uCAD_zj2LcSz6yrxc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;22,918,371&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(7,168,781&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;15,749,590&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A0_zN5cApLf4708" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;As
                          at December 31, 2025, the Company&#x2019;s financial instruments carried at fair value consisted of its
                          cash, short-term and long-term investments, accounts payable and accrued liabilities, and due to related
                          parties which are classified as Level 1, and its short-term and long-term receivables, deferred liabilities,
                          derivative liabilities, and other liabilities, which have been classified as Level 2. There were no
                          transfers between Levels 2 and 3 for recurring fair value measurements during the periods ended December
                          31, 2025 and June 30, 2025. &lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialRiskManagementExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001430"
      unitRef="CAD">16141406</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001432"
      unitRef="CAD">17829149</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001433"
      unitRef="CAD">22973079</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001434"
      unitRef="CAD">7002625</ifrs-full:CurrentLiabilities>
    <ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities contextRef="From2025-07-01to2025-12-31" id="Fact001436">&lt;p id="xdx_893_eifrs-full--MaturityAnalysisForNonderivativeFinancialLiabilities_ztKTKPnSvoT5" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at December 31, 2025, the Company had the following undiscounted contractual obligations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B2_zaMvWRWadqw8" style="display: none; visibility: hidden"&gt;Schedule of contractual obligations&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zYivS4uCgoB3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Less than 1 year&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zA1eKf1EjAKc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;1 to 3 years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20251231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z5qINbf2ADk2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;3 to 5 years&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20251231_zX6TBDltexTk" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--TradeAndOtherCurrentPayables_iI_d0_uCAD_zCpawnJQNOmi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;1,070,155&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;1,070,155&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iNI_di0_uCAD_zevZmyi2KRpk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due to related parties&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;111,230&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;111,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_ecustom--LeaseLiabilities1_iI_d0_uCAD_zc6VvaRxlau3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;267,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;850,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;767,336&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,884,766&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eifrs-full--OtherPayables_iI_d0_uCAD_zNDRD4GFsy8j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,111,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;6,853,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;10,964,800&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--DeferredLiabilities_iI_d0_uCAD_zPqGa2FGv1Ai" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,116,125&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,116,125&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;10,232,250&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40E_eifrs-full--OtherNoncurrentLiabilities_iI_d0_uCAD_zWDjFVQoaJE" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--UndiscountedFinancialLiabilities_iI_d0_uCAD_zc26X7n8bJrb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;22,948,283&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;12,819,453&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;767,336&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;36,535,072&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ifrs-full:MaturityAnalysisForNonderivativeFinancialLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001438"
      unitRef="CAD">1070155</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001439"
      unitRef="CAD">0</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001440"
      unitRef="CAD">0</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001441"
      unitRef="CAD">1070155</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001443"
      unitRef="CAD">-111230</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001444"
      unitRef="CAD">-0</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001445"
      unitRef="CAD">-0</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001446"
      unitRef="CAD">-111230</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <fnuc:LeaseLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001448"
      unitRef="CAD">267102</fnuc:LeaseLiabilities1>
    <fnuc:LeaseLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001449"
      unitRef="CAD">850328</fnuc:LeaseLiabilities1>
    <fnuc:LeaseLiabilities1
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001450"
      unitRef="CAD">767336</fnuc:LeaseLiabilities1>
    <fnuc:LeaseLiabilities1
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001451"
      unitRef="CAD">1884766</fnuc:LeaseLiabilities1>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001453"
      unitRef="CAD">4111800</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001454"
      unitRef="CAD">6853000</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001455"
      unitRef="CAD">0</ifrs-full:OtherPayables>
    <ifrs-full:OtherPayables
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001456"
      unitRef="CAD">10964800</ifrs-full:OtherPayables>
    <fnuc:DeferredLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001458"
      unitRef="CAD">5116125</fnuc:DeferredLiabilities>
    <fnuc:DeferredLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001459"
      unitRef="CAD">5116125</fnuc:DeferredLiabilities>
    <fnuc:DeferredLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001460"
      unitRef="CAD">0</fnuc:DeferredLiabilities>
    <fnuc:DeferredLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001461"
      unitRef="CAD">10232250</fnuc:DeferredLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001463"
      unitRef="CAD">12271871</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001464"
      unitRef="CAD">0</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001465"
      unitRef="CAD">0</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001466"
      unitRef="CAD">12271871</ifrs-full:OtherNoncurrentLiabilities>
    <fnuc:UndiscountedFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_NotLaterThanOneYearMember"
      decimals="0"
      id="Fact001468"
      unitRef="CAD">22948283</fnuc:UndiscountedFinancialLiabilities>
    <fnuc:UndiscountedFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="0"
      id="Fact001469"
      unitRef="CAD">12819453</fnuc:UndiscountedFinancialLiabilities>
    <fnuc:UndiscountedFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="0"
      id="Fact001470"
      unitRef="CAD">767336</fnuc:UndiscountedFinancialLiabilities>
    <fnuc:UndiscountedFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001471"
      unitRef="CAD">36535072</fnuc:UndiscountedFinancialLiabilities>
    <fnuc:ScheduleOfFairValueMeasurementOfLiabilitiesTextBlock contextRef="From2025-07-01to2025-12-31" id="Fact001482">&lt;p id="xdx_898_ecustom--ScheduleOfFairValueMeasurementOfLiabilitiesTextBlock_zbkQKDxQ5pt4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BF_z2SiKpLkYes7" style="display: none; visibility: hidden"&gt;Schedule of Fair Value Measurements&lt;/span&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: italic"&gt;December 31, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_z4ILiaEVPl63" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zNiKza7GPGpl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20251231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zw9Ptxj4iQkf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 3&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20251231_zaj24ITegCzi" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--OtherCashAndCashEquivalents_iI_d0_uCAD_zhLZbbm1Dxwi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;16,141,406&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;16,141,406&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eifrs-full--CurrentInterestReceivable_iI_d0_uCAD_z8JItqFEZuxh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term loan receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;29,395,726&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;29,395,726&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eifrs-full--ShorttermInvestmentsClassifiedAsCashEquivalents_iI_d0_uCAD_zRuXnDMMug04" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3,402,202&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;3,402,202&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--LongtermInvestment_iI_d0_uCAD_zdCrMKVRz8Yl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Long-term investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10,775,746&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;10,775,746&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--AccountsPayableAndAccruedLiabilities_iI_d0_uCAD_zCTC3f2XB9fc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,070,155&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(1,070,155&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_d0_uCAD_zSBebhQLNzj3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(111,230&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(111,230&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eifrs-full--LeaseLiabilities_iI_d0_uCAD_z7qnZycDfpe1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,226,882&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(1,226,882&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_404_ecustom--LoanPayable_iI_d0_uCAD_z1n25mscaJq9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loan payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(9,721,868&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(9,721,868&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--DeferredTaxLiabilities_iNI_di0_uCAD_zREfbST98GL4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iNI_di0_uCAD_zKWSh69zpkKb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Derivative liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(24,796&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(24,796&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_408_eifrs-full--OtherNoncurrentLiabilities_iNI_di0_uCAD_zG8dTX7ZQWUk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Other liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(12,271,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--TotalCashAndCashEquivalents_iI_d0_uCAD_zwdOMAYgam06" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;29,137,969&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(4,081,941&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;25,056,028&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;





















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: italic"&gt;June 30, 2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20250630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zkLKBzIrlQxf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZa9CRsRWwKf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250630__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVPt4C1zbqi3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Level 3&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20250630_zijftdAYuHR1" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eifrs-full--OtherCashAndCashEquivalents_iI_d0_uCAD_zKPzBJjuaYQ3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;17,829,149&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-weight: bold; text-align: right"&gt;17,829,149&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_403_eifrs-full--CurrentInterestReceivable_iI_d0_uCAD_zFLwdlfC40l8" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Short-term loan receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,046,450&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,046,450&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_eifrs-full--ShorttermInvestmentsClassifiedAsCashEquivalents_iI_d0_uCAD_zQ2Yb5BDRLKa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Short-term investments&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,660,738&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,660,738&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_409_eifrs-full--InterestReceivable_iIP3ifrs-full--ShorttermInvestmentsClassifiedAsCashEquivalents_d0_uCAD_zuMAUrTeqFA2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Long-term loan receivable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,128,932&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,128,932&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40F_ecustom--LongtermInvestment_iI_d0_uCAD_zAhHnwH5h7El" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Long-term investment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5,203,071&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;5,203,071&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--AccountsPayableAndAccruedLiabilities_iI_d0_uCAD_z5zl1omP1SRa" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable and accrued liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,646,662&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(1,646,662&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_d0_uCAD_z6NeohOHLgje" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Due to related party&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(127,925&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(127,925&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_406_eifrs-full--DeferredTaxLiabilities_iNI_di0_uCAD_zSDgI0bDuyu1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Deferred liabilities&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(10,232,250&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eifrs-full--NoncurrentDerivativeFinancialLiabilities_iNI_di0_uCAD_zXuqERxRLnR4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;Derivative liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(111,913&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(111,913&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_405_ecustom--TotalCashAndCashEquivalents_iI_d0_uCAD_zj2LcSz6yrxc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;22,918,371&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;(7,168,781&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;&#x2014;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"&gt;15,749,590&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</fnuc:ScheduleOfFairValueMeasurementOfLiabilitiesTextBlock>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001484"
      unitRef="CAD">16141406</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001485"
      unitRef="CAD">0</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001486"
      unitRef="CAD">0</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001487"
      unitRef="CAD">16141406</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001489"
      unitRef="CAD">0</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001490"
      unitRef="CAD">29395726</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001491"
      unitRef="CAD">0</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001492"
      unitRef="CAD">29395726</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001494"
      unitRef="CAD">3402202</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001495"
      unitRef="CAD">0</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001496"
      unitRef="CAD">0</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001497"
      unitRef="CAD">3402202</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001499"
      unitRef="CAD">10775746</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001500"
      unitRef="CAD">0</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001501"
      unitRef="CAD">0</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001502"
      unitRef="CAD">10775746</fnuc:LongtermInvestment>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001504"
      unitRef="CAD">-1070155</fnuc:AccountsPayableAndAccruedLiabilities>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001505"
      unitRef="CAD">0</fnuc:AccountsPayableAndAccruedLiabilities>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001506"
      unitRef="CAD">0</fnuc:AccountsPayableAndAccruedLiabilities>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001507"
      unitRef="CAD">-1070155</fnuc:AccountsPayableAndAccruedLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001509"
      unitRef="CAD">-111230</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001510"
      unitRef="CAD">0</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001511"
      unitRef="CAD">0</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001512"
      unitRef="CAD">-111230</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001514"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001515"
      unitRef="CAD">-1226882</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001516"
      unitRef="CAD">0</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001517"
      unitRef="CAD">-1226882</ifrs-full:LeaseLiabilities>
    <fnuc:LoanPayable
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001519"
      unitRef="CAD">0</fnuc:LoanPayable>
    <fnuc:LoanPayable
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001520"
      unitRef="CAD">-9721868</fnuc:LoanPayable>
    <fnuc:LoanPayable
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001521"
      unitRef="CAD">0</fnuc:LoanPayable>
    <fnuc:LoanPayable
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001522"
      unitRef="CAD">-9721868</fnuc:LoanPayable>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001524"
      unitRef="CAD">-0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001525"
      unitRef="CAD">10232250</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001526"
      unitRef="CAD">-0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001527"
      unitRef="CAD">10232250</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001529"
      unitRef="CAD">-0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001530"
      unitRef="CAD">24796</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001531"
      unitRef="CAD">-0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001532"
      unitRef="CAD">24796</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001534"
      unitRef="CAD">-0</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001535"
      unitRef="CAD">12271871</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001536"
      unitRef="CAD">-0</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001537"
      unitRef="CAD">12271871</ifrs-full:OtherNoncurrentLiabilities>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001539"
      unitRef="CAD">29137969</fnuc:TotalCashAndCashEquivalents>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001540"
      unitRef="CAD">-4081941</fnuc:TotalCashAndCashEquivalents>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001541"
      unitRef="CAD">0</fnuc:TotalCashAndCashEquivalents>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001542"
      unitRef="CAD">25056028</fnuc:TotalCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001553"
      unitRef="CAD">17829149</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001554"
      unitRef="CAD">0</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001555"
      unitRef="CAD">0</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:OtherCashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001556"
      unitRef="CAD">17829149</ifrs-full:OtherCashAndCashEquivalents>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001558"
      unitRef="CAD">0</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001559"
      unitRef="CAD">2046450</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001560"
      unitRef="CAD">0</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:CurrentInterestReceivable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001561"
      unitRef="CAD">2046450</ifrs-full:CurrentInterestReceivable>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001563"
      unitRef="CAD">1660738</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001564"
      unitRef="CAD">0</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001565"
      unitRef="CAD">0</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001566"
      unitRef="CAD">1660738</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:InterestReceivable
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001568"
      unitRef="CAD">0</ifrs-full:InterestReceivable>
    <ifrs-full:InterestReceivable
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001569"
      unitRef="CAD">1128932</ifrs-full:InterestReceivable>
    <ifrs-full:InterestReceivable
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001570"
      unitRef="CAD">0</ifrs-full:InterestReceivable>
    <ifrs-full:InterestReceivable
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001571"
      unitRef="CAD">1128932</ifrs-full:InterestReceivable>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001573"
      unitRef="CAD">5203071</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001574"
      unitRef="CAD">0</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001575"
      unitRef="CAD">0</fnuc:LongtermInvestment>
    <fnuc:LongtermInvestment
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001576"
      unitRef="CAD">5203071</fnuc:LongtermInvestment>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001578"
      unitRef="CAD">-1646662</fnuc:AccountsPayableAndAccruedLiabilities>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001579"
      unitRef="CAD">0</fnuc:AccountsPayableAndAccruedLiabilities>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001580"
      unitRef="CAD">0</fnuc:AccountsPayableAndAccruedLiabilities>
    <fnuc:AccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001581"
      unitRef="CAD">-1646662</fnuc:AccountsPayableAndAccruedLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001583"
      unitRef="CAD">-127925</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001584"
      unitRef="CAD">0</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001585"
      unitRef="CAD">0</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001586"
      unitRef="CAD">-127925</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001588"
      unitRef="CAD">-0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001589"
      unitRef="CAD">10232250</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001590"
      unitRef="CAD">-0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001591"
      unitRef="CAD">10232250</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001593"
      unitRef="CAD">-0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001594"
      unitRef="CAD">111913</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001595"
      unitRef="CAD">-0</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <ifrs-full:NoncurrentDerivativeFinancialLiabilities
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001596"
      unitRef="CAD">111913</ifrs-full:NoncurrentDerivativeFinancialLiabilities>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level1OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001598"
      unitRef="CAD">22918371</fnuc:TotalCashAndCashEquivalents>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001599"
      unitRef="CAD">-7168781</fnuc:TotalCashAndCashEquivalents>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-06-30_ifrs-full_Level3OfFairValueHierarchyMember"
      decimals="0"
      id="Fact001600"
      unitRef="CAD">0</fnuc:TotalCashAndCashEquivalents>
    <fnuc:TotalCashAndCashEquivalents
      contextRef="AsOf2025-06-30"
      decimals="0"
      id="Fact001601"
      unitRef="CAD">15749590</fnuc:TotalCashAndCashEquivalents>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001603">&lt;p id="xdx_80C_eifrs-full--DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_zAaPJj4qtUvi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;26.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_82E_zazDFAhD88ji"&gt;Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s E&amp;amp;E activities are subject to various laws and regulations governing the protection of the environment. These
laws and regulations are continually changing and generally becoming more restrictive. As at December 31, 2025, the Company believes
its operations are materially in compliance with all applicable laws and regulations. The Company expects to make future expenditures
to comply with such laws and regulations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of December 31, 2025, the Company has made a claim against certain former directors of the Company and their holding companies
for, among other things, breach of fiduciary duty as a result of, amongst other matters, of those directors approving changes
to the consulting agreements between the former CEO and COO and their holding companies, for termination payments of US $&lt;span id="xdx_90E_ecustom--ChangesMadeToConsultingAgreements_uUSD_c20250701__20251231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztXkPovMSlQ6" title="Changes made to Consulting Agreements"&gt;1,392,000&lt;/span&gt;
(to US $&lt;span id="xdx_900_ecustom--ChangesMadeToConsultingAgreements_uUSD_c20250701__20251231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zB3lJgt0fvd1" title="Changes made to Consulting Agreements"&gt;1,872,000&lt;/span&gt;) during a time where it was clear that a change of control of the Company was imminent and increased the range
of instances where they would be eligible for those payments. The Company takes the position that the amendments are void and
that the former CEO and COO were not entitled to any payments under their consulting agreements. The Company seeks to recover
the payments made to the former CEO and COO.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;As
of the date of approval of these consolidated financial statements, all defendants have now filed Statements of Defence. All defendants
have made counterclaims seeking indemnification for legal fees incurred in responding to this claim in relation to directors&#x2019;
indemnity agreements they have with the Company. The Company takes the position that the defendants are not eligible for indemnity
payments as a result of their breaches of fiduciary duties. The next step will be for the Company to file its Replies and Defences
to Counterclaims, and then proceed to discovery. As at December 31, 2025, as the outcome of the claims remains uncertain, the
Company had not recognized any contingent assets on the consolidated statements of financial position.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <fnuc:ChangesMadeToConsultingAgreements
      contextRef="From2025-07-012025-12-31_ifrs-full_BottomOfRangeMember"
      decimals="0"
      id="Fact001605"
      unitRef="USD">1392000</fnuc:ChangesMadeToConsultingAgreements>
    <fnuc:ChangesMadeToConsultingAgreements
      contextRef="From2025-07-012025-12-31_ifrs-full_TopOfRangeMember"
      decimals="0"
      id="Fact001607"
      unitRef="USD">1872000</fnuc:ChangesMadeToConsultingAgreements>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2025-07-01to2025-12-31" id="Fact001609">&lt;p id="xdx_80C_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zS48RxPS2F6l" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;27.&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_823_zXYiQ5TkfyYh"&gt;Subsequent
Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Acquisition
of GUE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 13, 2026, the Company completed the acquisition of the remaining &lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInJointVenture_pid_dp_uPure_c20260201__20260213__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zV843aH1f9mj" title="Acquisition of remaining"&gt;80.30&lt;/span&gt;% of the issued and outstanding shares of GUE.
The Acquisition was effected by way of a share scheme of arrangement and an option scheme of arrangement (together, the &#x201c;Schemes&#x201d;)
under Part 5.1 of the &lt;i&gt;Corporations Act 2001&lt;/i&gt; (Cth) of Australia, approved by GUE securityholders on January 27, 2026, and
sanctioned by the Federal Court of Australia on February 3, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
consideration for the Acquisition, the Company issued an aggregate of &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20260213__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zi2lEQ2Zn6cc" title="Aggregate of common shares"&gt;6,671,018&lt;/span&gt; common shares. &lt;span id="xdx_90C_eifrs-full--DescriptionOfAcquisitionOfEntityByMeansOfEquityIssue_c20260201__20260213__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zWX2jn7uQmm6" title="Description of acquisition"&gt;The Company also issued 393,108
warrants exercisable at US$4.8185 per share until April 21, 2028, and 522,519 warrants exercisable at US$5.5598 per share until
May 14, 2027, in replacement of all cancelled GUE options.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;/p&gt;





&lt;p style="margin: 0"&gt;&lt;/p&gt;















&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;Debt Settlement&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On February 24 and 25, 2026, the Company
settled an aggregate of US$&lt;span id="xdx_906_ecustom--TradePayablesSettledThroughIssuanceOfSharesAmount_uUSD_c20260224__20260225__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zV4EHVZbcdNi" title="Outstanding trade payables settled"&gt;1,000,000&lt;/span&gt; in outstanding trade payables through the issuance of &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20260225__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zjCtBJ28E9X" title="Trade payables settled through issuance of common shares"&gt;500,000&lt;/span&gt; common shares (&lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20260224__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember__custom--ShareIssuanceTrancheAxis__custom--TrancheOneMember_z6xmXZHO2ISc" title="Trade payables settled through issuance of common shares"&gt;100,000&lt;/span&gt; shares
and &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20260225__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember__custom--ShareIssuanceTrancheAxis__custom--TrancheTwoMember_zhYQ49rnHfjb" title="Trade payables settled through issuance of common shares"&gt;400,000&lt;/span&gt; shares, respectively)&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;RSU Redemptions &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, &lt;span id="xdx_90A_ecustom--NumberOfShareUnitsRedeemed_iI_pid_uShares_c20260101__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zRcMlC9Ajgub" title="RSUs redeemed"&gt;131,792&lt;/span&gt;
RSUs were redeemed for a cash equivalent amount of US$&lt;span id="xdx_907_eifrs-full--TradeAndOtherPayables_iI_uUSD_c20260101__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zDyd4Lu4Gv4b" title="Cash equivalent amount payable"&gt;499,955&lt;/span&gt;, which remains payable by the Company.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="text-decoration: underline"&gt;RSU Settlement and Debt Conversion Agreements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Subsequent to December 31, 2025, the Company
entered into arrangements concerning the settlement of certain RSU-related obligations. Those arrangements were superseded by settlement
and confirmation agreements effective June 30, 2026.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Effective June 30, 2026, the Company entered
into an RSU amending, confirmation and settlement agreement with certain RSU holders and related shareholders. Pursuant to the
agreement, &lt;span id="xdx_903_ecustom--CommonSharesConfirmedAndRecognized_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zRG3PkG0Sxvh" title="Common shares confirmed and recognized"&gt;7,098,872&lt;/span&gt; common shares were confirmed and recognized at a deemed price of US$&lt;span id="xdx_901_ecustom--CommonSharesConfirmedAndRecognizedDeemedPricePerShare_iI_pid_uUSDPShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zpEKVX7H9Fxd" title="Common shares confirmed and recognized deemed price per share"&gt;1.15&lt;/span&gt; per share as consideration for the
full and final release and settlement of claims relating to a prior RSU award. Following the settlement, no RSUs remain outstanding
in favour of the applicable participant. The executed agreement supports the characterization of the 7,098,872 shares as consideration
for the release, rather than settlement of the previously asserted cash equivalent amounts.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The agreement also settled a US$&lt;span id="xdx_908_ecustom--RestrictedShareUnitObligationSettledAmount_iI_uUSD_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_z2g6BnXNO3Yg" title="RSUs obligation settled"&gt;29,313&lt;/span&gt;
obligation relating to &lt;span id="xdx_90F_ecustom--NumberOfVestedRestrictedShareUnitsSettled_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zTd3UeEAwJLl" title="Vested RSUs settled"&gt;7,500&lt;/span&gt; vested RSUs through an aggregate of &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zH1ox28nCMg6" title="Shares issued for RSUs obligation settlement"&gt;25,489&lt;/span&gt; common shares at a deemed price of US$&lt;span id="xdx_905_eifrs-full--ParValuePerShare_iI_pid_uUSDPShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_z4zyM7RhgzTb" title="Deemed price per share"&gt;1.15&lt;/span&gt; per share. This
amount consists of &lt;span id="xdx_90D_ecustom--NumberOfSharesConfirmedAndRecognizedShareBasedSettlement_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zh7yF9M9jUWi" title="Shares issued for RSUs obligation settlement confirmed and recognized"&gt;13,055&lt;/span&gt; common shares that were confirmed and recognized and &lt;span id="xdx_90B_ecustom--NumberOfTreasurySharesToBeIssuedShareBasedSettlement_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zsjGsZdKDG" title="Shares issued for RSUs obligation settlement to be issued from treasury"&gt;12,434&lt;/span&gt; additional common shares to be issued from
treasury.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Also effective June 30, 2026, the Company
entered into an assignment, debt conversion and amending agreement pursuant to which A$6,332,613 of convertible note indebtedness
was converted into &lt;span id="xdx_909_ecustom--ConvertibleNoteIndebtednessConvertedIntoCommonSharesIssued_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zqiKRYrEScOl" title="Convertible note indebtedness converted into common shares issued"&gt;3,810,030&lt;/span&gt; common shares at a deemed price of US$&lt;span id="xdx_905_ecustom--ConvertibleNoteIndebtednessConvertedIntoCommonSharesDeemedPricePerShare_iI_pid_uUSDPShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zF8Uz1AoyL74" title="Convertible note indebtedness converted into common shares deemed price per share"&gt;1.15&lt;/span&gt; per share. Of those shares, &lt;span id="xdx_908_ecustom--NumberOfSharesConfirmedAndRecognizedDebtConversion_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zdPwM3A3gtw2" title="Convertible note indebtedness converted satisfied through confirmation and recognition"&gt;3,589,832&lt;/span&gt; common shares were
satisfied through the confirmation and recognition of existing common shares and &lt;span id="xdx_905_ecustom--NumberOfTreasurySharesToBeIssuedDebtConversion_iI_pid_uShares_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_zLawqBp7j0b2" title="Convertible note indebtedness converted to be issued from treasury"&gt;220,198&lt;/span&gt; additional common shares are to be issued
from treasury. The maturity date of a secured promissory note owing to the Company, with an aggregate balance of US$&lt;span id="xdx_908_ecustom--SecuredPromissoryNoteReceivableAmount_iI_uUSD_c20260630__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--SubsequentEventsMember_z2yY7x3GW7Ic" title="Secured promissory note owing to the Company"&gt;5,629,205&lt;/span&gt; as
at June 30, 2026, was extended to July 1, 2027.&lt;/p&gt;

</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="From2026-02-012026-02-13_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001611"
      unitRef="Pure">0.8030</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-02-13_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001613"
      unitRef="Shares">6671018</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:DescriptionOfAcquisitionOfEntityByMeansOfEquityIssue
      contextRef="From2026-02-012026-02-13_custom_SubsequentEventsMember"
      id="Fact001615">The Company also issued 393,108
warrants exercisable at US$4.8185 per share until April 21, 2028, and 522,519 warrants exercisable at US$5.5598 per share until
May 14, 2027, in replacement of all cancelled GUE options.</ifrs-full:DescriptionOfAcquisitionOfEntityByMeansOfEquityIssue>
    <fnuc:TradePayablesSettledThroughIssuanceOfSharesAmount
      contextRef="From2026-02-242026-02-25_custom_SubsequentEventsMember"
      decimals="0"
      id="Fact001625"
      unitRef="USD">1000000</fnuc:TradePayablesSettledThroughIssuanceOfSharesAmount>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-02-25_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001627"
      unitRef="Shares">500000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-02-24_custom_SubsequentEventsMember_custom_TrancheOneMember"
      decimals="INF"
      id="Fact001629"
      unitRef="Shares">100000</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-02-25_custom_SubsequentEventsMember_custom_TrancheTwoMember"
      decimals="INF"
      id="Fact001631"
      unitRef="Shares">400000</ifrs-full:NumberOfSharesIssued>
    <fnuc:NumberOfShareUnitsRedeemed
      contextRef="AsOf2026-01-01_custom_SubsequentEventsMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="INF"
      id="Fact001633"
      unitRef="Shares">131792</fnuc:NumberOfShareUnitsRedeemed>
    <ifrs-full:TradeAndOtherPayables
      contextRef="AsOf2026-01-01_custom_SubsequentEventsMember_ifrs-full_RestrictedShareUnitsMember"
      decimals="0"
      id="Fact001635"
      unitRef="USD">499955</ifrs-full:TradeAndOtherPayables>
    <fnuc:CommonSharesConfirmedAndRecognized
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001637"
      unitRef="Shares">7098872</fnuc:CommonSharesConfirmedAndRecognized>
    <fnuc:CommonSharesConfirmedAndRecognizedDeemedPricePerShare
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001639"
      unitRef="USDPShares">1.15</fnuc:CommonSharesConfirmedAndRecognizedDeemedPricePerShare>
    <fnuc:RestrictedShareUnitObligationSettledAmount
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="0"
      id="Fact001641"
      unitRef="USD">29313</fnuc:RestrictedShareUnitObligationSettledAmount>
    <fnuc:NumberOfVestedRestrictedShareUnitsSettled
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001643"
      unitRef="Shares">7500</fnuc:NumberOfVestedRestrictedShareUnitsSettled>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001645"
      unitRef="Shares">25489</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001647"
      unitRef="USDPShares">1.15</ifrs-full:ParValuePerShare>
    <fnuc:NumberOfSharesConfirmedAndRecognizedShareBasedSettlement
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001649"
      unitRef="Shares">13055</fnuc:NumberOfSharesConfirmedAndRecognizedShareBasedSettlement>
    <fnuc:NumberOfTreasurySharesToBeIssuedShareBasedSettlement
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001651"
      unitRef="Shares">12434</fnuc:NumberOfTreasurySharesToBeIssuedShareBasedSettlement>
    <fnuc:ConvertibleNoteIndebtednessConvertedIntoCommonSharesIssued
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001653"
      unitRef="Shares">3810030</fnuc:ConvertibleNoteIndebtednessConvertedIntoCommonSharesIssued>
    <fnuc:ConvertibleNoteIndebtednessConvertedIntoCommonSharesDeemedPricePerShare
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001655"
      unitRef="USDPShares">1.15</fnuc:ConvertibleNoteIndebtednessConvertedIntoCommonSharesDeemedPricePerShare>
    <fnuc:NumberOfSharesConfirmedAndRecognizedDebtConversion
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001657"
      unitRef="Shares">3589832</fnuc:NumberOfSharesConfirmedAndRecognizedDebtConversion>
    <fnuc:NumberOfTreasurySharesToBeIssuedDebtConversion
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="INF"
      id="Fact001659"
      unitRef="Shares">220198</fnuc:NumberOfTreasurySharesToBeIssuedDebtConversion>
    <fnuc:SecuredPromissoryNoteReceivableAmount
      contextRef="AsOf2026-06-30_custom_SubsequentEventsMember"
      decimals="0"
      id="Fact001661"
      unitRef="USD">5629205</fnuc:SecuredPromissoryNoteReceivableAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000231"
          xlink:label="Fact000231"
          xlink:type="locator"/>
        <link:footnote id="Footnote000317" xlink:label="Footnote000317" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">All
                                            Shares are shown on a post consolidation basis (Note 19)</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000231"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000238"
          xlink:label="Fact000238"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000238"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000250"
          xlink:label="Fact000250"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000250"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000257"
          xlink:label="Fact000257"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000257"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000274"
          xlink:label="Fact000274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000274"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000281"
          xlink:label="Fact000281"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000281"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000287"
          xlink:label="Fact000287"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000287"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000309"
          xlink:label="Fact000309"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000309"
          xlink:to="Footnote000317"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
